[
  {
    "question": "Are there microbes in human breast milk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Human breast milk is known to contain a variety of components that provide nutrition and immune protection to infants. Research has shown that breast milk also contains microbial communities, which are believed to play a role in shaping the infant's gut microbiome. The presence of microbes in breast milk has been confirmed through several studies, which have identified a range of bacterial species present in the milk.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can breastfeeding confer protection from type I diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Breastfeeding has been studied for its potential to provide protection against various diseases, including type I diabetes. Research has suggested that breastfeeding may have a protective effect, although the evidence is not conclusive. Some studies have found that exclusive breastfeeding for at least 3-4 months may reduce the risk of developing type I diabetes in children.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can pets affect infant microbiomed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Research has shown that exposure to pets in early life can have an impact on the development of an infant's microbiome. The microbiome refers to the collection of microorganisms living in and on the human body. Studies suggest that infants who grow up in households with pets may have a more diverse microbiome, which can potentially lead to better immune system development and reduced risk of allergies and asthma. This is often attributed to the increased exposure to a variety of microorganisms that pets bring into the home environment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between the human gut microbiome and depression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Research has shown that the human gut microbiome plays a significant role in various aspects of health, including mental health. Studies have found a link between the gut microbiome and depression, suggesting that an imbalance of gut bacteria, also known as dysbiosis, may contribute to the development of depressive symptoms. The gut-brain axis, a bidirectional communication network between the gut and the brain, allows for the exchange of signals and metabolites that can influence mood and behavior. Alterations in the gut microbiome have been observed in individuals with depression, and certain gut bacteria have been found to produce neurotransmitters and hormones that can affect mood regulation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is pembrolizumab effective against Ewing's sarcoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Pembrolizumab is an immunotherapy drug that has been effective against various types of cancer, including some sarcomas. Ewing's sarcoma is a rare type of cancer that typically affects bones or the soft tissue around them. Research into the effectiveness of pembrolizumab against Ewing's sarcoma is ongoing, with some clinical trials exploring its potential. However, as of my last update, there isn't conclusive evidence to widely establish its effectiveness specifically for Ewing's sarcoma, suggesting that while it may offer hope, it is not universally recognized as a standard treatment for this condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can gene therapy restore auditory function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Gene therapy has shown promise in treating genetic disorders, including those that affect hearing. Research has focused on using gene therapy to restore auditory function in individuals with genetic hearing loss. Several studies have demonstrated the potential of gene therapy to improve or restore hearing in animal models and human clinical trials.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does vesatolimod inhibit TLR7?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Vesatolimod is a drug that has been investigated for its potential therapeutic effects. To determine whether it inhibits TLR7, we need to consider what TLR7 is and how vesatolimod interacts with it. TLR7, or toll-like receptor 7, is a protein that plays a key role in the innate immune system, recognizing viral single-stranded RNA and triggering an immune response. Vesatolimod, on the other hand, is known to be a TLR7 agonist, which means it activates TLR7 rather than inhibiting it. Therefore, based on its mechanism of action as an agonist, vesatolimod does not inhibit TLR7 but instead stimulates its activity.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can simvastatin alleviate depressive symptoms?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Simvastatin is a statin medication primarily used to lower cholesterol levels and prevent cardiovascular disease. While its main use is not for treating depression, there has been some research into the potential effects of statins on depressive symptoms. Some studies suggest that statins, including simvastatin, may have anti-inflammatory properties and could potentially influence neurotransmitter systems in the brain, which might help alleviate depressive symptoms. However, the evidence is not conclusive, and more research is needed to fully understand any potential antidepressant effects of simvastatin.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does gepotidacin activate bacterial topoisomerase?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Gepotidacin is a novel antibiotic that targets bacterial topoisomerase enzymes, which are essential for bacterial DNA replication and transcription. To determine if gepotidacin activates bacterial topoisomerase, we need to consider its mechanism of action. Gepotidacin works by inhibiting bacterial topoisomerase, specifically topoisomerase II (also known as DNA gyrase) and topoisomerase IV, which are critical for bacterial DNA replication and cell division.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is obesity related to cognitive decline?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Obesity has been linked to various health issues, including an increased risk of cognitive decline. Research suggests that excess body weight, particularly around the abdominal area, can lead to inflammation and insulin resistance, which may negatively impact brain health and contribute to cognitive impairment. Studies have also found associations between obesity and a higher risk of dementia, including Alzheimer's disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are whole-genome duplications more divergent than small-scale duplications in yeast?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Whole-genome duplications result in the copying of an entire genome, while small-scale duplications involve the duplication of a smaller segment of DNA. The divergence of these duplicated regions can be influenced by various factors, including the mechanism of duplication, the rate of mutation, and the effects of natural selection. In yeast, studies have shown that whole-genome duplications can lead to greater divergence between the duplicated regions due to the increased genetic redundancy and the subsequent relaxation of selective pressure. This allows for more pronounced genetic drift and the accumulation of mutations, leading to greater divergence. On the other hand, small-scale duplications may be subject to stronger selective pressure, as the duplicated region is smaller and may be more likely to be retained if it confers a functional advantage.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do yeast LTR give rise to circular DNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Yeast LTRs, or Long Terminal Repeats, are retrotransposon elements that can replicate and insert themselves into different locations in the genome. The process of replication and integration can involve the formation of circular DNA intermediates. This is because the reverse transcription of the retrotransposon RNA genome into DNA can occur in a way that leads to the formation of circular DNA molecules before they integrate into the host genome.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Copy Number Variants (CNVs) depleted in regions of low mappability?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Copy Number Variants (CNVs) are known to be affected by various genomic factors, including mappability. Regions of low mappability can make it difficult to accurately detect CNVs due to the complexity of aligning sequencing reads to these areas. As a result, it is reasonable to consider that CNVs might be depleted in regions where the mappability is low, simply because these regions are harder to analyze and CNVs within them might be overlooked or misinterpreted.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can mitochondria be inherited by both parents in humans?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Mitochondria are inherited solely from mothers in humans, as only egg cells contribute mitochondria to the fertilized egg. Sperm typically do not pass on their mitochondria during fertilization.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Machine learning methods have been increasingly used in the field of psychiatry to predict the severity of various mental health disorders, including major depressive disorder (MDD). These methods involve training algorithms on large datasets of patient information, including demographic, clinical, and genetic data, to identify patterns and predictors of disease severity. By analyzing these patterns, machine learning models can predict the likelihood of severe MDD in individual patients, allowing for early intervention and personalized treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between suicide and autism in adolescents, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Research has indicated that adolescents with autism spectrum disorder (ASD) may have a higher risk of suicidal ideation and behaviors compared to their neurotypical peers. Factors such as social isolation, bullying, mental health comorbidities, and difficulties with social interactions and communication may contribute to this increased risk. Studies have shown that individuals with ASD are more likely to experience suicidal thoughts and attempts, highlighting the need for tailored support and interventions to address these concerns.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does allele phasing improve the phylogenetic utility of ultraconserved elements?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Allele phasing is a process that involves determining the haplotype of an individual, which can be useful in phylogenetic analysis. Ultraconserved elements are highly conserved genomic regions that can be used as markers for phylogenetic analysis. By phasing alleles, researchers can reconstruct the haplotypes of individuals and gain more accurate information about their evolutionary relationships. This can potentially improve the phylogenetic utility of ultraconserved elements by providing more detailed and accurate information about the evolutionary history of a species.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are ultraconserved enhancers important for normal development?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ultraconserved enhancers are sequences of DNA that are highly conserved across different species, suggesting they have important functions. They are often associated with genes involved in development and are thought to play a crucial role in regulating gene expression during embryonic development. Disruptions in these enhancers have been linked to developmental abnormalities and diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Bobble head doll syndrome associated with hydrocephalus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bobble head doll syndrome is a rare condition characterized by a distinctive head bobbing or nodding motion, often associated with various neurological disorders. One of the conditions linked to this syndrome is hydrocephalus, which involves an accumulation of cerebrospinal fluid in the brain, leading to increased intracranial pressure and potentially causing the bobbing motion.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tisagenlecleucel effective for B-Cell Lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tisagenlecleucel is a CAR-T cell therapy approved for certain types of blood cancers, including B-cell lymphoma. It works by using a patient's own T cells to fight cancer. The therapy has shown significant efficacy in clinical trials for patients with relapsed or refractory B-cell lymphoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is durvalumab used for lung cancer treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Durvalumab is a medication used in the treatment of various types of cancer. It is an immune checkpoint inhibitor that targets the PD-L1 protein. The primary use of durvalumab has been in the treatment of non-small cell lung cancer (NSCLC) and urothelial carcinoma. Specifically, for lung cancer, durvalumab is used as a consolidation therapy for patients with stage III NSCLC who have not progressed after chemoradiotherapy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Epidural anesthesia is a common pain management technique used during labor, and its effects on the infant, particularly on the Apgar score, have been studied. The Apgar score is a method to quickly summarize the health of newborn children against infant mortality. Several factors can influence the Apgar score, including the method of delivery and the use of anesthesia. Research indicates that epidural anesthesia, when properly administered, does not have a significant negative impact on the Apgar score of the infant. In fact, effective pain management can lead to a more controlled and less stressful delivery environment, potentially benefiting both the mother and the baby.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Has Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) been reported to be a plasminogen receptor in pathogenic bacteria?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a protein that has been implicated in various cellular processes, including glycolysis. Some studies have suggested that GAPDH may also play a role in the pathogenesis of certain bacteria by interacting with host proteins, such as plasminogen. Plasminogen is a protein that is involved in the fibrinolytic system and has been shown to bind to the surface of certain pathogenic bacteria, including Streptococcus pyogenes and Streptococcus pneumoniae.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can exposure to heavy metals like lead(Pb) or cadmium(Cd) cause changes in DNA methylation patterns in Isoetes sinensis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Exposure to heavy metals can cause various biological effects, including changes in DNA methylation patterns. Isoetes sinensis, a plant species, may experience epigenetic modifications due to heavy metal stress. Heavy metals like lead and cadmium are known to induce oxidative stress and damage to DNA, which can lead to alterations in DNA methylation patterns. These changes can affect gene expression and potentially impact the plant's development, growth, and response to environmental stresses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "In clinical trials, the H3 R antagonist CEP-26401 has a positive effect on cognition, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the question about the effect of H3 R antagonist CEP-26401 on cognition in clinical trials.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Yeast prions have been studied for their potential to model human amyloid diseases, which are characterized by the accumulation of misfolded proteins. The ability of yeast to propagate and study prions in a controlled environment has made them an attractive model system. Yeast prions can provide insights into the mechanisms of prion formation, propagation, and transmission, which can be applied to understanding human amyloid diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a link between BCL11B haploinsufficiency and syndromic neurodevelopmental delay?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"BCL11B is a gene that plays a crucial role in neurodevelopment. Haploinsufficiency of this gene has been associated with various neurodevelopmental disorders. Research studies have identified a link between BCL11B haploinsufficiency and syndromic neurodevelopmental delay, characterized by intellectual disability, developmental delay, and other neurological features.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is the PINES framework being used for the prediction of coding variants?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The PINES framework is a method used in genomics for predicting the impact of non-coding variants, but the question asks about coding variants. Coding variants are changes in the DNA sequence that affect the coding regions of genes, potentially altering the protein sequence. The PINES framework focuses on non-coding regions, which do not encode proteins but can still affect gene regulation and expression.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Tecovirimat effective for smallpox?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tecovirimat, also known as Tpoxx, is an antiviral medication that has been approved for the treatment of smallpox. It works by inhibiting the replication of the virus that causes smallpox. The drug has been shown to be effective in reducing the severity and duration of smallpox symptoms in animal models and in limited human clinical trials.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is cabozantinib effective for hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cabozantinib is a tyrosine kinase inhibitor that has been studied for its efficacy in treating various types of cancer, including hepatocellular carcinoma (HCC). The drug works by inhibiting multiple receptor tyrosine kinases, which are involved in tumor growth and angiogenesis. Clinical trials have investigated the use of cabozantinib in patients with advanced HCC, and the results have shown promising activity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Baloxavir effective for influenza?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Baloxavir is an antiviral medication that has been shown to be effective in treating influenza. It works by inhibiting the cap-dependent endonuclease enzyme, which is necessary for the replication of the influenza virus. Clinical trials have demonstrated that baloxavir can reduce the duration and severity of influenza symptoms, as well as reduce the risk of complications. The medication has been approved for use in several countries, including the United States and Japan, for the treatment of acute, uncomplicated influenza in patients 12 years of age and older.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is ibudilast effective for multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ibudilast is a medication that has been studied for its potential to treat multiple sclerosis. It has anti-inflammatory properties and has been shown to have neuroprotective effects. Some clinical trials have suggested that ibudilast may be effective in reducing the progression of disability in patients with multiple sclerosis, particularly in those with progressive forms of the disease. However, more research is needed to fully understand its efficacy and safety.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Adar3 involved in learning and memory?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Adar3, also known as adenosine deaminase acting on RNA 3, is an enzyme that has been studied for its potential role in various biological processes, including learning and memory. Research has suggested that Adar3 may play a role in the regulation of RNA editing, which is important for the proper functioning of the nervous system and may be involved in learning and memory.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the relationship between genetic deletions and their impact on cancer survival rates, specifically focusing on the deletion at 6q24.2-26 in patients with high-grade serous ovarian carcinoma (HGSOCs). The association between specific genetic alterations and survival outcomes in cancer can provide valuable insights into the biological behavior of the disease and potential therapeutic targets. Deletions in certain regions of the genome can lead to the loss of tumor suppressor genes, which might intuitively seem to worsen prognosis. However, the complex interplay of genetic alterations in cancer can sometimes lead to unexpected outcomes, where certain deletions might confer a survival advantage by disrupting oncogenic pathways or by being associated with a tumor phenotype that is more susceptible to treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is  LRP1 interacting with Urokinase receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) is known to interact with various receptors and proteins, including the urokinase receptor, also known as uPAR. The interaction between LRP1 and uPAR has been studied in the context of cell migration, proteolysis, and signal transduction. LRP1 can bind to uPAR and influence its activity, thereby modulating cellular processes such as migration and invasion.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is chlorotoxin a peptide?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Chlorotoxin is a molecule that has been studied for its potential to target and bind to cancer cells, specifically to the matrix metalloprotease-2 (MMP-2) protein on their surface. It is a 36-amino acid peptide, which means it is composed of a chain of amino acids, making it a peptide by definition.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is selenocysteine an aminoacid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Selenocysteine is considered the 21st amino acid, incorporated into proteins through a unique translation process. It contains selenium instead of sulfur, which is found in cysteine. This distinction makes it a special case among amino acids, as it is not one of the 20 standard amino acids encoded by the universal genetic code but is nonetheless crucial for the function of certain proteins, particularly enzymes involved in antioxidant defense systems.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Phospholipid hydroperoxide glutathione peroxidase is an enzyme that reduces hydroperoxides and is known to contain selenium in the form of selenocysteine in its active site, which is a characteristic of selenoproteins.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is P. gingivalis bacteria found in brain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the relationship between Porphyromonas gingivalis (P. gingivalis), a type of bacteria commonly associated with periodontal disease, and its potential presence in the brain. Research has explored the connection between periodontal pathogens and various systemic diseases, including those affecting the brain. Studies have suggested that P. gingivalis can be found in the brain of individuals with certain neurological conditions, implying a potential link between periodontal disease and neurodegenerative diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "There is no drug available to prevent HIV infection, Pre-exposure prophylaxis (PrEP), yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Pre-exposure prophylaxis (PrEP) is a medication regimen taken by individuals who are HIV-negative to prevent infection. The statement claims there is no drug available to prevent HIV infection, but PrEP is indeed a preventive measure.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is cariprazine effective for treatment of bipolar disorder?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cariprazine is an atypical antipsychotic that has been studied for its efficacy in treating bipolar disorder. It has shown promise in clinical trials for the treatment of manic or mixed episodes associated with bipolar I disorder. The medication works by acting on dopamine and serotonin receptors in the brain, which are involved in mood regulation. Its effectiveness has been demonstrated in reducing symptoms of mania and improving overall functioning in patients with bipolar disorder.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does Groucho related gene 5 (GRG5) have a role only in late development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Analyzing the question about the role of Groucho related gene 5 (GRG5) in development, it is necessary to consider what is known about its functions and expression patterns. If GRG5 is involved in developmental processes, determining whether its role is restricted to late development or if it also participates in earlier stages is crucial. The question hints at a specific temporal involvement of GRG5 in development, suggesting a focus on its late developmental roles. However, without specific details on GRG5's expression and functional studies across different developmental stages, it's challenging to conclusively state its exclusive role in late development. Considering the complexity of developmental biology and the multifaceted roles genes can play, it's plausible that GRG5 could be involved in both early and late developmental processes, given the broad range of functions Groucho-related genes are known to have in development and cell differentiation.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is the yeast (Saccharomyces cerevisiae) genome organized into topologically associated domains (TADs)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The yeast Saccharomyces cerevisiae has a relatively small and well-studied genome. Research has shown that its genome is organized into distinct chromosomal domains. Topologically associated domains (TADs) are a feature of genome organization in many organisms, characterized by regions of the chromosome that interact more frequently with each other than with other regions. Studies in yeast have identified similar domain-like structures, suggesting a level of chromatin organization that could be analogous to TADs in other species.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any role for HUWE1 in MYC signalling?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"HUWE1 is an E3 ubiquitin ligase that has been implicated in various cellular processes, including cell cycle regulation, apoptosis, and DNA damage response. MYC is a transcription factor that plays a critical role in cell proliferation, differentiation, and tumorigenesis. Recent studies have suggested that HUWE1 may regulate MYC signalling by modulating the stability and activity of MYC protein. HUWE1 has been shown to interact with MYC and regulate its ubiquitination and degradation, thereby influencing MYC-mediated transcriptional activity and cell growth.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"TIAM1 is a guanine nucleotide exchange factor that has been implicated in the regulation of various cellular processes, including cell migration and invasion. In the context of colorectal cancer (CRC), research has suggested that TIAM1 may play a role in promoting tumor progression. Studies have shown that TIAM1 expression is often upregulated in CRC tissues and that this upregulation is associated with more aggressive tumor behavior and poorer patient outcomes. Furthermore, functional studies have demonstrated that TIAM1 can enhance the migratory and invasive capabilities of CRC cells, which are key steps in the metastatic process. Therefore, based on the available evidence, it appears that TIAM1 does indeed favor tumor progression in CRC.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Are de novo mutations in regulatory elements responsible for neurodevelopmental disorders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"De novo mutations in regulatory elements have been implicated in various neurodevelopmental disorders, such as autism spectrum disorder and intellectual disability. These mutations can disrupt the normal functioning of genes involved in brain development, leading to abnormal brain function and behavior. Research has shown that de novo mutations in regulatory elements, such as enhancers and promoters, can contribute to the development of neurodevelopmental disorders by altering gene expression patterns.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are recessive coding variants responsible for the majority of undiagnosed nonconsanguineous individuals?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of recessive coding variants in genetic diseases, particularly in nonconsanguineous individuals. Recessive coding variants are changes in the DNA code that can lead to disease when an individual inherits two copies of the variant, one from each parent. Nonconsanguineous individuals are those whose parents are not closely related. The question of whether recessive coding variants are responsible for the majority of undiagnosed cases in this population involves understanding the genetic basis of diseases and how these variants contribute to them.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is the NLM medical text indexer (MTI) still useful and relevant?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The NLM Medical Text Indexer (MTI) is a tool developed by the National Library of Medicine to index and organize medical texts. To determine its usefulness and relevance, we need to consider its current functionality, user base, and the overall landscape of medical text indexing. The MTI was designed to facilitate the indexing of biomedical literature, which is a crucial task for researchers, clinicians, and students. However, the rapid evolution of natural language processing (NLP) and machine learning technologies has led to the development of more advanced and sophisticated tools for text analysis and indexing. Despite this, the MTI may still be useful for specific tasks or communities, particularly those with limited resources or expertise in NLP.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is cohesin linked to myeloid differentiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cohesin is a protein complex that plays a crucial role in chromosome segregation and gene expression. Recent studies have shown that cohesin is also involved in the regulation of hematopoiesis, including myeloid differentiation. Myeloid differentiation is the process by which hematopoietic stem cells differentiate into myeloid cells, such as granulocytes and monocytes. Cohesin has been shown to regulate the expression of genes involved in myeloid differentiation, and mutations in cohesin subunits have been associated with myeloid malignancies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Erythropoietin has been studied for its potential neuroprotective effects and its role in treating various neurological disorders, including amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord, leading to loss of muscle control. The effectiveness of erythropoietin for treating ALS would depend on its ability to protect motor neurons from degeneration or to slow down the progression of the disease. While erythropoietin has shown promise in preclinical studies, its efficacy in human clinical trials for ALS treatment is still under investigation and debate.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mogamulizumab is a monoclonal antibody used in the treatment of certain types of cancer, including cutaneous T-cell lymphoma. It targets the CCR4 receptor, which is often expressed on the surface of malignant T cells in this disease. By binding to CCR4, mogamulizumab helps to eliminate these cancerous cells, thereby reducing tumor burden and alleviating symptoms. Given its mechanism of action and clinical efficacy, mogamulizumab has been approved for the treatment of cutaneous T-cell lymphoma in various countries.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ivosidenib is an IDH1 inhibitor used in the treatment of acute myeloid leukemia (AML). The FDA approval status of ivosidenib for AML should be checked for the most current information. As of my last update, ivosidenib has been approved for the treatment of adult patients with relapsed or refractory AML with a susceptible IDH1 mutation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can CPX-351 be used for the treatment of tuberculosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"CPX-351 is a liposomal formulation of cytarabine and daunorubicin, used for the treatment of acute myeloid leukemia. There is no evidence to suggest that CPX-351 is used for the treatment of tuberculosis, which is a bacterial infection caused by Mycobacterium tuberculosis and typically treated with antibiotics.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does lucatumumab bind to CD140?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Lucatumumab is a monoclonal antibody that targets CD40, not CD140. CD140 refers to the platelet-derived growth factor receptors PDGFR-alpha and PDGFR-beta. Therefore, based on the information about lucatumumab's target, it does not bind to CD140.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is lucatumumab a polyclonal antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Lucatumumab is a monoclonal antibody, which is different from a polyclonal antibody. Monoclonal antibodies are made by identical immune cells, cloned from a unique parent cell, and are directed against a single specific antigen. Polyclonal antibodies, on the other hand, are a mixture of different antibodies that are directed against different antigens. Given this distinction, we can determine if lucatumumab is a polyclonal antibody.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can midostaurin inhibit angiogenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Midostaurin is a tyrosine kinase inhibitor with multiple targets, including some involved in angiogenesis. Angiogenesis is the process of forming new blood vessels, which is crucial for tumor growth and metastasis. By inhibiting certain kinases, midostaurin could potentially interfere with signaling pathways that promote angiogenesis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can enasidenib be used for the treatment of acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Enasidenib is an isocitrate dehydrogenase-2 (IDH2) inhibitor used in the treatment of certain types of cancer. It has been specifically approved for the treatment of acute myeloid leukemia (AML) with an IDH2 mutation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is lithium effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Lithium has been studied for its potential therapeutic effects on amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease. Research has explored whether lithium, known for its mood-stabilizing properties in psychiatric disorders, could also exert neuroprotective effects that might slow the progression of ALS. However, the effectiveness of lithium in treating ALS has been a subject of debate and investigation.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is celecoxib effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that has been studied for its potential effects on various diseases, including amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. The effectiveness of celecoxib for the treatment of ALS has been explored in research, considering its anti-inflammatory properties and potential neuroprotective effects. However, the primary question revolves around whether celecoxib has shown significant benefits in treating or slowing the progression of ALS.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is pacritinib effective for treatment of myelofibrosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Pacritinib is a kinase inhibitor with activity against JAK2 and IRAK1, which has been investigated for the treatment of myelofibrosis, a type of bone marrow disorder. Clinical trials have evaluated its efficacy and safety in patients with myelofibrosis, including those with severe thrombocytopenia. The results of these trials have shown that pacritinib can reduce spleen volume and improve symptoms in some patients, but its effectiveness may vary depending on the individual and the specific characteristics of their disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do raspberries improve postprandial glucose and acute and chronic inflammation in adults with type 2 Diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Raspberries have been studied for their potential health benefits, including their impact on postprandial glucose and inflammation in adults with type 2 diabetes. The fiber, anthocyanins, and other polyphenols in raspberries may help improve insulin sensitivity and reduce inflammation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has Hesperidin any role as a Neuroprotective Agent?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Hesperidin is a flavonoid glycoside found in citrus fruits, and research has been conducted to explore its potential health benefits, including its effects on the nervous system. Studies have investigated the neuroprotective properties of hesperidin, examining its ability to protect against neurodegenerative diseases and conditions, such as Alzheimer's and Parkinson's. The potential mechanisms of hesperidin's neuroprotective effects include antioxidant activity, anti-inflammatory properties, and the ability to improve blood flow to the brain.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there tools for visualizing and processing long-read sequencing data?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Long-read sequencing data can be complex and require specialized tools for visualization and processing. Several tools have been developed to address this need, including those for aligning, assembling, and visualizing long-read data.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a deep-learning algorithm for protein solubility prediction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the current state of research in bioinformatics and deep learning, particularly in the area of protein solubility prediction. Protein solubility is a critical factor in various biotechnological and biomedical applications, including drug development and protein engineering. Deep learning algorithms have been increasingly applied to predict protein properties due to their ability to learn complex patterns from large datasets.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is cabozantinib effective for Hepatocellular Carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cabozantinib is a tyrosine kinase inhibitor that has been studied for its efficacy in treating various types of cancer, including Hepatocellular Carcinoma (HCC). The drug has shown promise in clinical trials for its ability to inhibit tumor growth and improve survival rates in patients with advanced HCC. Specifically, cabozantinib has been found to be effective in treating HCC patients who have previously received sorafenib, a standard treatment for the disease. The CELESTIAL trial, a phase 3 clinical trial, demonstrated that cabozantinib significantly improved overall survival and delayed disease progression in patients with advanced HCC.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is dupilumab effective for treatment of asthma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Dupilumab is a medication used to treat certain conditions by reducing inflammation. It is known to be effective in treating atopic dermatitis and has been approved for use in asthma patients with specific characteristics, such as eosinophilic asthma. The effectiveness of dupilumab for asthma treatment, particularly for severe asthma with an eosinophilic phenotype, has been demonstrated in clinical trials, showing improvements in lung function and reductions in exacerbations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is verubecestat effective for Alzheimerâ€™s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Verubecestat is an investigational drug that was being studied for the treatment of Alzheimer's disease. It was designed to inhibit the beta-site amyloid precursor protein cleaving enzyme (BACE1), which is involved in the production of beta-amyloid peptides that accumulate in the brains of people with Alzheimer's disease. However, in 2018, the drug's developer, Merck, announced that it was discontinuing the development of verubecestat due to lack of efficacy in phase 3 clinical trials.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does Eucommia ulmoides leaf extract ameliorates steatosis/fatty liver induced by high-fat diet?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Eucommia ulmoides is a plant used in traditional Chinese medicine, and its leaf extract has been studied for various potential health benefits. Steatosis, or fatty liver, is a condition characterized by the accumulation of excess fat in the liver, often induced by a high-fat diet. To determine if Eucommia ulmoides leaf extract ameliorates steatosis/fatty liver, we need to consider the biochemical effects of the extract on liver fat metabolism and its potential anti-inflammatory and antioxidant properties.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there ultraconserved regions in the budding yeast (Saccharomyces cerevisiae)?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Ultraconserved regions are typically found in the genomes of higher organisms, such as humans and other animals, where they are defined as stretches of DNA that are absolutely conserved between species. However, the concept of ultraconservation can also be applied to other organisms, including yeast. In the case of the budding yeast Saccharomyces cerevisiae, while there may not be ultraconserved regions in the classical sense, there are indeed highly conserved regions within its genome, particularly in areas crucial for basic cellular functions and survival.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Are there graph kernel libraries available implemented in JAVA?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the availability of graph kernel libraries in Java. Graph kernels are used in machine learning and data mining to compute the similarity between graphs, which is essential in various applications such as graph classification and clustering. Several libraries provide implementations of graph kernels, and some of them are written in Java or have Java interfaces.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can you computationally predict Molecular Recognition Features (MoRFs) regions in Intrinsically Disordered Proteins (IDPs)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the current state of computational biology and its capabilities in predicting specific features of proteins, particularly Intrinsically Disordered Proteins (IDPs) and their Molecular Recognition Features (MoRFs). IDPs are proteins that lack a stable three-dimensional structure under physiological conditions, yet they are involved in crucial biological processes. MoRFs are regions within these disordered proteins that can undergo disorder-to-order transitions upon binding to their partners, facilitating molecular recognition. The prediction of MoRFs is challenging due to the intrinsic disorder of these regions, which do not fit the traditional structural biology paradigms. However, advances in computational methods, including machine learning algorithms and bioinformatics tools, have made it possible to predict MoRFs with a certain degree of accuracy. These methods often rely on the analysis of sequence characteristics, such as hydrophobicity, charge, and the presence of specific motifs known to be involved in protein-protein interactions. Given the complexity of IDPs and the dynamic nature of MoRFs, the development of accurate predictive models requires large datasets and sophisticated computational approaches.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there tools for reviewing variant calls?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To address this question, we need to consider the process of variant calling in bioinformatics and genomics. Variant calling is the process of identifying genetic variations, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variations, from genomic sequencing data. Given the complexity and importance of accurate variant calling for research and clinical applications, it is reasonable to assume that tools for reviewing these calls would be necessary for quality control and validation purposes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is baricitinib effective for rheumatoid arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Baricitinib is a medication used to treat rheumatoid arthritis. It is a Janus kinase inhibitor that works by reducing inflammation and slowing down the progression of the disease. Clinical trials have shown that baricitinib is effective in reducing symptoms and improving physical function in patients with rheumatoid arthritis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is galcanezumab effective for treatment of migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Galcanezumab is a medication specifically designed for the prevention of migraine. It works by blocking the activity of calcitonin gene-related peptide (CGRP), a protein that plays a significant role in the development of migraines. Clinical trials have shown that galcanezumab can significantly reduce the frequency of migraine days compared to placebo. The effectiveness of galcanezumab for the treatment of migraine has been demonstrated in several studies, leading to its approval by regulatory authorities such as the U.S. Food and Drug Administration (FDA).\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Lasmiditan effective for migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Lasmiditan is a medication that has been studied for its effectiveness in treating migraines. It works by binding to serotonin receptors in the brain, which can help to reduce pain and other symptoms associated with migraines. Clinical trials have shown that Lasmiditan can be effective in treating migraines, particularly in reducing pain and other symptoms such as sensitivity to light and sound.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is pimavanserin effective for Parkinson's disease psychosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Pimavanserin is an atypical antipsychotic drug specifically developed for the treatment of psychosis associated with Parkinson's disease. It has shown efficacy in reducing psychotic symptoms in patients with Parkinson's disease psychosis without worsening motor symptoms.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does an interferon (IFN) signature exist for SLE patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies and inflammation in multiple organs. Interferons (IFNs) are cytokines that play a crucial role in the immune response, and an IFN signature refers to the increased expression of IFN-regulated genes. Previous studies have shown that many SLE patients have an elevated IFN signature, which is associated with disease activity and severity. The IFN signature in SLE patients is often characterized by the upregulation of type I IFN-regulated genes, such as IFIT1, IFI44L, and MX1. This suggests that an IFN signature does indeed exist for SLE patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can Diazepam be beneficial  in the treatment of  traumatic brain injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Diazepam is a benzodiazepine with various clinical applications, including anxiety, alcohol withdrawal, and muscle spasms. Its use in traumatic brain injury (TBI) is considered due to its potential neuroprotective effects, such as reducing intracranial pressure and controlling seizures, which are common complications following TBI. However, the effectiveness and safety of diazepam in TBI treatment are subjects of ongoing research, with concerns about potential adverse effects on cognitive recovery and the risk of dependence.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are genes that escape X-chromosome inactivation related to mental impairment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"X-chromosome inactivation is a process that silences one of the two X chromosomes in female mammals to avoid a doubling of gene expression. However, some genes on the X chromosome can escape this inactivation, leading to their overexpression. Research has suggested that these genes may play a role in various neurological and psychiatric disorders, including mental impairment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "As of Feb 2019, are major brain gangliosides a target for the treatment of Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the question about the treatment of Alzheimer's disease as of Feb 2019, it is necessary to consider what research and medical findings were available up to that point. Gangliosides are a type of lipid molecule found in the brain and have been studied for their potential role in neurodegenerative diseases, including Alzheimer's. The question is whether major brain gangliosides were considered a target for treatment as of the specified date.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is pazopanib an effective treatment of glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Pazopanib is a tyrosine kinase inhibitor that has been investigated for its potential in treating various types of cancer, including glioblastoma. Glioblastoma is a highly aggressive and malignant form of brain cancer with limited treatment options and poor prognosis. The effectiveness of pazopanib in treating glioblastoma would depend on clinical trial results and comparisons with existing treatments.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is avelumab effective for bladder cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Avelumab is an immunotherapy drug that has been studied for its effectiveness in treating various types of cancer, including bladder cancer. It works by targeting the PD-L1 protein on cancer cells, which can help the immune system recognize and attack the cancer. Clinical trials have investigated the use of avelumab in patients with advanced bladder cancer, particularly those who have failed previous treatments. The results of these trials have shown that avelumab can provide significant benefits in terms of overall survival and response rates for some patients with bladder cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can pazopanib be used for treatment von Hippel-Lindau disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Pazopanib is a multi-targeted receptor tyrosine kinase inhibitor that has been used in the treatment of various cancers, including renal cell carcinoma and soft tissue sarcoma. Von Hippel-Lindau disease is a genetic disorder that predisposes individuals to develop certain types of tumors, including renal cell carcinoma. Considering the mechanism of action of pazopanib and its use in treating renal cell carcinoma, it is plausible that it could be used in the treatment of von Hippel-Lindau disease, especially in cases where renal cell carcinoma is present.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Miller-Dieker syndrome is a rare genetic disorder characterized by lissencephaly, a condition where the brain is smooth due to the lack of folds, and other physical anomalies. It is known to be associated with a specific genetic abnormality. The condition is linked to a deletion on the short arm of chromosome 17, specifically at 17p13.3, which involves the LIS1 gene and possibly other neighboring genes. This deletion leads to the various symptoms and characteristics of Miller-Dieker syndrome. Therefore, considering the question of whether Miller-Dieker syndrome is associated with abnormalities of chromosome 1, the information indicates that the syndrome is actually related to chromosome 17, not chromosome 1.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should dacomitinib be used for treatment of glioblastoma patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Dacomitinib is a potent and selective inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. Glioblastoma is a type of brain cancer that is often resistant to treatment. While dacomitinib has shown promise in treating certain types of cancer, its effectiveness in treating glioblastoma is still being researched. There is limited evidence to support the use of dacomitinib as a treatment for glioblastoma, and it is not currently approved by the FDA for this indication.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is inositol effective for trichotillomania?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Inositol is a naturally occurring molecule that has been studied for its potential therapeutic effects on various psychiatric conditions, including trichotillomania. Trichotillomania, also known as hair-pulling disorder, is characterized by a recurring and irresistible urge to pull out one's own hair, resulting in noticeable hair loss. Research into the efficacy of inositol for treating trichotillomania has shown some promise, with studies suggesting that it may help reduce the symptoms of the disorder. Inositol is believed to influence serotonin levels in the brain, which could contribute to its potential therapeutic effects on obsessive-compulsive spectrum disorders like trichotillomania.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is eculizumab used for treatment of myasthenia gravis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Eculizumab is a medication used to treat certain medical conditions, including paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. It works by inhibiting the complement system, which is part of the immune system. Myasthenia gravis is an autoimmune disease characterized by weakness and rapid fatigue of the muscles under voluntary control. The standard treatments for myasthenia gravis include medications such as acetylcholinesterase inhibitors, immunosuppressive drugs, and in some cases, thymectomy. However, eculizumab has been explored for its potential in treating certain cases of myasthenia gravis, particularly those with a specific antibody profile.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Semagacestat effective for treatment of Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Semagacestat is a gamma-secretase inhibitor that was investigated as a potential treatment for Alzheimer's disease. However, clinical trials have shown that it does not have a significant benefit in treating the disease and may even have adverse effects.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does simvastatin improve outcomes of aneurysmal subarachnoid hemorrhage?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Simvastatin is a statin medication that has been studied for its potential effects on improving outcomes in various medical conditions, including aneurysmal subarachnoid hemorrhage. The condition involves bleeding into the space surrounding the brain, which can lead to severe complications. Research into the use of simvastatin for this condition has explored its potential to reduce inflammation, improve endothelial function, and possibly limit the severity of vasospasm, a common and dangerous complication of subarachnoid hemorrhage. However, the effectiveness of simvastatin in improving outcomes specifically for aneurysmal subarachnoid hemorrhage would depend on clinical trial results and comprehensive medical research.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does tremelimumab improve survival of mesothelioma patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tremelimumab is an anti-CTLA-4 antibody used in cancer immunotherapy. Mesothelioma is a type of cancer that affects the lining of the lungs and other organs. Research on tremelimumab's effectiveness in treating mesothelioma has shown promise in improving survival rates when combined with other treatments.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Axitinib is a tyrosine kinase inhibitor that has been investigated for its potential to treat various types of cancer, including pancreatic cancer. To determine whether Axitinib prolongs the survival of pancreatic cancer patients, it is essential to examine clinical trial data and research studies that have evaluated its efficacy in this context.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does Panitumumab prolong survival of biliary tract cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Panitumumab is a fully human monoclonal antibody that targets the epidermal growth factor receptor (EGFR). It has been used in the treatment of various cancers, including colorectal cancer. The effectiveness of Panitumumab in treating biliary tract cancer is not well-established, and clinical trials have shown mixed results. However, some studies suggest that it may have some benefit in combination with other therapies.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is the enzyme ERAP2 associated with the disease birdshot chorioretinopathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The enzyme ERAP2 has been studied for its potential role in various diseases, including birdshot chorioretinopathy. Birdshot chorioretinopathy is a rare autoimmune disease that affects the eyes. Research has investigated the genetic factors contributing to this condition. ERAP2, which stands for Endoplasmic Reticulum Aminopeptidase 2, is involved in the processing of antigens for presentation to the immune system. Variations in the gene encoding ERAP2 have been associated with several autoimmune diseases, suggesting its potential role in immune regulation and autoimmunity. Therefore, considering the involvement of ERAP2 in antigen processing and its association with autoimmune conditions, it is plausible that ERAP2 could be linked to birdshot chorioretinopathy, given the autoimmune nature of the disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is ADP-ribosylation a PTM?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"ADP-ribosylation is a post-translational modification (PTM) that involves the transfer of one or more ADP-ribose moieties from NAD+ to a target protein, resulting in the modification of protein function or interactions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is collagen the most abundant human protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Collagen is a major structural protein found in the human body, making up a significant portion of connective tissue. It is known for its role in providing strength and elasticity to tissues such as skin, tendons, and ligaments. Given its widespread presence and essential functions, it is reasonable to consider that collagen could be the most abundant protein in the human body.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Mesenchymal stem cells (MSC) multipotent cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mesenchymal stem cells (MSC) are known for their ability to differentiate into various cell types, including osteoblasts, chondrocytes, and adipocytes. This characteristic is a key feature of multipotent cells, which are capable of giving rise to multiple cell types. Given this, it can be inferred that MSCs are indeed multipotent.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is TIM-3 a target for cancer immunotherapy in NSCLC?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"TIM-3 is a protein that can be found on certain immune cells and some cancer cells. It is known to play a role in regulating the immune response. In the context of non-small cell lung cancer (NSCLC), research has been exploring various targets for immunotherapy, which aims to enhance the body's immune response against cancer. TIM-3 has been identified as a potential target because its expression on cancer cells or immune cells within the tumor microenvironment can suppress anti-tumor immune responses. By targeting TIM-3, it is possible to block its immune suppressive signals, thereby potentially enhancing the effectiveness of the immune response against NSCLC.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are phagosomal proteins ubiquitinated?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to understand the process of phagocytosis and the role of ubiquitination in it. Phagocytosis is a process by which cells engulf and internalize particles or microorganisms. The phagosome is the membrane-bound vesicle that forms around the ingested material. Proteins associated with the phagosome can undergo various post-translational modifications, including ubiquitination, which is the addition of ubiquitin proteins. This modification can affect protein function, localization, and stability. Given the complexity of phagocytic processes and the regulatory role of ubiquitination in protein function and degradation, it is reasonable to consider that phagosomal proteins could be subject to ubiquitination as a means of regulating their activity, localization, or turnover during the phagocytic process.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any approved treatment for NAFLD?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"NAFLD, or non-alcoholic fatty liver disease, is a condition where excess fat accumulates in the liver of people who drink little or no alcohol. While there are various approaches to managing NAFLD, including lifestyle modifications and potential pharmacological interventions, the question pertains to approved treatments. As of my last update, there are no universally approved pharmacological treatments specifically for NAFLD. Management strategies often focus on addressing risk factors and underlying conditions such as obesity, diabetes, and high cholesterol through diet, exercise, and medications that target these conditions. However, research is ongoing, and some medications are being investigated for their potential in treating NAFLD.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are tumour specific antigens originating from known protein coding genes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tumour specific antigens can originate from various sources, including mutations in protein coding genes, alternative splicing, or post-translational modifications. Some tumour specific antigens are derived from known protein coding genes, while others may arise from non-coding regions or other genomic elements.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is treatment with Bacillus Calmette Guerin used for bladder cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bacillus Calmette Guerin (BCG) is a vaccine primarily used against tuberculosis, but it has also been found to be effective in treating certain types of cancer, particularly bladder cancer. The BCG treatment for bladder cancer involves instilling the vaccine directly into the bladder, which stimulates the immune system to attack and destroy cancer cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does Rhamnose have any effect on aging?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Rhamnose is a naturally occurring deoxy sugar. It has been studied for its potential effects on various biological processes, including aging. Some research suggests that rhamnose may have anti-aging properties, although the current evidence is limited and more studies are needed to fully understand its effects.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"ApoE mimetics are being researched for their potential therapeutic effects on various diseases, including Alzheimer's disease. Apolipoprotein E (apoE) plays a significant role in lipid metabolism and has been implicated in the pathogenesis of Alzheimer's disease. ApoE mimetics are compounds designed to mimic the beneficial functions of apoE, potentially offering a new approach to treating Alzheimer's disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is L-4F an apoE mimetic peptide?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"L-4F is known as an apoA-I mimetic peptide, which mimics the functions of apolipoprotein A-I, a major component of high-density lipoprotein (HDL) cholesterol. It is designed to capture the anti-inflammatory and antioxidant properties of apoA-I. The question asks if L-4F is an apoE mimetic peptide, which would imply it mimics apolipoprotein E, a different protein involved in lipid metabolism.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can oleuropein aglycone interfere with amyloid aggregation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Oleuropein aglycone is a compound found in olive oil and has been studied for its potential health benefits, including its effects on neurodegenerative diseases. Amyloid aggregation is a key feature of several neurodegenerative diseases, including Alzheimer's disease. Research has investigated the potential of oleuropein aglycone to interfere with amyloid aggregation, which could have implications for the prevention or treatment of these diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Crocus sativus compounds being considered against Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Crocus sativus, commonly known as saffron, contains various compounds that have been studied for their potential medicinal properties. Some of these compounds have shown promise in neuroprotective effects and may be considered for their potential in treating or preventing neurodegenerative diseases such as Alzheimer's disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do Crocus sativus extracts loosen the blood-brain barrier?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Crocus sativus, commonly known as saffron, has been studied for its various pharmacological properties, including its potential effects on the brain and nervous system. The blood-brain barrier is a highly selective permeable barrier that separates the circulating blood from the brain's extracellular fluid in the central nervous system. To determine if Crocus sativus extracts loosen the blood-brain barrier, we need to look into scientific research that has investigated the effects of saffron extracts on this barrier.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Netrin-1 a secreted protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Netrin-1 is a protein that plays a significant role in axon guidance during the development of the nervous system. It is known to be involved in the regulation of cell migration and differentiation. Considering its function, analyzing whether it is secreted or not is crucial. Secreted proteins are typically involved in signaling processes, interacting with other cells or the extracellular matrix. Given Netrin-1's role in guiding axons and influencing cell movement, it likely interacts with the extracellular environment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Have apolipoprotein mimetics been used in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Apolipoprotein mimetics are compounds that mimic the functions of apolipoproteins, which are proteins that bind to lipids to form lipoproteins. They have been researched for their potential to treat various diseases, including cardiovascular disease and inflammation. To determine if they have been used in clinical trials, we need to look at the current state of research and development in this area.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has strimvelis been approved by the European Medicines Agency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Strimvelis is a gene therapy drug used to treat adenosine deaminase deficiency, a rare genetic disorder. The European Medicines Agency (EMA) is responsible for evaluating and approving medicines in the European Union. To answer this question, we need to check if Strimvelis has received approval from the EMA.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein Asporin related to disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Asporin is a protein that has been studied for its potential role in various diseases, including osteoarthritis, where it is thought to influence the progression of the disease by modulating the activity of growth factors involved in cartilage degradation and synthesis. Research has also explored its association with other conditions, indicating a possible link between asporin and disease pathology.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is lactotransferrin a tumour suppressor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Lactotransferrin has been studied for its potential role in cancer prevention and treatment. It has been shown to have antimicrobial and anti-inflammatory properties, and some studies suggest it may have antitumor effects. However, its role as a tumor suppressor is still being researched and debated.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has the protein SIRT2 been associated to cervical cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the current scientific understanding of SIRT2 and its potential role in cervical cancer. SIRT2, or sirtuin 2, is a member of the sirtuin family of proteins, which have been implicated in various cellular processes including aging, inflammation, and metabolism. Some research has suggested that sirtuins may play a role in cancer development and progression, including cervical cancer. However, the specific involvement of SIRT2 in cervical cancer would depend on studies that have directly investigated this relationship.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does RUNX2 inhibit astrocyte differentiation?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of RUNX2 in cellular differentiation, particularly in the context of astrocyte development. RUNX2 is a transcription factor known for its critical role in the regulation of osteoblast differentiation and bone formation. However, its influence extends beyond osteogenesis, potentially affecting the differentiation pathways of other cell types, including neural cells. The process of astrocyte differentiation is complex, involving a series of molecular and cellular events that can be influenced by various transcription factors and signaling pathways. If RUNX2 plays a role in inhibiting astrocyte differentiation, it would likely do so by regulating the expression of genes involved in the astrocytic lineage commitment or by interacting with other transcription factors that promote astrocyte differentiation.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can miR-122 target RUNX2?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer whether miR-122 can target RUNX2, we need to consider the role of microRNAs (miRNAs) in gene regulation. miRNAs are small non-coding RNAs that play crucial roles in post-transcriptional regulation of gene expression by binding to the 3'-untranslated regions (3'-UTR) of target mRNAs, leading to their degradation or inhibition of translation. miR-122 is a liver-specific miRNA that has been extensively studied for its role in liver development, differentiation, and disease, including its involvement in the regulation of cholesterol and lipid metabolism. RUNX2, on the other hand, is a key transcription factor involved in bone formation and development. The potential interaction between miR-122 and RUNX2 would be significant, as it could imply a regulatory mechanism connecting liver function with bone metabolism. However, the specific interaction between miR-122 and RUNX2 needs to be experimentally verified or supported by bioinformatic predictions that identify potential binding sites for miR-122 in the 3'-UTR of RUNX2 mRNA.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can antisense threapy be used for Huntington's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Antisense therapy is a medical treatment that uses single-stranded DNA or RNA molecules to bind to specific sequences of RNA, preventing their translation into proteins. Huntington's disease is a neurodegenerative disorder caused by an expansion of a CAG repeat in the huntingtin gene, leading to the production of a toxic protein. Researchers have explored the use of antisense oligonucleotides to target the huntingtin gene and reduce the production of the toxic protein.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can prevnar 13 be used in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Prevnar 13 is a pneumococcal conjugate vaccine that is used to protect against serious infections caused by Streptococcus pneumoniae. It is approved for use in children and is often administered as part of a routine vaccination schedule.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Was stelara developed by Amgen?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Stelara, also known as ustekinumab, is a medication used to treat various autoimmune diseases. It was developed by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson. Amgen is a separate biotechnology company known for developing different medications.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is ustekinumab a polyclonal antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Ustekinumab is a human monoclonal antibody. It targets interleukin-12 and interleukin-23, which are proteins involved in inflammation and immune response. Monoclonal antibodies are made from a single clone of cells and are directed against a single target, whereas polyclonal antibodies are made from different clones of cells and can target multiple epitopes on an antigen.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do tumour-associated macrophages have a prognostic role in gliomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tumour-associated macrophages have been studied for their role in various types of cancer, including gliomas. They can influence the tumour microenvironment, affecting tumour growth, progression, and response to treatment. The presence and polarization of these macrophages can have different implications for patient outcomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can cardiospheres be produced from skin fibroblasts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cardiospheres are typically produced from cardiac cells, but research has explored the use of other cell types, including skin fibroblasts, for cardiac cell generation through reprogramming or differentiation techniques.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The interaction between MOV10 and RNASEH2 and its impact on L1 retrotransposition needs to be considered. MOV10 is an RNA helicase that has been implicated in the regulation of LINE-1 (L1) retrotransposition, which is a process by which L1 elements copy themselves and insert the new copies into different genomic locations. RNASEH2 is involved in the degradation of RNA-DNA hybrids and has roles in maintaining genome stability. The interaction between these two could potentially influence the activity and mobility of L1 elements.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Tocilizumab is an anti-TNF antibody, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Tocilizumab is an interleukin-6 receptor antagonist, not an anti-TNF antibody. It is used to treat various inflammatory conditions, including rheumatoid arthritis. Anti-TNF antibodies, such as infliximab, adalimumab, and etanercept, target tumor necrosis factor-alpha (TNF-alpha), a different cytokine involved in inflammation.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Velocardial facial syndrome, also known as Di George syndrome, is a disorder caused by a defect in chromosome 22, not chromosome 21. The deletion occurs in the q11.2 region of chromosome 22.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Anaplasma phagocytophilum is an obligate gram-negative, intracellular bacterium, yes  or no",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Anaplasma phagocytophilum is a bacterium that infects humans and is known to be an obligate intracellular pathogen. It is indeed gram-negative.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are cardenolides inhibitors of Na+/K+ ATPase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cardenolides are a class of compounds known for their role in inhibiting the Na+/K+ ATPase enzyme, which is crucial for maintaining the balance of sodium and potassium ions across cell membranes. This inhibition can have significant effects on heart function and is the basis for the use of certain cardenolides, like digoxin, in the treatment of heart conditions such as atrial fibrillation and congestive heart failure. The mechanism of action involves the binding of cardenolides to the Na+/K+ ATPase pump, thereby reducing its activity and leading to an increase in intracellular sodium and a subsequent increase in intracellular calcium through the sodium-calcium exchanger. This increase in calcium levels enhances the contractility of cardiac muscle cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is it possible to analyze exosomes with FACS?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Exosomes are small extracellular vesicles that can be challenging to analyze due to their size and complexity. Flow cytometry (FACS) is a powerful tool for analyzing cells and particles, but its ability to analyze exosomes depends on various factors such as the size and labeling of the exosomes. Recent advancements in FACS technology have improved its sensitivity and resolution, allowing for the detection and analysis of smaller particles, including exosomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can mitochondria transfer from cell to cell?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mitochondria are organelles found in the cells of most eukaryotes, including animals, plants, and fungi. They are often referred to as the powerhouses of the cell because they generate most of the cell's supply of adenosine triphosphate (ATP), which is used as a source of chemical energy. In addition to their role in energy production, mitochondria are involved in a range of other processes, including signaling, cellular differentiation, cell death, as well as the control of the cell cycle and cell growth. The question of whether mitochondria can transfer from cell to cell is complex and has been the subject of research. There are instances where mitochondrial transfer has been observed, such as in the context of mitochondrial dysfunction or disease, where healthy mitochondria from one cell can be transferred to another cell to restore mitochondrial function. This phenomenon has been noted in certain types of stem cells and in some pathological conditions. However, the extent and mechanisms of such transfers are still under investigation and not fully understood. Mitochondrial transfer between cells has potential implications for the treatment of diseases characterized by mitochondrial dysfunction, suggesting a possible therapeutic avenue.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can mitochondria pass through membrane nanotubes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Membrane nanotubes are narrow, tube-like structures that can form between cells, allowing for the exchange of molecules and even organelles. Mitochondria are organelles found in the cells of most eukaryotes, including animals, plants, and fungi, and are known for their role in generating most of the cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy. The question of whether mitochondria can pass through membrane nanotubes involves understanding the size and flexibility of both the mitochondria and the nanotubes, as well as the mechanisms by which organelles might move through such structures. Given the small diameter of membrane nanotubes, it seems plausible that only certain components or smaller organelles could pass through, but the possibility of mitochondria, which are relatively large, doing so is less clear without specific evidence or research findings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is TNF-Î± an activator of pancreatic stellate cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"TNF-Î±, or tumor necrosis factor-alpha, is a cytokine involved in systemic inflammation and is known to play a role in various cellular processes, including the activation of pancreatic stellate cells. Pancreatic stellate cells, when activated, can contribute to fibrosis in the pancreas, a condition characterized by the excessive formation of connective tissue. The activation of these cells is a key event in the pathogenesis of chronic pancreatitis and pancreatic cancer. TNF-Î±, through its signaling pathways, can promote the activation of pancreatic stellate cells, leading to the production of extracellular matrix proteins and the progression of pancreatic fibrosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are protamines ubiquitously expressed?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Protamines are a group of arginine-rich, highly basic nucleoproteins that are found in the sperm cells of many animals, including mammals, birds, and fish. They play a crucial role in the packaging and condensation of DNA in sperm heads. However, their expression is not limited to sperm cells and can be found in other cell types, although at much lower levels. The question of whether protamines are ubiquitously expressed depends on the definition of ubiquitous, which typically means being present everywhere at the same time. Given that protamines are primarily associated with sperm cells but can also be detected in other tissues or cell types under certain conditions, it might be more accurate to say they are not ubiquitously expressed in the same high levels across all cell types but are rather specifically expressed in certain cell types, notably sperm cells.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can therapeutic levels of  Vedolizumab be found in the breast milk of nursing mothers following treatment for Inflammatory bowel disease?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Vedolizumab is a medication used to treat inflammatory bowel disease (IBD). The presence of therapeutic levels of vedolizumab in breast milk is a concern for nursing mothers. Studies have investigated the transfer of vedolizumab into breast milk, and the results indicate that low levels of vedolizumab are present in breast milk, but the levels are generally considered to be low and not expected to cause harm to the infant. However, the exact levels and potential effects on the infant are still being researched.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the current state of Alzheimer's disease treatment and the role of anti-amyloid antibodies. Alzheimer's disease is a complex condition characterized by the accumulation of amyloid-beta plaques in the brain, among other factors. Anti-amyloid antibodies are designed to target and reduce these plaques, potentially slowing or halting disease progression. Several anti-amyloid antibodies have been investigated in clinical trials for their safety and efficacy in treating Alzheimer's disease. One notable example is aducanumab, which has been at the center of significant attention and debate within the medical and scientific communities.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is subdural empyema a complication of sinusitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Subdural empyema is a collection of pus in the space between the brain and its outer protective membrane, known as the dura. It can be caused by various factors, including bacterial infections. Sinusitis, which is an inflammation or infection of the sinuses, can lead to complications if the infection spreads. One of the potential complications of sinusitis is the spread of infection to the brain, which can result in conditions such as subdural empyema. Therefore, considering the potential pathways of infection spread, it is reasonable to conclude that subdural empyema can indeed be a complication of sinusitis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are artificial blood cells available?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Artificial blood cells are being researched and developed, but their availability for medical use is still limited. Several companies and research institutions are working on creating artificial blood cells, also known as synthetic red blood cells, that can mimic the function of natural red blood cells. However, these artificial blood cells are not yet widely available for clinical use.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is actin present in the nucleus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Actin is a protein that is typically associated with the cytoskeleton, but there is evidence that it can also be present in the nucleus, where it may play a role in various nuclear processes such as transcription and chromatin remodeling. However, its presence and function in the nucleus are not as well understood as its role in the cytoskeleton.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Philadelphia chromosome a fusion between parts of chromosomes 1 and 9?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The Philadelphia chromosome is a result of a translocation between chromosomes 9 and 22, not chromosomes 1 and 9. This specific chromosomal abnormality is commonly associated with chronic myeloid leukemia (CML) and some cases of acute lymphoblastic leukemia (ALL).\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is collagen matrix of human articular cartilage changing with disease?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The collagen matrix in human articular cartilage plays a crucial role in its structure and function. In diseases such as osteoarthritis, the composition and organization of this matrix can be altered, leading to changes in the mechanical properties of the cartilage. These changes can include degradation of collagen fibers, alterations in collagen types, and changes in the cross-linking between collagen molecules, which can affect the integrity and function of the cartilage.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can TAD disruption lead to disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Topologically associating domains (TADs) are crucial for the spatial organization of chromosomes and play a significant role in gene regulation. Disruption of TADs has been linked to various diseases, including developmental disorders and cancer, by altering gene expression patterns. This can occur through changes in the interactions between genes and their regulatory elements, such as enhancers, when the normal TAD structure is disrupted.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does Estrogen lead to forkhead FoxA1 activation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Estrogen is known to influence the activity of various transcription factors, including those in the forkhead family. FoxA1 is a member of this family and plays a significant role in the regulation of gene expression, particularly in the context of hormone-dependent tissues. The activation of FoxA1 by estrogen would typically involve estrogen binding to its receptor, which then acts as a transcription factor to regulate the expression of target genes, including potentially influencing the activity or expression of FoxA1 itself. This process can vary depending on the cellular context and the specific genes being regulated.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Apelin usually decreased in diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Analyzing the relationship between Apelin and diabetes, considering the role of Apelin in glucose metabolism and its potential as a biomarker or therapeutic target for diabetes management.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Pim-1 a protein phosphatase?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Pim-1 is a serine/threonine kinase, analyzing its function to determine if it is a protein phosphatase.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is the crystal structure of Pim-1 available?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to check if the crystal structure of Pim-1, which is a serine/threonine kinase, has been determined and made available in protein structure databases such as the Protein Data Bank (PDB).\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is myc a tumour suppressor gene?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The myc gene is often associated with cancer and cell proliferation. It is typically considered an oncogene, which means it has the potential to cause cancer when mutated or overexpressed. However, the question asks if it is a tumor suppressor gene. Tumor suppressor genes are genes that help control cell growth and prevent cancer. Given the role of myc in promoting cell growth and proliferation, it does not function as a tumor suppressor.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is CD63 an exosomal marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CD63 is a tetraspanin protein that is often used as a marker for exosomes, which are small extracellular vesicles that are secreted by cells. It is commonly found on the surface of exosomes and is used to identify and isolate these vesicles.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does association with the nuclear pore promote gene silencing?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether being associated with the nuclear pore has an effect on gene silencing. Gene silencing is the regulation of gene expression by preventing the expression of a specific gene. The nuclear pore is a complex that regulates the flow of molecules between the nucleus and cytoplasm. Research has shown that association with the nuclear pore can indeed influence gene expression, including promoting gene silencing by sequestering genes at the nuclear periphery or by recruiting silencing factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the process of DNA loop-extrusion independent of ATP?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"DNA loop-extrusion is a process by which cohesin and condensin complexes organize the genome into loops, and it has been studied extensively in the context of chromosome organization and gene regulation. The process involves the extrusion of DNA loops by these complexes, which can be influenced by various factors including ATP. To determine if the process is independent of ATP, we need to consider the role of ATP in the activity of cohesin and condensin. Cohesin is known to be an ATPase, and its ability to extrude DNA loops is dependent on ATP hydrolysis. Therefore, considering the dependence of cohesin's activity on ATP, it suggests that the process of DNA loop-extrusion is not independent of ATP.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Are lamina-associated domains (LADs) associated with transcriptional activation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Lamina-associated domains (LADs) are genomic regions that interact with the nuclear lamina, a protein network that lines the nuclear envelope. They are typically characterized by low gene density and transcriptional activity. However, some studies have suggested that LADs can also be associated with transcriptional activation, particularly at specific genomic loci. The relationship between LADs and transcriptional activation is complex and may depend on various factors, including the specific cell type and the presence of specific transcriptional regulators.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are the members of the KRAB-ZNF  gene family promoting gene repression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The KRAB-ZNF gene family is a group of transcription factors that play a crucial role in regulating gene expression. They are known to be involved in various biological processes, including development, cell differentiation, and immune response. The KRAB domain is a protein-protein interaction domain that is often associated with gene repression. It recruits transcriptional co-repressors, such as KAP1, which in turn recruit chromatin-modifying enzymes that compact chromatin and repress gene expression. Therefore, it is likely that the members of the KRAB-ZNF gene family are promoting gene repression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does deletion of cohesin change gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cohesin is a protein complex that plays a crucial role in holding sister chromatids together during cell division. It also has a role in gene regulation by forming long-range chromatin loops that bring enhancers and promoters into close proximity, thus facilitating gene expression. Deletion or mutation of cohesin subunits has been associated with changes in gene expression, as it disrupts the normal chromatin architecture and the interactions between enhancers and promoters. This can lead to the misregulation of genes, including those involved in development and cell growth. Therefore, considering the role of cohesin in chromatin organization and gene regulation, its deletion would indeed impact gene expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SATB1 expressed in thymocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"SATB1 is a nuclear matrix-associated protein that plays a crucial role in the regulation of gene expression, particularly in the context of immune cells. Thymocytes are immature T cells that undergo development and selection in the thymus. Given SATB1's involvement in chromatin remodeling and its expression in various cell types, including immune cells, it is reasonable to consider whether SATB1 is expressed in thymocytes, which are critical for T cell development.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there negative enhancers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Negative enhancers are elements in the genome that decrease the transcription of a gene when particular transcription factors bind to them. They can be contrasted with positive enhancers, which increase transcription when bound by specific transcription factors. The concept of negative enhancers highlights the complexity of gene regulation, where different sequences can either promote or suppress gene expression depending on the context and the factors involved.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SATB1 necessary for T-cell maturation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"SATB1 is a protein that plays a crucial role in the regulation of gene expression, particularly in the context of chromatin organization and transcriptional control. In T-cells, SATB1 has been implicated in the regulation of genes involved in T-cell development and maturation. Studies have shown that SATB1 is required for the proper maturation of T-cells, as it regulates the expression of genes involved in T-cell receptor signaling and the development of T-cell subsets. Therefore, based on the available evidence, it appears that SATB1 is necessary for T-cell maturation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does SATB1 regulate the RAG1 and RAG2 genes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"SATB1 is a nuclear matrix-associated protein that regulates gene expression by modifying chromatin structure. The RAG1 and RAG2 genes are crucial for V(D)J recombination, a process that assembles the variable region of antibodies and T-cell receptors. SATB1 has been shown to regulate the expression of various genes involved in immune function and development. Given its role in regulating chromatin structure and gene expression, it is plausible that SATB1 could regulate the RAG1 and RAG2 genes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is CTCF bound at nucleosome free regions?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CTCF is a transcription factor that plays a crucial role in genome organization and regulation. Nucleosome-free regions are areas of the genome where nucleosomes, the basic units of chromatin, are absent or depleted. CTCF binding sites are often found at specific genomic locations, including enhancers, promoters, and insulators. The relationship between CTCF binding and nucleosome occupancy has been studied, and it has been observed that CTCF tends to bind to regions of the genome that are depleted of nucleosomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does metformin alleviate atherosclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Metformin is a medication commonly used to treat type 2 diabetes. It has been studied for its potential effects on various conditions, including atherosclerosis, which is the buildup of plaque in the arteries leading to their hardening. Research has indicated that metformin may have beneficial effects on cardiovascular health, including potentially alleviating atherosclerosis, through several mechanisms such as improving insulin sensitivity, reducing inflammation, and affecting lipid metabolism.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does GRHL2 over-expression lead to EMT?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"GRHL2 is a transcription factor involved in the regulation of epithelial cell development and maintenance. Over-expression of GRHL2 has been linked to various cellular processes, including the suppression of epithelial-to-mesenchymal transition (EMT), a process associated with the loss of epithelial characteristics and the acquisition of mesenchymal traits. However, the relationship between GRHL2 over-expression and EMT is complex and context-dependent. In some studies, GRHL2 over-expression has been shown to inhibit EMT, while in others, it may promote EMT under specific conditions. Therefore, the effect of GRHL2 over-expression on EMT is not universally agreed upon and may vary depending on the cellular context and other factors.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is PRDM9 essential for meiosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"PRDM9 is a protein that plays a crucial role in meiosis, specifically in the process of meiotic recombination. It is involved in the recognition and binding of specific DNA sequences, which helps to initiate the recombination process. The absence or mutation of PRDM9 has been associated with meiotic defects and infertility in some organisms. Therefore, PRDM9 appears to be essential for proper meiotic function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does the chromatin remodeling complex, RSC target H2A.Z nucleosomes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The RSC complex is known for its role in chromatin remodeling, and it has been found to interact with various types of nucleosomes. H2A.Z is a histone variant that is often associated with active genes and regulatory regions. Research has shown that the RSC complex can target and remodel nucleosomes containing H2A.Z, which suggests a potential role in regulating gene expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The tyrosine kinase BTK is involved in B cell receptor signaling and has been implicated in various immune responses. Its role in autoimmunity has been studied, with evidence suggesting that BTK contributes to the development and progression of autoimmune diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is induction of interferon by TLR7 higher in males?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of TLR7 in the immune system and its interaction with interferon. TLR7 is a toll-like receptor that recognizes single-stranded RNA, which is associated with viral infections. Upon recognition, TLR7 activates a signaling cascade that leads to the production of type I interferons, which are crucial for antiviral defense. The question of whether the induction of interferon by TLR7 is higher in males involves considering gender differences in immune responses. Research has shown that there are indeed gender differences in the immune system, with some studies suggesting that males and females may differ in their susceptibility to certain infections and in their immune responses, including the production of cytokines like interferon. However, the specific question of TLR7-induced interferon production being higher in males requires looking into studies that have directly compared TLR7 signaling and interferon production between genders.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does CXorf21 escape X chromosome inactivation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CXorf21 is a gene located on the X chromosome, and the question is asking whether it escapes X chromosome inactivation, a process by which one of the two X chromosomes in female mammals is inactivated to avoid a doubling of gene expression. To answer this question, we need to consider the properties of the CXorf21 gene and its behavior during X chromosome inactivation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SATB1 positioned close to AT-rich sequences?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"SATB1 is a nuclear matrix-associated protein that has been shown to bind to special AT-rich sequences, which are characteristic of matrix attachment regions. This suggests a close relationship between SATB1 and these specific DNA sequences.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Niraparib effective for ovarian cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Niraparib is a medication used for the treatment of ovarian cancer, specifically for patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It works as a PARP inhibitor, which helps in stopping the cancer cells from repairing their DNA, thereby killing them. The effectiveness of Niraparib has been demonstrated in clinical trials, showing its ability to significantly improve progression-free survival in patients with these types of cancers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is palbociclib effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Palbociclib is a medication used in the treatment of certain cancers, most notably breast cancer. It works by inhibiting cyclin-dependent kinases 4 and 6, which are involved in cell cycle progression. Glioblastoma is a type of brain cancer known for its aggressive nature and poor prognosis. The effectiveness of palbociclib for glioblastoma would depend on clinical trials and research studies. As of my last update, there was ongoing research into various treatments for glioblastoma, including targeted therapies like palbociclib. However, without specific data or study results indicating its efficacy for glioblastoma, it's challenging to definitively state its effectiveness for this particular cancer type.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can LB-100 sensitize ovarian carcinoma to cisplatin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"LB-100 is a protein phosphatase 2A inhibitor that has been studied for its potential to sensitize cancer cells to chemotherapy. Cisplatin is a commonly used chemotherapeutic agent for the treatment of ovarian carcinoma. Research has shown that LB-100 can enhance the efficacy of cisplatin in ovarian carcinoma cells by inhibiting protein phosphatase 2A, which can lead to increased apoptosis and reduced cell survival. Therefore, based on the available evidence, it appears that LB-100 can sensitize ovarian carcinoma to cisplatin.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has LB-100 been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"LB-100 is a compound that has been studied for its potential therapeutic effects. To determine if it has been tested in clinical trials, we need to look at scientific research and clinical trial databases. Clinical trials are a crucial step in evaluating the safety and efficacy of new treatments.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can LB-100 downregulate miR-33?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to understand what LB-100 is and its relationship with miR-33. LB-100 is known as a protein phosphatase 2A (PP2A) inhibitor, and miR-33 is a microRNA involved in various cellular processes. The question asks whether LB-100 can downregulate miR-33, meaning can it decrease the expression or activity of miR-33?\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can PRL3-zumab inhibit PRL3+ cancer cells in vitro and in vivo?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"PRL3-zumab is an antibody that targets PRL3, a protein often overexpressed in certain cancer cells. The ability of PRL3-zumab to inhibit PRL3+ cancer cells both in laboratory settings (in vitro) and within living organisms (in vivo) would depend on its capacity to specifically bind to PRL3 and effectively induce cell death or inhibit cell proliferation. Given the context, it is reasonable to consider that PRL3-zumab could have such inhibitory effects, assuming it has been designed or demonstrated to have these capabilities.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the accuracy of predicting discharge destinations using the Risk Assessment and Prediction Tool (RAPT). To answer this, we need to consider the capabilities and limitations of the RAPT model in predicting patient outcomes, specifically discharge destinations. The RAPT model is designed to assess various risk factors and predict potential outcomes, which may include discharge destinations. However, the accuracy of such predictions can depend on several factors, including the quality of the data used to train the model, the complexity of the patient's condition, and the specific discharge destinations considered.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is AZD5153 active in prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"AZD5153 is an androgen receptor inhibitor being investigated for its potential in treating prostate cancer. To determine if it is active in prostate cancer, we need to consider the results of clinical trials and preclinical studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is GRG5 involved only in late embryonic mouse development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"GRG5 is a gene that has been studied in the context of embryonic development in mice. To answer whether GRG5 is involved only in late embryonic mouse development, we need to consider its expression and functional roles at different stages of development. If GRG5 is expressed and plays a role in early embryonic stages as well, then it is not limited to late development.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does BNN27 promote memory loss?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"BNN27 is a selective agonist for the cannabinoid receptor CB1, research on its effects on memory is needed to determine if it promotes memory loss.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is BNN20 involved in Parkinson's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"BNN20, or brain-derived neurotrophic factor, is involved in various neurological processes and diseases, including Parkinson's disease, which is a neurodegenerative disorder. Research has indicated that neurotrophic factors like BDNF play a role in the survival and function of neurons, and alterations in their levels or activity might contribute to the pathogenesis of Parkinson's disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has istadefylline been considered as a treatment for Parkinson's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Istadefylline is an adenosine receptor antagonist that has been investigated for its potential therapeutic effects on Parkinson's disease. It has been considered as a treatment option due to its ability to modulate adenosine receptors, which play a role in motor control and movement. Several studies have explored the efficacy and safety of istradefylline in patients with Parkinson's disease, particularly in those experiencing motor fluctuations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is amantadine ER the first approved treatment for akinesia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Amantadine ER is an extended-release form of amantadine, which has been used for various neurological conditions. To answer whether it is the first approved treatment for akinesia, we need to consider what akinesia is and the common treatments for it. Akinesia refers to a lack of movement or a reduction in voluntary movement, often associated with Parkinson's disease and other neurological disorders. Several treatments are available for managing akinesia, including dopamine agonists, MAO-B inhibitors, and COMT inhibitors. Amantadine itself has been used for Parkinson's disease symptoms, including akinesia, but its extended-release formulation and specific approval status for akinesia need clarification.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Has amantadine ER been approved by the FDA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to check the FDA's approved drugs list for amantadine ER. Amantadine is known for its use in treating influenza A and as a treatment in Parkinson's disease. The extended-release (ER) formulation would be designed to release the drug over a longer period. Checking the FDA's database for the most current information on approved drugs and their formulations will provide the answer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is pimavanserin a typical antipsychotic?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Pimavanserin is an atypical antipsychotic that is used for the treatment of psychosis associated with Parkinson's disease. It has a unique mechanism of action, selectively targeting serotonin receptors, which differentiates it from typical antipsychotics that primarily act on dopamine receptors.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Has ProSavin undergone phase IV clinical trials by 2018?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"ProSavin is a gene therapy treatment for Parkinson's disease. To answer whether it has undergone phase IV clinical trials by 2018, we need to look at the clinical trial history of ProSavin up to that point. Phase IV trials are post-marketing studies that assess the long-term effects of a treatment in a larger population after it has been approved by regulatory authorities.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does ProSavin use an adenoviral vector?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"ProSavin is a gene therapy product, and it uses a specific type of vector to deliver the therapeutic gene to cells. The vector used in ProSavin is an adeno-associated virus (AAV) vector, but the question asks about an adenoviral vector. Adenoviral vectors are commonly used in gene therapy due to their ability to infect a wide range of cell types and express high levels of the transgene. However, ProSavin specifically utilizes an AAV vector, not an adenoviral vector.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is BCL11B involved in schizophrenia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"BCL11B is a gene that has been studied for its potential role in various neurological and psychiatric disorders. Research has investigated its involvement in schizophrenia, a complex mental health condition characterized by disruptions in thought processes, perceptions, and emotional responsiveness and social interactions. Although the exact mechanisms and genetic factors contributing to schizophrenia are not fully understood, studies have explored the association between genetic variations, including those affecting the BCL11B gene, and the susceptibility to schizophrenia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are CD8+ (cytotoxic) T cells and  CD4+ Helper T cells generated in the thyroid and express the T-cell receptor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"CD8+ (cytotoxic) T cells and CD4+ Helper T cells are types of T lymphocytes that play crucial roles in the immune system. They are generated in the thymus, not the thyroid. The thymus is the site where T cells mature and are selected or eliminated based on their ability to recognize self-antigens. Both CD8+ and CD4+ T cells express the T-cell receptor (TCR) on their surface, which is essential for recognizing antigens presented by major histocompatibility complex (MHC) molecules. The TCR is a heterodimer composed of either alpha and beta chains (in the case of most T cells) or gamma and delta chains (in the case of a smaller subset of T cells). The expression of the TCR is critical for the function of T cells, as it allows them to recognize and respond to specific antigens.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do MAIT cells have a role in multiple myeloma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"MAIT cells are a type of innate-like T cell that play a role in the immune system, particularly in the context of bacterial infections and autoimmune diseases. Recent studies have explored their involvement in various types of cancer, including multiple myeloma. Multiple myeloma is a cancer of plasma cells, and the immune system's response to it is complex, involving multiple cell types. The role of MAIT cells in multiple myeloma could involve modulating the immune response, either by promoting anti-tumor activity or by contributing to an immunosuppressive environment that favors tumor growth. Research into the specific functions and interactions of MAIT cells within the context of multiple myeloma is ongoing, aiming to understand their potential as therapeutic targets or biomarkers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the BAGEL algorithm used for arrayed CRISPR screens?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The BAGEL algorithm is used for analyzing arrayed CRISPR screens, which involves the use of CRISPR-Cas9 genome editing technology to systematically knock out genes in an arrayed format, allowing for the study of gene function and identification of genes involved in specific phenotypes.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is Ubrogepant effective for migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ubrogepant is a medication that has been studied for its efficacy in treating migraines. It belongs to a class of drugs known as calcitonin gene-related peptide receptor antagonists, which work by blocking the action of a protein that is involved in the development of migraines. Clinical trials have shown that ubrogepant is effective in relieving migraine symptoms, including pain, nausea, and sensitivity to light and sound.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is modified vaccinia Ankara effective for smallpox?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Modified vaccinia Ankara (MVA) is a highly attenuated strain of the vaccinia virus, which has been used as a vaccine against smallpox. It was developed by serial passage of the chorioallantois vaccinia virus Ankara in chicken embryo fibroblasts. MVA has been shown to be safe and immunogenic in various clinical trials, and it has been used as an alternative to traditional smallpox vaccines, particularly for individuals with compromised immune systems or other contraindications to traditional vaccines. The effectiveness of MVA in preventing smallpox has been demonstrated in several studies, including a study in which MVA was shown to provide protection against smallpox in non-human primates.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Apremilast effective for BehÃ§etâ€™s Syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Apremilast is a medication used to treat various inflammatory conditions, and its effectiveness for BehÃ§etâ€™s Syndrome has been explored in clinical studies. BehÃ§etâ€™s Syndrome is a rare disorder that causes blood vessel inflammation throughout the body, leading to symptoms such as mouth sores, genital sores, skin rashes, and eye inflammation. Apremilast, with its mechanism of action as a phosphodiesterase 4 inhibitor, has shown potential in reducing inflammation and modulating the immune response.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Selinexor effective for multiple myeloma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Selinexor is a drug that has been studied for its effectiveness in treating multiple myeloma. It works by inhibiting the nuclear export protein XPO1, which can help to induce apoptosis in cancer cells. Clinical trials have shown that selinexor can be effective in treating multiple myeloma, particularly in patients who have relapsed or are refractory to other treatments.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does teplizumab hold promise for diabetes prevention?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Teplizumab is an investigational drug that has shown potential in delaying the onset of type 1 diabetes in clinical trials. It works by targeting the immune system to prevent it from attacking the insulin-producing beta cells in the pancreas. The results of several studies have been promising, suggesting that teplizumab could be an effective treatment for preventing or delaying the onset of type 1 diabetes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does nintedanib hold promise for lung disease associated with systemic sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Nintedanib is an antifibrotic drug that has shown efficacy in treating idiopathic pulmonary fibrosis (IPF), a condition characterized by scarring of the lungs. Systemic sclerosis, also known as scleroderma, is an autoimmune disease that can cause lung fibrosis, among other complications. Given nintedanib's mechanism of action and its success in IPF, it is reasonable to consider its potential in treating lung disease associated with systemic sclerosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is mesothelioma caused by asbestos exposure?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mesothelioma is a rare form of cancer that affects the lining of the lungs, abdomen, and heart. The primary cause of mesothelioma is exposure to asbestos, a group of minerals that were widely used in construction, insulation, and other industries. When asbestos fibers are inhaled, they can become lodged in the lungs and cause genetic damage to the cells, leading to cancer. The link between asbestos exposure and mesothelioma has been well-established through numerous scientific studies and epidemiological research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Hemochromatosis type 4, also known as ferroportin disease, is caused by mutations in the SLC40A1 gene. This gene provides instructions for making a protein called ferroportin, which plays a critical role in the regulation of iron export from cells. The mutations can be inherited in an autosomal dominant pattern, meaning a mutation in one of the two copies of the gene is sufficient to cause the condition. However, some cases may exhibit an autosomal recessive pattern depending on the specific mutation and its impact on ferroportin function.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Huntington's disease is caused by expansion of a CTG repeat in the HTT gene on Chromosome 4?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Huntington's disease is caused by an expansion of a CAG repeat in the HTT gene on Chromosome 4, not a CTG repeat. The CTG repeat expansion is actually associated with myotonic dystrophy type 1, a different genetic disorder.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can radiation induced meningiomas be treated with radiosurgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Radiation-induced meningiomas are a type of brain tumor that can develop after exposure to radiation, and radiosurgery is a treatment option that uses high doses of radiation to destroy tumor cells. The effectiveness of radiosurgery for treating radiation-induced meningiomas depends on various factors, including the size and location of the tumor, as well as the patient's overall health.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an increased risk of meningiomas in atomic bomb survivors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the relationship between radiation exposure and the development of meningiomas, particularly in atomic bomb survivors, to determine if there's an increased risk.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiation for tinea capitis increases brain tumor risk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tinea capitis is a fungal infection of the scalp, and radiation therapy has been used in the past to treat it. However, the use of radiation for tinea capitis has raised concerns about potential long-term health effects, including an increased risk of brain tumors. Studies have investigated this association, and the evidence suggests that radiation therapy for tinea capitis may be linked to a higher risk of developing brain tumors, particularly in children and adolescents.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can secondary glioblastoma be caused by brain irradiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Secondary glioblastoma refers to a type of glioblastoma that develops in a location where a previous brain tumor or cancer was treated with radiation. Brain irradiation is a known risk factor for the development of secondary brain tumors, including glioblastoma. The radiation can cause genetic mutations in the brain cells, leading to the formation of a new tumor. Therefore, it is possible for brain irradiation to contribute to the development of secondary glioblastoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does head ct increase brain tumor risk?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Analyzing the relationship between head CT scans and brain tumor risk, considering the use of ionizing radiation in CT scans and its potential impact on brain tissue.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is there an increased risk for meningiomas in childhood leukemia survivors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Childhood leukemia survivors may have an increased risk of developing secondary cancers, including brain tumors such as meningiomas, due to radiation therapy and other treatments. Research has shown that there is a higher incidence of meningiomas in individuals who have undergone cranial radiation, particularly at a young age.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can radiotherapy cause radiation induced osteosarcoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Radiotherapy is a treatment that uses high-energy radiation to kill cancer cells. However, it can also cause damage to healthy cells, including bone cells. Radiation-induced osteosarcoma is a rare but potential side effect of radiotherapy, particularly in patients who have received high doses of radiation to the bone or surrounding tissue. The risk of developing radiation-induced osteosarcoma is generally low, but it is higher in patients who have undergone radiotherapy at a young age or have received high doses of radiation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Chernobyl survivors at increased risk for breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the relationship between Chernobyl survivors and breast cancer risk, considering radiation exposure effects.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for Hodgkin disease increases risk for lung cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Radiotherapy is a common treatment for Hodgkin disease, and it has been shown to increase the risk of secondary cancers, including lung cancer. The radiation exposure can cause damage to the lung tissue, leading to an increased risk of developing lung cancer. Studies have demonstrated that patients who receive radiotherapy for Hodgkin disease have a higher risk of developing lung cancer compared to the general population.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for cervical cancer increases risk of colon cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the relationship between radiotherapy for cervical cancer and the risk of colon cancer, it is known that radiation therapy can increase the risk of secondary cancers in the irradiated field. The colon is in close proximity to the cervix and may receive scattered radiation during radiotherapy for cervical cancer. Several studies have investigated this potential link, indicating that there is an increased risk of developing colon cancer after radiotherapy for cervical cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for prostate cancer increase bladder cancer risk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the relationship between radiotherapy for prostate cancer and the risk of bladder cancer, considering the potential side effects of radiation treatment on surrounding tissues and organs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a role for MRPL53 in cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the function and implications of MRPL53 in cellular processes and its potential link to cancer. MRPL53 is a mitochondrial ribosomal protein, which suggests its primary role is in the translation of mitochondrial mRNAs into proteins. Mitochondria are crucial for energy production, and alterations in their function can impact cellular metabolism, proliferation, and survival - all of which are relevant to cancer development and progression. If MRPL53 is involved in maintaining mitochondrial function or if its dysregulation affects cellular metabolism, there could indeed be a role for MRPL53 in cancer, either as a factor influencing tumor growth, metastasis, or response to therapy.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is there a role for TET proteins in invariant natural killer T cells (iNKT) cell fate?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"TET proteins are involved in DNA demethylation and have been implicated in the regulation of gene expression in various cell types, including immune cells. Invariant natural killer T cells (iNKT) are a subset of T cells that play a crucial role in bridging the innate and adaptive immune responses. The role of TET proteins in iNKT cell fate is an area of ongoing research, with studies suggesting that TET proteins may regulate the expression of key genes involved in iNKT cell development and function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the question about Uc.63+ and its potential role in promoting sensitivity to treatment in prostate cancer, it's essential to consider what Uc.63+ refers to and its implications in cancer research. However, without specific details on what Uc.63+ is, the question is challenging to address directly. Assuming Uc.63+ could refer to a specific gene, protein, or compound related to cancer treatment, the question essentially inquires whether this entity enhances the effectiveness of treatments for prostate cancer.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Do de novo truncating mutations in WASF1 cause cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to understand what de novo truncating mutations are and how they might affect the WASF1 gene. De novo mutations are genetic alterations that are not inherited from either parent, but rather occur spontaneously in the individual. Truncating mutations are a type of mutation that leads to the premature termination of protein synthesis, often resulting in a non-functional protein. The WASF1 gene is involved in various cellular processes, including cytoskeleton remodeling and cell migration. Mutations in this gene could potentially disrupt these processes, leading to uncontrolled cell growth or other cancer-related phenotypes. However, the direct link between de novo truncating mutations in WASF1 and cancer would depend on specific scientific evidence.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does the Mcm2-Ctf4-PolÎ± axis play a role in transfer of histones to leading strand DNA at the replication forks?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The Mcm2-Ctf4-PolÎ± axis is involved in the replication process, specifically in the transfer of histones to leading strand DNA at the replication forks. This process is crucial for maintaining genome stability and ensuring proper chromatin assembly during DNA replication.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is AND-1/Ctf4 essential for proliferation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"AND-1/Ctf4 is a protein that plays a crucial role in the replication process, particularly in the initiation and elongation phases of DNA replication. It interacts with DNA polymerase and other replication factors to ensure accurate and efficient DNA synthesis. Given its involvement in DNA replication, it is reasonable to consider its importance in cell proliferation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a BRCA mutation analysis in the Greek population?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the availability of genetic testing and research within the Greek population, specifically focusing on BRCA mutations which are associated with increased risks of breast and ovarian cancer. Various studies and genetic services around the world, including in Greece, have been conducting analyses to identify and understand the prevalence of BRCA1 and BRCA2 mutations among different populations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can Patient-derived organoids (PDOs) recapitulate patient responses in the clinic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Patient-derived organoids (PDOs) are three-dimensional cell cultures derived from patient tissues, and they have been shown to recapitulate the genetic and phenotypic characteristics of the original tumor or tissue. Studies have demonstrated that PDOs can be used to predict patient responses to various treatments, including chemotherapy and targeted therapies. The use of PDOs in personalized medicine has the potential to revolutionize the way we approach cancer treatment and other diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Verubecestat effective for Alzheimer's Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Verubecestat is an investigational drug that was being studied for its potential to treat Alzheimer's disease. It was designed to inhibit the beta-site amyloid precursor protein cleaving enzyme (BACE1), which is involved in the production of beta-amyloid, a protein that accumulates in the brains of people with Alzheimer's disease. However, in 2018, the drug's developer, Merck, announced that it was discontinuing the development of Verubecestat due to lack of efficacy in clinical trials.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The LINCS L1000 data set is a collection of gene expression profiles for various cell lines treated with different drugs, the data set contains information on how gene expression changes in response to drug treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is bortezomib a Proteasome inhibitor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bortezomib is a drug used in the treatment of certain cancers. It works by inhibiting the 26S proteasome, a protein complex involved in degrading ubiquitinated proteins. This inhibition can affect various cellular processes, including those involved in cell cycle regulation and apoptosis. Given its mechanism of action, bortezomib can indeed be classified as a proteasome inhibitor.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are breaks in double stranded DNA associated with ionizing radiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ionizing radiation is known to cause damage to DNA, including double-stranded breaks. This type of radiation has enough energy to remove tightly bound electrons from atoms, resulting in the formation of free radicals that can damage DNA. Double-stranded breaks are particularly harmful because they can lead to genetic instability and cancer if not properly repaired. Therefore, it is reasonable to conclude that breaks in double-stranded DNA are indeed associated with ionizing radiation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Thymoquinone is ineffective against radiation induced enteritis, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Thymoquinone has been studied for its potential protective effects against radiation-induced damage, including enteritis. However, the effectiveness of thymoquinone specifically against radiation-induced enteritis needs to be evaluated based on scientific evidence. Enteritis refers to inflammation of the intestines, which can be a complication of radiation therapy, particularly in the treatment of abdominal or pelvic cancers. Thymoquinone, a compound found in the seeds of Nigella sativa, has been researched for its antioxidant, anti-inflammatory, and potential anti-cancer properties. While it shows promise in various medical applications, its efficacy in preventing or treating radiation-induced enteritis would depend on specific studies targeting this condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Autophagy is a process where cells degrade and recycle their own components, it is not directly related to how a virus obtains nutrients from its host.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are stretch enhancers transcribed more than super-enhancers?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Stretch enhancers and super-enhancers are both types of regulatory elements in the genome that play crucial roles in gene expression. Super-enhancers are large clusters of enhancers that are densely occupied by transcriptional coactivators and are often associated with cell identity genes. Stretch enhancers, on the other hand, are large domains of active chromatin that can span hundreds of kilobases and are thought to regulate gene expression through long-range chromatin interactions. The question of whether stretch enhancers are transcribed more than super-enhancers requires an understanding of their transcriptional activity.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is the FIP virus thought to be a mutated strain for the Feline enteric Coronavirus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The FIP virus, or Feline Infectious Peritonitis virus, is indeed closely related to the Feline enteric Coronavirus. Research suggests that FIP virus is a mutated strain of the Feline enteric Coronavirus, which typically causes mild gastrointestinal symptoms in cats. The mutation allows the virus to infect and replicate within certain cells of the cat's immune system, leading to the more severe and often fatal disease known as FIP.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Poliosis circumscripta refers to a condition characterized by a well-defined area of depigmentation, which can affect both the skin and hair. This condition is indeed marked by the presence of a white or unpigmented patch, which can be found on the hair or skin.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are stem cell transplants used to treat acute kidney injury?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Stem cell transplants have been explored for various medical treatments, including potential applications in kidney repair. Acute kidney injury (AKI) is a condition where the kidneys suddenly lose their function, and researchers have investigated the use of stem cells to help regenerate or repair damaged kidney tissues. The idea is that stem cells could potentially differentiate into kidney cells, replacing damaged ones and restoring kidney function. However, the effectiveness and safety of this approach are still under investigation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do circular exons increase gene expression?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Circular exons are a type of exon that can be found in some genes, and their presence can affect gene expression. Research has shown that circular exons can lead to increased gene expression in some cases, as they can create additional isoforms of a gene that can be translated into protein. However, the relationship between circular exons and gene expression is complex and can vary depending on the specific gene and context.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Are there lncRNAs that control the extent of neuronal outgrowth?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Long non-coding RNAs (lncRNAs) have been implicated in various cellular processes, including the regulation of neuronal development and function. Neuronal outgrowth, which is critical for the formation of neural circuits, is a complex process that involves the coordinated action of multiple genes and regulatory pathways. Recent studies have identified specific lncRNAs that play a role in controlling the extent of neuronal outgrowth, suggesting a potential mechanism by which these molecules influence neural development and function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Selumetinib effective for low-grade glioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Selumetinib is being studied for its effectiveness in treating low-grade glioma, a type of brain tumor. It is a MEK inhibitor, which means it targets a specific pathway involved in cancer cell growth. Clinical trials have shown promising results, with Selumetinib demonstrating the ability to reduce tumor growth and improve progression-free survival in patients with low-grade glioma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does gavestinel improve outcomes of stroke patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Gavestinel is a drug that was investigated for its potential to improve outcomes in stroke patients. It is a glycine antagonist that was thought to have neuroprotective effects. However, clinical trials have shown mixed results, and its efficacy in improving outcomes of stroke patients is not well established.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can Enlimomab improve stroke outcomes?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Enlimomab is an immunomodulatory drug that has been investigated for its potential to improve outcomes in various conditions, including stroke. The drug works by modulating the immune system's response, which can play a role in the damage caused by stroke. Research into Enlimomab's effects on stroke outcomes has shown promise in preclinical studies, suggesting that it could potentially reduce inflammation and improve recovery. However, the effectiveness of Enlimomab in improving stroke outcomes would depend on the results of clinical trials, which are crucial for determining the safety and efficacy of any new treatment.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Should tirilazad be used for treatment of ischemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Tirilazad is a drug that was investigated for its potential to treat ischemic stroke. It is a 21-aminosteroid compound with antioxidant properties, designed to reduce the damage caused by lipid peroxidation during the acute phase of ischemic stroke. However, clinical trials did not demonstrate a significant benefit of tirilazad in improving outcomes in patients with ischemic stroke, leading to its limited use or recommendation for this purpose.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Aptiganel effective for treatment of stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Aptiganel is a drug that was investigated for its potential to treat stroke by acting as an NMDA receptor antagonist. However, its development and clinical trials did not yield sufficient evidence to support its efficacy and safety for this indication. As a result, it did not receive approval for the treatment of stroke.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should Lubeluzole be used for treatment of ischemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Lubeluzole is a drug that was investigated for its potential to treat ischemic stroke by inhibiting the release of glutamate, a neurotransmitter involved in the pathology of stroke. However, clinical trials did not demonstrate a significant benefit in improving outcomes for patients with acute ischemic stroke, leading to its limited use or recommendation against its use for this purpose.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is there a vaccine for peanut allergy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Currently, there are no widely approved vaccines for peanut allergy, but research into immunotherapies and desensitization treatments is ongoing.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Have toll-like receptor 2 activators been found in food?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Toll-like receptor 2 (TLR2) is a protein that plays a key role in the innate immune system. It recognizes and responds to various microbial components, including those from bacteria, viruses, and fungi. The question asks whether TLR2 activators have been found in food, which implies the presence of substances in food that can activate TLR2 and potentially modulate immune responses. To answer this, we need to consider the types of compounds that are known to activate TLR2 and whether these compounds are present in food sources.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Rad4/XPC a DNA damage sensing protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Rad4/XPC is a protein complex involved in the recognition of DNA damage, specifically in the nucleotide excision repair pathway. It plays a crucial role in detecting distortions in the DNA helix caused by UV-induced photoproducts and other types of DNA damage.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there interactions between short and long noncoding RNAs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Interactions between short and long noncoding RNAs can occur through various mechanisms, including competition for shared microRNA binding sites, regulation of transcription, and influence on chromatin structure. These interactions can have significant effects on gene expression and cellular processes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Indinavir is an antiretroviral drug used to treat HIV/AIDS. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. There is no established link between indinavir and the treatment of ALS. The effectiveness of indinavir for ALS treatment is not supported by scientific evidence.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is golimumab effective for sarcoidosis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Golimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha), which plays a role in inflammation. Sarcoidosis is a disease characterized by inflammation in various parts of the body. Research and clinical trials have investigated the efficacy of golimumab in treating sarcoidosis, particularly in patients who do not respond to conventional therapies. The effectiveness of golimumab for sarcoidosis can depend on various factors, including the severity of the disease, the specific organs involved, and the patient's overall health.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is marimastat effective for small-cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Marimastat is a matrix metalloproteinase inhibitor that has been investigated for its potential in treating various types of cancer, including small-cell lung cancer. The effectiveness of marimastat for small-cell lung cancer would depend on clinical trial results and research data.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are astronauts in higher risk for developing cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Astronauts are exposed to higher levels of cosmic radiation in space, which can increase their risk of developing cancer. Prolonged space missions and deeper space travel increase this risk due to the higher and more prolonged exposure to cosmic radiation. However, the current evidence and research are still being studied to fully understand the extent of this risk.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is g-H2AX a marker for double strand breaks?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether g-H2AX is a marker for double strand breaks. g-H2AX, also known as gamma-H2AX, is a phosphorylated form of the H2AX protein, which is a component of the histone H2A family. It is known to play a critical role in the response to DNA damage, particularly double-strand breaks (DSBs). When DSBs occur, the H2AX protein surrounding the break is phosphorylated, forming g-H2AX. This phosphorylation event serves as a signal that recruits DNA repair proteins to the site of damage, facilitating the repair process. Therefore, the presence of g-H2AX is often used as an indicator or marker of double-strand breaks in cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does natalizumab improve disease course of secondary progressive multiple sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Natalizumab is a medication used to treat multiple sclerosis (MS). It is known to be effective in treating relapsing forms of MS. Secondary progressive MS (SPMS) is a type of MS where the disease worsens more steadily over time, with or without occasional flare-ups, after an initial relapsing-remitting course. The effectiveness of natalizumab in SPMS is not as well-established as in relapsing-remitting MS, and clinical trials have shown mixed results.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are multipotent adult progenitor cells effective for treatment of stroke?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Multipotent adult progenitor cells have been studied for their potential in treating various diseases, including stroke. These cells have the ability to differentiate into multiple cell types, which could potentially replace or repair damaged cells in the brain after a stroke. Research has shown that these cells can promote neuroregeneration, reduce inflammation, and improve functional outcomes in animal models of stroke. However, the effectiveness of multipotent adult progenitor cells for the treatment of stroke in humans is still being investigated in clinical trials.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is ozanezumab effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Ozanezumab is an antibody that targets the Nogo-A protein, which is involved in inhibiting axonal regeneration. It has been investigated as a potential treatment for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease. However, clinical trials have shown mixed results, and its efficacy is still uncertain.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are gut microbiota profiles altered by irradiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Irradiation can have significant effects on the gut microbiota, with studies showing changes in the composition and diversity of gut microbiota profiles after exposure to radiation. This alteration can be due to the direct effects of radiation on microbial cells or indirect effects through changes in the host's immune system and gut environment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are genomic regulatory blocks (GRBs) any different than TADs?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Genomic regulatory blocks (GRBs) and topologically associating domains (TADs) are both concepts related to the spatial organization of chromosomes. TADs refer to regions of the genome where chromatin interactions are more frequent within the domain than with adjacent domains, suggesting a level of insulation or separation between different genomic regions. GRBs, on the other hand, specifically refer to larger chromosomal regions that encompass multiple genes and their regulatory elements, which are thought to be coordinately regulated. While TADs are more about the physical organization and insulation of chromatin, GRBs focus on the regulatory aspect, implying a functional coordination within these blocks. Therefore, while there is overlap between the concepts, with GRBs often being contained within TADs, they are not exactly the same thing.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is Nivolumab (Opdivo) a PD-L1 inhibitor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Nivolumab, also known as Opdivo, is a medication used in the treatment of various types of cancer. It works by targeting the PD-1 receptor on T cells, which are a type of immune cell. PD-L1 is a protein that can bind to the PD-1 receptor, helping cancer cells evade the immune system. While Nivolumab targets the PD-1 receptor, there are other medications that specifically target the PD-L1 protein.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is PF-05190457 an inverse agonist of the ghrelin receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"PF-05190457 is a compound that has been studied for its potential effects on the ghrelin receptor. The ghrelin receptor, also known as the growth hormone secretagogue receptor (GHSR), plays a significant role in regulating various physiological processes, including appetite, energy balance, and growth hormone secretion. An inverse agonist is a type of drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist. To determine if PF-05190457 acts as an inverse agonist of the ghrelin receptor, we need to consider its mechanism of action and how it interacts with the GHSR.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Analyzing the relationship between LY6K overexpression and non-small cell lung cancer prognosis to determine if it leads to better outcomes for patients.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does the BRAFV600E mutation have an effect on clinical response to radioiodine therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The BRAFV600E mutation is a genetic alteration commonly found in papillary thyroid cancer, which can affect the behavior of the cancer cells. Radioiodine therapy is a treatment used for certain types of thyroid cancer, including papillary thyroid cancer. The effectiveness of radioiodine therapy depends on the ability of the thyroid cells to uptake iodine. The BRAFV600E mutation may influence the clinical response to radioiodine therapy by altering the iodine uptake and retention in thyroid cancer cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does metformin has as an antitumor effect?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Metformin is a medication commonly used to treat type 2 diabetes, and there is evidence to suggest that it may have antitumor effects. Research has shown that metformin can inhibit the growth of cancer cells and induce apoptosis, or cell death, in various types of cancer, including breast, prostate, and colon cancer. The exact mechanisms by which metformin exerts its antitumor effects are not fully understood, but it is thought to involve the activation of AMP-activated protein kinase (AMPK) and the inhibition of the mTOR pathway, which are both involved in cell growth and proliferation. Additionally, metformin has been shown to have anti-angiogenic effects, which can help to prevent the formation of new blood vessels that tumors need to grow and spread.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"xaliproden is a drug that has been studied for its potential to improve the prognosis of amyotrophic lateral sclerosis (ALS), a progressive and fatal neurodegenerative disease. The question requires an analysis of the available clinical trial data and research findings to determine whether xaliproden has a positive effect on the prognosis of ALS patients.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is celecoxib effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that has been studied for its potential effects on various conditions, including amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Research into the effectiveness of celecoxib for ALS has been conducted, but the outcomes have been mixed or inconclusive, with some studies suggesting potential benefits in slowing disease progression and others finding no significant effect. The use of celecoxib for ALS would be considered off-label, as it is not approved specifically for this condition. Given the complexity of ALS and the variability in patient responses to different treatments, the effectiveness of celecoxib can depend on various factors, including the stage of the disease and the individual patient's condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should Pentoxifylline be used for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Pentoxifylline is a medication that has been used for various conditions, including improving blood flow and reducing inflammation. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease. The question is whether Pentoxifylline should be used for the treatment of ALS. To answer this, we need to consider the efficacy and safety of Pentoxifylline in the context of ALS treatment. There is limited evidence to suggest that Pentoxifylline has a significant benefit in treating ALS. Most treatments for ALS focus on slowing the progression of the disease and managing its symptoms, and the primary treatments are riluzole and edaravone, which have shown some efficacy in clinical trials. Without strong evidence supporting the use of Pentoxifylline for ALS, its use for this purpose is not generally recommended.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Analyzing the question about the use of minocycline for amyotrophic lateral sclerosis (ALS) involves looking into clinical trial data. Minocycline is an antibiotic that has been explored for its potential neuroprotective effects. The question essentially asks whether there is clinical evidence to support its use in treating ALS.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Dexmecamylamine effective for depression?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Dexmecamylamine is a medication that has been used for various purposes, including as an anticholinergic and ganglionic blocker. However, its effectiveness for treating depression is not well-established. The primary use of Dexmecamylamine has been for conditions such as hypertension and for its antispasmodic properties, rather than for psychiatric disorders like depression. There is limited information available on its efficacy for depression, suggesting it is not a commonly recommended treatment for this condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is NicVAX vaccine effective for smoking cessation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"NicVAX is a vaccine designed to help people quit smoking by targeting the nicotine molecule, making it less effective at producing the pleasurable effects that lead to addiction. The vaccine works by stimulating the immune system to produce antibodies that bind to nicotine, preventing it from entering the brain and reducing the rewarding effects of smoking. However, the effectiveness of NicVAX has been a subject of debate and research.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Figitumumab effective for non-small cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Figitumumab is an investigational drug that has been studied for its potential in treating various types of cancer, including non-small cell lung cancer. The effectiveness of Figitumumab for non-small cell lung cancer is based on clinical trials and research studies. However, as of my last update, it has not received approval for this specific use, suggesting limitations or lack of sufficient evidence to support its efficacy in this context.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Semagacestat effective for Alzheimer's Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Semagacestat is a gamma-secretase inhibitor that was investigated as a potential treatment for Alzheimer's disease. However, clinical trials have shown that it does not significantly slow down cognitive decline in patients with Alzheimer's disease and may even have adverse effects.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can Systemic Lupus Erythematosus cause seizures?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect various parts of the body, including the nervous system. Neurological manifestations of SLE can include seizures, which are a type of abnormal electrical activity in the brain. The exact mechanism by which SLE causes seizures is not fully understood, but it is thought to be related to inflammation and autoantibody production in the brain.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is MAGE-A3 immunotherapeutic effective for non-small-cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"MAGE-A3 is a type of immunotherapeutic that has been studied for its effectiveness in treating various types of cancer, including non-small-cell lung cancer. The MAGE-A3 antigen is expressed in many types of cancer cells, making it a potential target for immunotherapy. Several clinical trials have been conducted to evaluate the efficacy of MAGE-A3 immunotherapeutic in non-small-cell lung cancer.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Impetigo a viral infection that affects the skin?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Impetigo is a highly contagious skin infection, but it can be caused by either bacterial or viral pathogens, with the most common causes being Staphylococcus aureus and Streptococcus pyogenes. However, it can also be caused by viral infections such as herpes simplex virus or coxsackievirus, though bacterial causes are more prevalent.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Î±CGRP a member of the CGRP family?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the question, it asks if Î±CGRP is a member of the CGRP family. Î±CGRP stands for alpha calcitonin gene-related peptide, which is a peptide that belongs to the calcitonin family of peptides. The CGRP family includes several peptides, with Î±CGRP and Î²CGRP being the most well-known. Given this context, Î±CGRP indeed falls within the CGRP family.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do genes with monoallelic expression contribute proportionally to genetic diversity in humans?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Genes with monoallelic expression are those where only one allele is expressed, while the other allele is silenced. This phenomenon can contribute to genetic diversity by allowing for the expression of different alleles in different cells or tissues, which can lead to increased variation in the population. However, the extent to which monoallelic expression contributes to genetic diversity is still a topic of research and debate.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is deletion at 6q24.2-26 associated with shorter survival for ovarian cancer patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the potential impact of genetic deletions on cancer prognosis. Deletions at specific chromosomal regions can lead to the loss of tumor suppressor genes, which are crucial for controlling cell growth and preventing cancer. The region 6q24.2-26 is of interest in various cancers for its potential to harbor genes that, when deleted, could contribute to a more aggressive cancer phenotype. In the context of ovarian cancer, any genetic alteration that disrupts normal cellular regulation could potentially lead to a worse outcome. Therefore, considering the role of genetic alterations in cancer progression and prognosis, it is plausible that a deletion at 6q24.2-26 could be associated with shorter survival in ovarian cancer patients.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does promoter shape vary across populations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the shape of promoters, which are regions of DNA that initiate transcription, varies across different populations. This requires an understanding of genetics and population biology. Promoters are crucial for gene expression, and their shape or structure could influence how genes are turned on or off. Variations in promoter shape could be due to genetic differences among individuals or populations, potentially affecting how genes are expressed and contributing to phenotypic diversity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the CADM2 gene associated with differences in information processing speed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The CADM2 gene has been studied for its potential role in various cognitive functions, including information processing speed. Research has indicated that genetic variations can influence individual differences in cognitive abilities. Therefore, it is plausible that the CADM2 gene could be associated with differences in information processing speed.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is KAT2A involved in Acute myeloid leukemia (AML)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"KAT2A, also known as GCN5, is a histone acetyltransferase that has been implicated in various types of cancer, including leukemia. Acute myeloid leukemia (AML) is a type of blood cancer characterized by the rapid growth of abnormal white blood cells. Research has shown that KAT2A is overexpressed in AML and plays a role in the development and progression of the disease. KAT2A has been found to regulate the expression of genes involved in cell proliferation, differentiation, and survival, which are critical for the maintenance of leukemia cells. Therefore, KAT2A is indeed involved in AML.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question is asking whether AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1. To answer this, we need to consider the role of AhR ligands and their relationship with Cyp1a1. AhR stands for aryl hydrocarbon receptor, which is a ligand-activated transcription factor involved in the regulation of biological responses to planar aromatic hydrocarbons. Cyp1a1 is a gene that encodes for an enzyme involved in the metabolism of various substances, including drugs and toxins. The induction of Cyp1a1 by AhR ligands can have significant implications for drug development, as it may affect the metabolism and efficacy of drugs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Glucoraphanin from broccoli can help reduce obesity , yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Glucoraphanin is a compound found in broccoli that has been studied for its potential health benefits, including its effects on obesity. Research has shown that glucoraphanin may have anti-obesity properties by influencing various biological pathways involved in energy metabolism and fat storage.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has saracatinib been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Saracatinib is a drug that has been investigated for its potential therapeutic effects. To determine whether it has been tested in clinical trials, a review of clinical trial databases and scientific literature is necessary. Clinical trials are a crucial step in the development and approval of new drugs, allowing researchers to assess their safety and efficacy in humans.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does saracatinib promote oncogenesis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Saracatinib is a Src kinase inhibitor that has been investigated for its potential to treat various types of cancer. However, its role in oncogenesis, which is the process by which normal cells are transformed into cancer cells, needs to be considered. Src kinase is known to play a role in the regulation of cell growth, differentiation, and survival, and its overexpression or abnormal activity has been implicated in the development and progression of several types of cancer. By inhibiting Src kinase, saracatinib could potentially suppress oncogenic processes. Nevertheless, the complexity of cancer biology and the potential for compensatory mechanisms or off-target effects mean that the overall impact of saracatinib on oncogenesis could be nuanced and dependent on the specific context of its use.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Has MLE4901 been tested in phase III clinical trials?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, we need to check the current status of MLE4901 in clinical trials. MLE4901, also known as Nelotanserin, is a drug that has been investigated for various potential therapeutic uses. Checking the latest clinical trial databases and research publications will provide the most accurate information on whether MLE4901 has been tested in phase III clinical trials.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does ESN364 activate the hypothalamic-pituitary-gonadal axis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to understand what ESN364 is and its effects on the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a complex neuroendocrine system that regulates reproductive and sexual functions in the body. If ESN364 is a compound or substance that influences this axis, it could potentially activate it, leading to various physiological responses related to reproduction and development.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is traditional Chinese medicine associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the potential interactions between traditional Chinese medicine (TCM) and doxorubicin treatment in breast cancer patients, focusing on the risk of heart failure. Doxorubicin is known for its cardiotoxic effects, which can lead to heart failure. If TCM has properties that mitigate this cardiotoxicity or enhance cardiac protection, it could theoretically decrease the risk of heart failure in these patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein ABCG2 (ATP-Binding Cassette, subfamily G, member 2, transporter) excreting uric acid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The protein ABCG2 is a transporter involved in the efflux of various compounds, including drugs and metabolites. It has been implicated in the transport of uric acid, a byproduct of purine metabolism. Research suggests that ABCG2 plays a role in the excretion of uric acid from the body.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein ABCG2 transmembrane?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The protein ABCG2 is known to be involved in the transport of various substances across cell membranes, suggesting it has transmembrane properties. Analysis of its structure indicates it spans the membrane multiple times, which is characteristic of transmembrane proteins.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can brain derived exosomes carry APP molecules?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Brain-derived exosomes are known to carry various molecules, including proteins and RNAs, between cells in the brain. Amyloid precursor protein (APP) is a key protein involved in Alzheimer's disease. Research has shown that exosomes can indeed carry APP molecules, which may play a role in the spread of Alzheimer's disease pathology. Therefore, considering the role of exosomes in intercellular communication and the involvement of APP in neurodegenerative diseases, it is reasonable to conclude that brain-derived exosomes can carry APP molecules.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can Flotillin be used as exosomal marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Flotillin is a protein that has been associated with lipid rafts and has been found in exosomes. It is often used as a marker for exosomes, along with other proteins such as CD9, CD63, and CD81. The presence of Flotillin in exosomes can be used to identify and isolate these vesicles.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has the Spanich flu virus been reconstructed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The Spanish flu, also known as the 1918 flu pandemic, was a global outbreak caused by an H1N1 influenza A virus. In 2005, researchers announced that they had reconstructed the 1918 Spanish flu virus from fragments of viral RNA recovered from preserved tissue samples from victims of the pandemic. The reconstruction was done to study the virus and understand its virulence and transmissibility.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Liâ€“Fraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Li-Fraumeni syndrome is a rare genetic disorder that significantly increases the risk of developing several types of cancer, particularly in children and young adults. It is known to be inherited in an autosomal dominant pattern, meaning a mutation in one of the two copies of the gene is sufficient to increase cancer risk. The most common genetic cause is a mutation in the TP53 tumor suppressor gene.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are ICAMS, Intracellular Adhesion Molecules, part of the immunoglobulin superfamily?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"ICAMS, or Intracellular Adhesion Molecules, are a type of molecule involved in cell adhesion and the immune response. The immunoglobulin superfamily is a large group of proteins that share structural and sequence similarities to immunoglobulins, or antibodies. ICAMS, specifically ICAM-1, are known to belong to this superfamily due to their structural characteristics and their role in immune cell interactions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The Paramyxovirus genome consists of a single strand of RNA. It is a negative-sense RNA virus, meaning its genetic material needs to be transcribed into a complementary positive-sense RNA before it can be translated into proteins. The genome is not segmented, it is a single piece of RNA.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is there a vaccine for rotavirus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Rotavirus is a common cause of diarrhea and vomiting, especially in children. Vaccines have been developed to protect against rotavirus infection. The most commonly used vaccines are RotaTeq and Rotarix, which have been shown to be effective in preventing severe rotavirus disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors(MPNST) rare in neurofibromatosis patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors (MPNST) are a type of tumor that arises from the nerve sheath, and they can occur in patients with neurofibromatosis. Neurofibromatosis is a genetic disorder that increases the risk of developing certain types of tumors, including MPNST. However, the specific occurrence of Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors in neurofibromatosis patients needs to be considered in the context of their overall rarity and the increased risk associated with neurofibromatosis.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does AZD3759 cross the blood brain barrier?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"AZD3759 is a drug that has been investigated for its potential to cross the blood-brain barrier, which is a specialized barrier that separates the brain from the bloodstream. To answer this question, we need to consider the properties of AZD3759 and its ability to penetrate the central nervous system.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is PTEN a tumour suppressor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"PTEN is a gene that encodes a protein that acts as a tumor suppressor by regulating cell division and preventing the growth of cancer cells. The PTEN protein helps to repair damaged DNA and can initiate programmed cell death, or apoptosis, in cells with damaged DNA. Mutations in the PTEN gene have been associated with a range of cancers, including prostate, breast, and brain tumors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is MLL3 part of the ASCOM complex?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"MLL3 is a histone methyltransferase and part of the ASCOM complex, which is involved in various cellular processes including transcriptional regulation and chromatin modification.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are astrocytes part of the blood brain barrier?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Astrocytes are a type of glial cell in the brain that play a crucial role in maintaining the blood-brain barrier (BBB). They have foot processes that ensheath the capillaries, regulating the exchange of substances between the blood and the brain. This suggests a close relationship between astrocytes and the blood-brain barrier.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein MCL-1 anti-apoptotic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"MCL-1 is a member of the BCL-2 family of proteins, which are known to play a crucial role in regulating apoptosis. The BCL-2 family includes both pro-apoptotic and anti-apoptotic proteins. MCL-1 is classified as an anti-apoptotic protein because it acts to inhibit apoptosis, or programmed cell death.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are bacteria in the genus Clostridium facultative anaerobes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Clostridium genus bacteria are typically known for their ability to thrive in environments with little to no oxygen. Facultative anaerobes are organisms that can live with or without oxygen, switching between aerobic and anaerobic respiration as needed. Obligate anaerobes, on the other hand, cannot survive in the presence of oxygen. The genus Clostridium includes species that are known to be obligate anaerobes, meaning they require an oxygen-free environment to grow and cannot survive in the presence of oxygen.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Has ORMD-0801 been tested in patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to check if there is any information available about ORMD-0801 being tested in patients, which would typically involve clinical trials.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Was vivotif licensed in Europe and the US at the same time?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Vivotif is an oral typhoid vaccine. To answer whether it was licensed in Europe and the US at the same time, we need to consider the regulatory approval processes in both regions. The vaccine has been used globally for protection against typhoid fever, a disease caused by Salmonella Typhi. Licensing and approval timelines can vary between the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) due to differences in regulatory requirements and review processes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can AGY be used as antidiuretic replacement therapy?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"AGY, or arginine vasopressin, is a synthetic version of the antidiuretic hormone (ADH), which plays a crucial role in regulating water balance in the body. Its mechanism of action involves binding to vasopressin receptors in the kidneys, promoting water reabsorption and thus reducing urine production. Given its biological activity and pharmacological properties, AGY could potentially be used to replace or mimic the action of natural ADH in conditions where its deficiency or dysfunction leads to excessive urine production, such as in central diabetes insipidus. Therefore, considering its pharmacological profile and the underlying pathophysiology of conditions requiring antidiuretic replacement therapy, AGY could indeed serve as an antidiuretic replacement therapy.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Have the rotavirus vaccines changed the predominant rotavirus genotypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The introduction of rotavirus vaccines has had an impact on the epidemiology of rotavirus infections, potentially altering the distribution of predominant rotavirus genotypes. Rotavirus vaccines have been highly effective in reducing the incidence of severe rotavirus gastroenteritis, especially in countries with high vaccination coverage. However, the vaccines may exert selective pressure on the rotavirus population, potentially leading to changes in the predominant genotypes over time. Studies have indeed observed shifts in the genotype distribution in some regions following the introduction of vaccination programs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can leuprorelin acetate be used as androgen deprivation therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Leuprorelin acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist, which can be used to treat hormone-responsive cancers such as prostate cancer by reducing testosterone levels, thus it can be used as androgen deprivation therapy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can MVA85A confer immunity against smallpox?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"MVA85A is a vaccine designed to protect against tuberculosis, but it is based on a modified vaccinia virus Ankara, which is related to the smallpox vaccine. The question is whether MVA85A can confer immunity against smallpox.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is the drug Exubera currently (March 2020) available?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Exubera is an inhalable insulin drug that was approved by the FDA in 2006 but was withdrawn from the market in 2007 due to poor sales. As of March 2020, it is not available on the market.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Has the drug Afrezza been approved by the FDA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks whether the drug Afrezza has been approved by the FDA. To answer this, we need to know the current status of Afrezza's approval. Afrezza is an inhalable insulin powder used for the control of high blood sugar in adults with type 1 and type 2 diabetes. It was developed by MannKind Corporation. Checking the FDA's approval history, Afrezza received FDA approval on June 27, 2014.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine are both produced by Sanofi Pasteur, which suggests they are made by the same company.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can Daptacel be used instead of IPOL?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Daptacel is a vaccine that protects against diphtheria, tetanus, and pertussis, while IPOL is a vaccine that protects against polio. They are different vaccines and cannot be used interchangeably.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can CMB305 be used against sarcomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CMB305 is an oncolytic virus being researched for its potential to treat various types of cancer, including sarcomas. The question inquires about the specific application of CMB305 against sarcomas, which requires an understanding of its current research status and clinical trials.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has ZP-PTH been tested in a phase II clinical trial?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to know if ZP-PTH has been tested in a phase II clinical trial. This requires knowledge of current clinical trials and their status.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SARS virus interacting with ACE2 encoded protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The SARS virus is known to interact with the ACE2 encoded protein, which is an enzyme that plays a crucial role in regulating blood pressure. The virus uses the ACE2 protein as a receptor to gain entry into host cells, specifically binding to the protein on the surface of cells in the lungs and other organs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is ACE2 expressed on cell surfaces?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"ACE2, or angiotensin-converting enzyme 2, is known to play a significant role in the renin-angiotensin system and has been identified as the receptor for the SARS-CoV and SARS-CoV-2 viruses. Its expression on cell surfaces is crucial for the viruses to enter and infect cells. Given its function as a receptor, it is logical to deduce that ACE2 must be expressed on the surfaces of cells to facilitate its interaction with these viruses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is cathepsin L active in endosomes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cathepsin L is a lysosomal cysteine protease, which implies it is active in the lysosomes. However, the question asks about its activity in endosomes. Endosomes are compartments that are part of the endocytic pathway and can fuse with lysosomes, forming endolysosomes. Given that cathepsin L is involved in protein degradation and is active in acidic environments, such as those found in lysosomes and potentially in late endosomes or endolysosomes, it suggests that cathepsin L could indeed be active in certain types of endosomes, especially those that are transitioning towards or have merged with lysosomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is endotrophin derived from collagen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Endotrophin is a protein fragment that has been studied for its role in various biological processes, including fibrosis and cancer. It is derived from the breakdown of collagen type VI, which is a type of collagen found in the extracellular matrix.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Protoporphyrinogen oxidase localized to the mitochondrium?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Protoporphyrinogen oxidase is an enzyme involved in the biosynthesis of heme, a crucial component of hemoglobin and other hemoproteins. The localization of this enzyme is important for understanding its role in cellular processes. The mitochondrium is a key organelle where many enzymatic reactions, including those involved in heme synthesis, take place.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is aggrephagy a variant of autophagy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Aggrephagy refers to the process of autophagy that specifically targets protein aggregates for degradation. Autophagy is a cellular process responsible for the degradation and recycling of cellular components. Given that aggrephagy involves the selective removal of protein aggregates through autophagic pathways, it can be considered a variant or a subtype of autophagy focused on aggregate clearance.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does protein ALEX1 contain armadillo repeats?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to analyze the structure of protein ALEX1 and determine if it contains armadillo repeats, which are a type of protein domain. Armadillo repeats are a series of helical repeats that are often involved in protein-protein interactions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Bcl-2-like protein 1 an pro apoptotic protein?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Bcl-2-like protein 1, also known as Bcl-xL or Bcl2l1, is a member of the Bcl-2 family of proteins. The Bcl-2 family is known for its role in regulating apoptosis, or programmed cell death. While some members of this family are anti-apoptotic, others are pro-apoptotic. Bcl-2-like protein 1 is generally considered to be anti-apoptotic, as it can inhibit apoptosis by preventing the release of cytochrome c from mitochondria and thereby blocking the activation of caspases, which are key enzymes in the apoptotic pathway.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do nematodes contain a CTCF gene?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer whether nematodes contain a CTCF gene, we need to understand what CTCF is and its presence across different species. CTCF, or CCCTC-binding factor, is a highly conserved transcription factor found in many organisms, playing crucial roles in genome regulation, including chromatin insulation, long-range chromatin interactions, and transcriptional control. Nematodes, a diverse phylum of unsegmented, bilaterally symmetrical worms, include species like Caenorhabditis elegans, which is a widely used model organism in biological research. The presence of specific genes in nematodes can be determined through genomic sequencing and comparative genomics studies. Given the essential regulatory functions of CTCF in other organisms, it's plausible that nematodes could have a homolog of the CTCF gene, but the confirmation would depend on specific genomic analyses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Steroid 5A-Reductase deficiency is a genetic disorder that affects the production of dihydrotestosterone (DHT), a hormone involved in the development of male characteristics. Individuals with this deficiency are often born with external genitalia that appear female or ambiguous, despite having a 46,XY karyotype. As they mature, they may develop male secondary sexual characteristics, such as facial hair and a deep voice. The condition does not typically result in hermaphroditism, which is a condition where an individual has both ovarian and testicular tissue. Instead, individuals with 5A-Reductase deficiency usually have testes and a male internal genital tract, but may have external genitalia that are not typically male.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is the TFR1 gene dispensable for erythropoiesis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The TFR1 gene, also known as transferrin receptor 1, plays a crucial role in the regulation of iron metabolism, which is essential for erythropoiesis, the process of red blood cell production. However, studies have shown that while TFR1 is important for iron uptake in erythroid cells, its absence can be compensated by other mechanisms, suggesting a level of dispensability in certain contexts.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Are somatic mutations positioned towards the nuclear periphery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Somatic mutations are genetic alterations that occur in non-germline cells and are not inherited. The positioning of these mutations within the cell nucleus can be influenced by various factors, including the nuclear architecture and the organization of chromatin. Research has shown that the nuclear periphery is a distinct environment that can affect the frequency and distribution of somatic mutations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Mediator present at super enhancers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mediator is a large protein complex that plays a crucial role in regulating gene transcription. Super enhancers are regions of the genome that are densely occupied by transcription factors and other regulatory proteins, and are often associated with highly expressed genes. The Mediator complex has been shown to interact with transcription factors and RNA polymerase II, and is thought to play a key role in facilitating the assembly of pre-initiation complexes at enhancers and promoters. Given its role in transcriptional regulation, it is likely that Mediator is present at super enhancers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tcf3 associated with the Wnt pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tcf3, also known as Transcription factor 3, is a transcription factor involved in various cellular processes, including development and cell differentiation. The Wnt signaling pathway is a key regulator of these processes. Tcf3 has been shown to interact with the Wnt/Î²-catenin pathway, which suggests an association between Tcf3 and the Wnt pathway.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Nanog repressed in pluripotent stem cells?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Nanog is a transcription factor that plays a crucial role in maintaining the pluripotency of stem cells. It is typically highly expressed in pluripotent stem cells, such as embryonic stem cells, to help them maintain their ability to differentiate into any cell type. The repression of Nanog would likely lead to a loss of pluripotency. Therefore, considering the role of Nanog in stem cells, it is not repressed in pluripotent stem cells but rather actively expressed.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do nematodes contain architectural proteins like CTCF?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Nematodes are a diverse group of organisms that include roundworms. CTCF (CCCTC-binding factor) is a highly conserved architectural protein found in many eukaryotes, known for its role in genome organization and regulation. The presence of CTCF or CTCF-like proteins in nematodes would suggest a level of complexity in their genome organization similar to that in more complex eukaryotes. Research into the genomes of nematodes, such as Caenorhabditis elegans, has identified various transcription factors and regulatory elements, but specific studies on the presence of architectural proteins like CTCF are necessary to confirm their existence and function in these organisms.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Do polycomb group proteins (PcG) mediate the formation of chromatin loops?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Polycomb group proteins (PcG) are known to play a crucial role in the regulation of gene expression, particularly in the context of chromatin structure and organization. They are involved in the formation of higher-order chromatin structures, including chromatin loops, which are important for the regulation of gene expression. PcG proteins have been shown to interact with other chromatin-associated proteins and DNA elements to facilitate the formation of chromatin loops, which can bring distant regulatory elements into close proximity, thereby influencing gene expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are super enhancers structurally insulated in chromatin loops?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Super enhancers are regions in the genome that drive high-level transcription of genes involved in cell identity. Chromatin loops are three-dimensional structures formed by the folding of chromatin, which can bring distant regulatory elements into close proximity. The relationship between super enhancers and chromatin loops is complex, with evidence suggesting that super enhancers can be located within chromatin loops, but the question of whether they are structurally insulated within these loops requires consideration of the dynamic and hierarchical organization of chromatin. Structural insulation in this context would imply that super enhancers are segregated from other regulatory elements or genes within distinct chromatin loops, potentially facilitating their specific functions. Recent studies have indeed shown that super enhancers often reside in insulated neighborhoods or domains, which are maintained by architectural proteins like CTCF and cohesin. These domains can form loops that keep super enhancers and their target genes in close spatial proximity while insulating them from neighboring regions. Therefore, considering the role of chromatin architecture in regulating gene expression and the specific characteristics of super enhancers, it is reasonable to conclude that super enhancers can indeed be structurally insulated in chromatin loops.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Are there negative enhancers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Negative enhancers are regulatory elements in the DNA that decrease the transcription of a gene when particular transcription factors bind to them. They can be contrasted with traditional enhancers, which increase gene transcription upon the binding of specific transcription factors. The concept of negative enhancers highlights the complexity of gene regulation, where different elements can either promote or suppress gene expression based on the cellular context and the factors involved.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are enhancers directional in their targeting of gene promoters?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Enhancers are short segments of DNA that can increase the transcription of a gene by interacting with its promoter region. The directionality of enhancers in targeting gene promoters is a topic of ongoing research. While enhancers can act over long distances and in an orientation-independent manner, some studies suggest that their activity can be influenced by their position and orientation relative to the promoter.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is the zelda transcription factor a chromatin remodeller?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The Zelda transcription factor is known for its role in regulating gene expression during early Drosophila development. It binds to specific DNA sequences and helps activate the transcription of key genes involved in developmental processes. Chromatin remodellers, on the other hand, are proteins that alter the structure of chromatin, making it more or less accessible to transcription factors and other regulatory proteins. While Zelda itself does not have the characteristic enzymatic activities of chromatin remodellers, its ability to bind and open up chromatin for transcription suggests an indirect role in chromatin remodelling.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is methotrexate used for the treatment of Rheumatoid Arthritis (RA)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Methotrexate is a commonly used medication for the treatment of various conditions, including Rheumatoid Arthritis (RA). It is a disease-modifying antirheumatic drug (DMARD) that helps to reduce inflammation and slow down the progression of the disease. Methotrexate is often prescribed as a first-line treatment for RA, and it is usually taken orally or by injection.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can ATAC-Seq be employed in single-cell mode?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"ATAC-Seq, or Assay for Transposase-Accessible Chromatin using Sequencing, is a method used to analyze chromatin accessibility. Single-cell modes of various sequencing technologies have been developed to study individual cells. Given the nature of ATAC-Seq, which involves the insertion of sequencing adapters into accessible regions of chromatin by a hyperactive transposase, it is theoretically possible to adapt this technique for single-cell analysis. This would involve optimizing the protocol to work with the much smaller amount of DNA present in a single cell, which is a significant technical challenge. However, advancements in molecular biology and sequencing technologies have made it feasible to perform such analyses at the single-cell level.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is yeast fbp1 affected by glucose starvation stress?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Yeast fbp1 is a gene that encodes a protein involved in glucose metabolism. Glucose starvation stress can affect the expression and activity of various genes and proteins in yeast, including those involved in glucose metabolism. Therefore, it is reasonable to consider that yeast fbp1 could be affected by glucose starvation stress.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does an antiphlogistic promotes inflammation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"An antiphlogistic is a type of medication or treatment that is used to reduce or counteract inflammation. The term 'antiphlogistic' itself implies an action against inflammation, which suggests that it does not promote inflammation but rather works to alleviate it.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can SMAD6 variants cause craniosynostosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"SMAD6 is a gene involved in the BMP signaling pathway, which plays a crucial role in bone formation and development. Variants in the SMAD6 gene have been associated with craniosynostosis, a condition characterized by the premature fusion of the bones of the skull. Research has shown that SMAD6 variants can lead to altered BMP signaling, resulting in abnormal bone growth and development, including craniosynostosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can propofol cause green urine?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Propofol is a medication used for anesthesia and sedation. It is known to have various side effects, but the question is whether it can cause green urine. This would involve propofol or its metabolites interacting with the urinary system in such a way as to alter the color of the urine to green. Typically, changes in urine color can be due to the presence of certain medications or their byproducts, as well as other medical conditions. To determine if propofol can cause green urine, we would need to look into its pharmacokinetics and any reported cases of urine color changes associated with its use.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Can radiosurgery be used for the DNET tumors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Radiosurgery is a treatment option for certain types of brain tumors, including dysembryoplastic neuroepithelial tumors (DNET). DNETs are rare, benign brain tumors that typically occur in children and young adults. Radiosurgery, such as gamma knife or cyberknife, can be used to treat DNETs, especially in cases where surgical resection is not possible or would be too risky. The effectiveness of radiosurgery for DNETs depends on various factors, including the size and location of the tumor, as well as the patient's overall health.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Was golimumab tested for diabetes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Golimumab is a medication used to treat various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. To determine if golimumab was tested for diabetes, we need to consider its mechanism of action and any clinical trials or studies that may have investigated its effects on diabetes. Golimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha), a cytokine involved in inflammation. While TNF-alpha inhibitors like golimumab have been shown to have various effects on the body, their impact on diabetes is not entirely clear. However, some studies suggest that TNF-alpha inhibitors may improve insulin sensitivity, which could potentially benefit people with diabetes. Nevertheless, golimumab is not approved for the treatment of diabetes, and its primary use remains in the treatment of autoimmune diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cabergoline is a dopamine agonist that is used to treat various conditions, including hyperprolactinemia and Parkinson's disease. Nelson's syndrome is a rare condition that occurs in some patients who have undergone bilateral adrenalectomy for Cushing's disease. It is characterized by an aggressive growth of a pituitary tumor. The treatment of Nelson's syndrome typically involves surgery, radiation therapy, or medical therapy. Cabergoline has been used off-label for the treatment of Nelson's syndrome, particularly in cases where the tumor expresses dopamine receptors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is proton beam therapy used for treatment of craniopharyngioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Proton beam therapy is a type of radiation therapy that uses protons instead of X-rays to treat cancer and other conditions. Craniopharyngioma is a rare type of brain tumor that occurs near the pituitary gland. Proton beam therapy has been used to treat craniopharyngioma due to its ability to deliver a high dose of radiation to the tumor while minimizing damage to surrounding healthy tissue.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can Panitumumab cause trichomegaly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Panitumumab is a medication used to treat certain types of cancer, including colorectal cancer. It is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR). One of the known side effects of panitumumab is the growth of eyelashes, a condition known as trichomegaly. This occurs because EGFR plays a role in the regulation of hair growth. Therefore, when panitumumab inhibits EGFR, it can lead to an overgrowth of eyelashes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Kabuki syndrome type 1 (KS1) is a rare genetic disorder caused by mutations in the KMT2D gene. The question asks whether exon 38 or 39 KMT2D missense variants are associated with this condition. To answer this, we need to consider the genetic basis of KS1 and the specific role of the KMT2D gene, as well as the potential impact of missense variants in exons 38 and 39.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is tirabrutinib effective for lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tirabrutinib is a medication that has been investigated for its potential in treating certain types of lymphoma. It belongs to a class of drugs known as Bruton's tyrosine kinase inhibitors, which work by blocking the activity of Bruton's tyrosine kinase, an enzyme that plays a crucial role in the signaling pathways that promote the growth and survival of B cells, a type of white blood cell involved in lymphoma. Clinical trials and studies have been conducted to assess the efficacy and safety of tirabrutinib in patients with lymphoma, particularly those with mantle cell lymphoma and other B-cell lymphomas. The results from these studies have shown promising outcomes, with tirabrutinib demonstrating significant activity against these cancers, including inducing responses in patients who have relapsed or are refractory to other treatments.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is fusobacterium associated with Lemierre's syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Lemierre's syndrome is a rare condition characterized by a bacterial infection, typically of the throat, which spreads to the bloodstream and can lead to further complications such as thrombophlebitis of the internal jugular vein. The most common bacteria associated with Lemierre's syndrome is Fusobacterium necrophorum, a type of anaerobic bacterium. Therefore, considering the association of Fusobacterium with Lemierre's syndrome:\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is progeria caused by an autosomal recessive gene?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Progeria, also known as Hutchinson-Gilford progeria syndrome, is a rare genetic disorder that affects approximately 1 in 4 million people. It is caused by a mutation in the LMNA gene, which codes for the lamin A protein. This mutation leads to the production of a toxic form of the protein, known as progerin, which accumulates in cells and causes the characteristic symptoms of progeria. The inheritance pattern of progeria is typically autosomal dominant, meaning that a single copy of the mutated gene is enough to cause the condition. However, most cases of progeria are sporadic, meaning that they occur in people with no family history of the condition. Given this information, we can determine whether progeria is caused by an autosomal recessive gene.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is there a genetic cause of craniostenosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Craniostenosis, also known as craniosynostosis, is a condition where the bones of the skull fuse together prematurely. To determine if there is a genetic cause, we need to consider the role of genetics in the development of this condition. Research has shown that genetic mutations can play a significant role in the development of craniosynostosis. Certain genetic syndromes, such as Apert, Crouzon, and Pfeiffer syndromes, are associated with an increased risk of craniosynostosis. Additionally, some cases of craniosynostosis have been linked to specific genetic mutations, such as mutations in the FGFR2 gene. However, not all cases of craniosynostosis have a clear genetic cause, and environmental factors may also contribute to the development of the condition.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is acupotomy used to treat muscle stiffness?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Acupotomy is a surgical procedure that involves making small incisions in specific areas of the body to treat various conditions, including muscle stiffness. It is a form of traditional Chinese medicine that aims to restore balance and promote healing by stimulating certain points on the body. The procedure is often used to treat conditions such as muscle stiffness, pain, and limited range of motion.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is carpal tunnel syndrome a type of nerve entrapment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Carpal tunnel syndrome is a medical condition that occurs when the median nerve, which runs from the forearm into the palm of the hand, becomes pressed or squeezed at the wrist. This compression can cause numbness, tingling, and other symptoms in the hand and arm. Nerve entrapment refers to the compression or pinching of a nerve, which can occur at various points in the body. Given that carpal tunnel syndrome involves the compression of the median nerve at the wrist, it fits the definition of nerve entrapment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any role of genotoxic pks + E. coli in cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Genotoxic pks + E. coli may have a role in cancer as some studies suggest that certain strains of E. coli can produce genotoxins that can damage DNA and contribute to cancer development. The genotoxic potential of these compounds can lead to mutations and chromosomal instability, which are hallmarks of cancer. However, more research is needed to fully understand the relationship between genotoxic pks + E. coli and cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is avelumab effective for urothelial carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Avelumab is an immune checkpoint inhibitor that targets PD-L1. It has been studied in various clinical trials for its efficacy in treating different types of cancer, including urothelial carcinoma. Urothelial carcinoma, also known as transitional cell carcinoma, is the most common type of bladder cancer. The effectiveness of avelumab for this specific cancer type can be determined by looking at the results of clinical trials and studies that have investigated its use in patients with urothelial carcinoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does a comet assay measure radiation induced mutations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The comet assay, also known as single cell gel electrophoresis, is a technique used to measure DNA damage and repair in individual cells. It can detect various types of DNA damage, including strand breaks and oxidative damage, which can be induced by radiation. Therefore, the comet assay can be used to measure radiation-induced DNA damage, which can lead to mutations if not properly repaired.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"MIS-C, or Multisystem Inflammatory Syndrome in Children, has been observed in children following a COVID-19 infection, suggesting a potential link between the two. The condition involves inflammation in multiple organs, such as the heart, lungs, and kidneys, and has been reported in children who have tested positive for COVID-19 or have been exposed to someone with the virus. While the exact relationship between COVID-19 and MIS-C is still being researched, the temporal association and the fact that many children with MIS-C have antibodies against SARS-CoV-2 indicate that COVID-19 could be a triggering factor for MIS-C.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SLIC-CAGE used for quantification of translation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"SLIC-CAGE is a method related to the analysis of gene expression, specifically focusing on the transcription start site and the quantification of transcripts. However, the question is about the quantification of translation, which involves the process of translating mRNA into protein. To determine if SLIC-CAGE is used for this purpose, we need to consider if it directly measures protein synthesis or translation efficiency.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is adenosine signaling prognostic for cancer outcome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Adenosine signaling has been implicated in various physiological and pathological processes, including cancer. It plays a role in modulating the immune response and has been shown to affect tumor growth and progression. The prognostic value of adenosine signaling in cancer outcome is an area of active research, with studies suggesting that alterations in adenosine signaling pathways can impact patient outcomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does bleomycin cause lung toxicity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bleomycin is a chemotherapeutic agent known for its potential to cause pulmonary toxicity, which can lead to conditions such as pneumonitis and pulmonary fibrosis. This side effect is a significant concern in the administration of bleomycin, particularly at higher doses or with prolonged use. The mechanism behind bleomycin-induced lung toxicity involves the generation of free radicals, which can damage lung tissue. Given this information, it is clear that bleomycin has the potential to cause lung toxicity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there sex differences in oncogenic mutational processes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the question to determine if there are sex differences in oncogenic mutational processes, which involves understanding the biological and genetic factors that contribute to cancer development in males and females.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the association between co-loss of BRCA2-RB1 and prognosis for prostate cancer patients. To answer this, we need to consider the role of BRCA2 and RB1 in cancer. BRCA2 is a tumor suppressor gene involved in DNA repair, and RB1 is also a tumor suppressor gene that regulates cell cycle progression. Loss of these genes can lead to increased genetic instability and uncontrolled cell growth, which are hallmarks of cancer. However, the specific impact of co-loss of BRCA2-RB1 on prostate cancer prognosis is not immediately clear without considering the complex interactions between these genes and other factors in prostate cancer development and progression.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is there a role for Dickkopf-1 (DKK1) in prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of Dickkopf-1 (DKK1) in prostate cancer, including its potential involvement in tumor progression, metastasis, and the Wnt signaling pathway, which is crucial for cell proliferation and differentiation. DKK1 is known to be an antagonist of the Wnt/Î²-catenin signaling pathway, which plays a significant role in various cancers, including prostate cancer. The expression levels of DKK1 and its impact on the progression and metastasis of prostate cancer need to be considered.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Benralizumab effective for Chronic Spontaneous Urticaria?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Benralizumab is a monoclonal antibody that targets the interleukin-5 receptor alpha subunit on eosinophils, and it has been studied for its efficacy in various diseases, including asthma and hypereosinophilic syndrome. For Chronic Spontaneous Urticaria (CSU), the primary treatments often involve antihistamines, corticosteroids, and in some cases, biologics like omalizumab. The effectiveness of benralizumab specifically for CSU would depend on its mechanism of action and how it interacts with the underlying pathophysiology of the disease. Given that CSU can involve eosinophilic inflammation in some cases, a drug that depletes eosinophils, like benralizumab, might theoretically offer some benefit. However, as of my last update, the primary use of benralizumab has been in the treatment of severe asthma with an eosinophilic phenotype, and its use in CSU would be considered off-label and not widely established without specific clinical trial data supporting its efficacy for this condition.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is belimumab effective for the lupus nephritis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Belimumab is a medication used to treat systemic lupus erythematosus (SLE), and its effectiveness for lupus nephritis, a common complication of SLE, has been studied. Lupus nephritis is a type of kidney inflammation caused by SLE. The efficacy of belimumab for lupus nephritis is a subject of clinical research.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is liraglutide effective for weight reduction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Liraglutide is a medication used for the treatment of type 2 diabetes and has also been investigated for its potential in weight management. It works by mimicking the action of a natural hormone in the body that helps to regulate appetite and food intake. Studies have shown that liraglutide can lead to significant weight loss in obese individuals, making it a potential treatment option for those seeking to reduce their weight.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Eflornithine and Sulindac are being studied for their potential to prevent the progression of Familial Adenomatous Polyposis (FAP), a condition characterized by the development of hundreds to thousands of polyps in the colon and rectum, significantly increasing the risk of colorectal cancer. Eflornithine is an inhibitor of ornithine decarboxylase, an enzyme involved in cell growth and proliferation, while Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) that has been shown to reduce the number and size of polyps in patients with FAP. Research and clinical trials have explored the efficacy of these drugs in preventing the progression of FAP.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is ofatumumab effective for multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ofatumumab is a medication used to treat multiple sclerosis. It is a monoclonal antibody that targets CD20-positive B cells. Studies have shown that ofatumumab can reduce the frequency of relapses and delay the progression of disability in people with relapsing forms of multiple sclerosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Olaparib effective for prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Olaparib is a medication used for the treatment of certain types of cancer, including breast and ovarian cancer, by inhibiting poly (ADP-ribose) polymerase (PARP). Its effectiveness in prostate cancer, particularly in those with specific genetic mutations such as BRCA1 or BRCA2, has been explored in clinical trials. The results indicate that olaparib can be effective in treating a subset of prostate cancer patients, especially those with metastatic castration-resistant prostate cancer and DNA repair gene mutations.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has tocilizumab been assessed against Covid-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tocilizumab is an immunosuppressive drug, and its application against Covid-19 has been explored due to the cytokine storm associated with severe cases of the disease. Several studies and clinical trials have been conducted to assess its efficacy and safety in treating Covid-19 patients.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is tocilizumab a tumor necrosis factor inhibitor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Tocilizumab is an interleukin-6 receptor antagonist, not a tumor necrosis factor inhibitor. It is used to treat various conditions, including rheumatoid arthritis and cytokine release syndrome.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is tofacitinib a JAK inhibitor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tofacitinib is a medication known for its use in treating various inflammatory conditions. It operates by inhibiting specific enzymes in the body. The JAK enzymes are a group of proteins that play a significant role in the body's immune response. Tofacitinib specifically targets these JAK enzymes, which are involved in the signaling of cytokines and growth factors. By inhibiting these enzymes, tofacitinib reduces inflammation and modifies the immune response. Given this mechanism of action, it is classified as a JAK inhibitor.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does the use of bDMARDs during pregnancy impact neonatal development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The use of biologic disease-modifying antirheumatic drugs (bDMARDs) during pregnancy has been a topic of interest in recent years, particularly in relation to their potential impact on neonatal development. bDMARDs are used to treat various autoimmune diseases, such as rheumatoid arthritis and psoriasis. Studies have investigated the safety of these medications during pregnancy, focusing on their effects on the fetus and neonatal outcomes. While some bDMARDs may cross the placenta, current evidence suggests that they do not significantly impact neonatal development in terms of birth weight, gestational age, or congenital malformations. However, the transfer of these drugs from mother to fetus, especially during the third trimester, can lead to detectable drug levels in the newborn, potentially affecting the infant's immune system. Despite this, most infants exposed to bDMARDs in utero do not exhibit significant adverse effects on their development or immune function postnatally. It is essential for pregnant women or those planning to become pregnant to discuss the use of bDMARDs with their healthcare provider to weigh the benefits and risks and make informed decisions about their treatment plan.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is tocilizumab a csDMARD?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Tocilizumab is an interleukin-6 receptor antagonist used in the treatment of rheumatoid arthritis and other inflammatory conditions. It is classified as a biologic DMARD (bDMARD), not a conventional synthetic DMARD (csDMARD). csDMARDs are typically small molecule drugs, whereas bDMARDs are large molecule biologics.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is vocimagene amiretrorepvec effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Vocimagene amiretrorepvec is an experimental gene therapy being investigated for its potential to treat glioblastoma, a type of brain cancer. The therapy involves injecting a virus that selectively infects and kills cancer cells, while sparing healthy cells. Clinical trials have been conducted to assess its safety and efficacy.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does addition of valproic acid improve survival of patients with diffuse intrinsic pontine glioma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question is asking whether the addition of valproic acid to the treatment regimen improves the survival rate of patients diagnosed with diffuse intrinsic pontine glioma, a type of brain tumor. To answer this, we need to consider the available clinical evidence and research findings regarding the efficacy of valproic acid in treating this specific condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is capmatinib effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Capmatinib is a medication that has been studied for its potential effectiveness in treating various types of cancer, including glioblastoma. Glioblastoma is a aggressive and malignant form of brain cancer. The effectiveness of capmatinib for glioblastoma would depend on clinical trial results and research studies.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Cerebrolysin is a nootropic drug used to support the recovery of brain function after stroke, traumatic brain injury, and other conditions. Its use in aneurysmal subarachnoid hemorrhage is not widely established as a standard treatment. However, some studies suggest it may have neuroprotective effects. The decision to use cerebrolysin should be based on clinical judgment and consideration of current evidence.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Tranexamic acid effective for intracerebral haemorrhage?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Tranexamic acid is an antifibrinolytic agent that has been studied for its potential to improve outcomes in patients with intracerebral haemorrhage (ICH) by reducing hematoma expansion. The effectiveness of tranexamic acid for ICH has been investigated in several clinical trials.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can thiotepa be recommended for treatment of osteosarcoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Thiotepa is a chemotherapy drug used to treat various types of cancer. Osteosarcoma is a type of bone cancer. To determine if thiotepa can be recommended for the treatment of osteosarcoma, we need to consider its efficacy and safety in this context. Thiotepa has been used in the treatment of several cancers, but its use in osteosarcoma is less common and typically considered in specific scenarios, such as in cases where other treatments have failed or in palliative care. The standard treatment for osteosarcoma usually involves a combination of surgery, chemotherapy with drugs like methotrexate, doxorubicin, and cisplatin, and sometimes radiation. Thiotepa's role would be more adjunctive or in clinical trials for osteosarcoma.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does hypofractionated radiotherapy offers any benefit for DIPG?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Hypofractionated radiotherapy is a type of radiation therapy that delivers higher doses of radiation in fewer sessions. For Diffuse Intrinsic Pontine Glioma (DIPG), a rare and aggressive brain tumor, the standard treatment includes radiation therapy. The question is whether hypofractionated radiotherapy offers any benefits for DIPG patients. Analyzing the available data and research studies, it appears that hypofractionated radiotherapy may provide some benefits, such as reduced treatment time and potential improvement in quality of life, but its impact on overall survival rates is still being investigated.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is isradipine effective for Parkinson's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Isradipine is a calcium channel blocker that has been studied for its potential effects on Parkinson's disease. Research has explored its ability to slow the progression of the disease by possibly providing neuroprotection. However, its effectiveness specifically for treating the symptoms of Parkinson's disease or halting its progression is still under investigation and not conclusively established.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should nerinetide be used for treatment of ischaemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Nerinetide is an experimental drug that has been studied for its potential to improve outcomes in patients with ischemic stroke. The results of clinical trials have shown mixed results, with some studies suggesting that nerinetide may improve functional outcomes and reduce disability, while others have found no significant benefit. The decision to use nerinetide for the treatment of ischemic stroke should be based on a thorough evaluation of the available evidence and consideration of the individual patient's circumstances.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Lanabecestat effective for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Lanabecestat is an investigational drug that was being developed for the treatment of Alzheimer's disease. It was designed to inhibit the activity of beta-secretase, an enzyme involved in the production of beta-amyloid, a protein that accumulates in the brains of people with Alzheimer's disease. However, the development of Lanabecestat was halted due to lack of efficacy in clinical trials.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should minocycline be used for mild Alzheimer disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Minocycline is an antibiotic that has been studied for its potential neuroprotective effects, but its use in treating mild Alzheimer's disease is still a topic of debate. While some research suggests that minocycline may have anti-inflammatory and antioxidant properties that could be beneficial in reducing the progression of Alzheimer's, other studies have raised concerns about its efficacy and safety in this context. The current evidence is not sufficient to support the routine use of minocycline for mild Alzheimer's disease, and more research is needed to fully understand its potential benefits and risks.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is MK-1602 a CGRP antagonist?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer whether MK-1602 is a CGRP antagonist, we first need to understand what CGRP stands for and what an antagonist does. CGRP stands for Calcitonin Gene-Related Peptide, which is a neuropeptide that plays a significant role in the transmission of pain, especially migraine pain. An antagonist, in pharmacological terms, is a type of drug that binds to a receptor and decreases the action of that receptor. If MK-1602 acts as a CGRP antagonist, it would bind to CGRP receptors and reduce the activity of CGRP, potentially alleviating conditions like migraines. Given this context, we need to confirm if MK-1602 specifically targets CGRP receptors to classify it as a CGRP antagonist.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has ubrogepant entered clinical phase III trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer whether ubrogepant has entered clinical phase III trials, we need to understand what ubrogepant is and its development status. Ubrogepant is a drug candidate for the treatment of migraine. Clinical phase III trials are a critical step in the development of new drugs, involving large-scale trials to confirm efficacy, monitor side effects, compare the drug to commonly used treatments, and collect information that will allow the experimental drug to be used safely. Given the context, we can proceed to determine if ubrogepant has reached this stage.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there small molecule CGRPs under development for the treatment of migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Several pharmaceutical companies are working on developing small molecule CGRP inhibitors for the treatment of migraine, which would provide an alternative to monoclonal antibody treatments.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is eptinezumab a small molecule?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Eptinezumab is a medication used for the preventive treatment of migraine. It is a monoclonal antibody, which is a type of large molecule, not a small molecule.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is gabapentin effective for chronic pelvic pain?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Gabapentin is an anticonvulsant medication that has been used to treat various types of chronic pain, including neuropathic pain. Its effectiveness for chronic pelvic pain has been studied, with some research suggesting that it may be beneficial in reducing pain symptoms. However, the evidence is not yet conclusive, and more research is needed to fully determine its efficacy for this specific condition.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does trimetazidine protect from myocardial injury after percutaneous coronary intervention?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Trimetazidine is a metabolic agent that has been studied for its potential to protect against myocardial injury in various clinical settings, including percutaneous coronary intervention (PCI). The mechanism of trimetazidine involves optimizing energy production in cardiac cells, which could potentially reduce injury during procedures like PCI. Several studies have investigated its effects on myocardial injury after PCI, with some indicating a protective effect by reducing markers of cardiac damage or improving clinical outcomes. However, the evidence may vary, and not all studies might show a significant benefit. Considering the potential of trimetazidine to influence cardiac energy metabolism positively and reduce ischemic damage, it is plausible that it could offer some protection against myocardial injury after PCI.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does inactivation of CYLD help in colorectal cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The CYLD gene is a tumor suppressor gene that plays a crucial role in regulating inflammation and cell growth. Inactivation of CYLD has been implicated in various types of cancer, including colorectal cancer. Studies have shown that loss of CYLD function can lead to increased cell proliferation, survival, and migration, which are hallmarks of cancer. Additionally, CYLD inactivation can also lead to the activation of various oncogenic signaling pathways, including the NF-ÎºB pathway, which is known to promote cancer development and progression. Therefore, inactivation of CYLD may contribute to the development and progression of colorectal cancer.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is there a role for TFII-I in megakaryopoiesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"TFII-I is a transcription factor involved in various cellular processes, including cell growth, differentiation, and survival. Megakaryopoiesis is the process of megakaryocyte development, which is crucial for platelet production. To determine if TFII-I plays a role in megakaryopoiesis, we need to consider the potential involvement of TFII-I in the regulation of genes specific to megakaryocyte development and function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is istiratumab effective for pancreatic cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Istiratumab is an experimental medication being researched for its potential in treating various types of cancer, including pancreatic cancer. Its effectiveness would depend on clinical trial results and FDA approval.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does erenumab target the calcitonin gene-related peptide?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Erenumab is a medication used to treat migraine. It works by blocking the calcitonin gene-related peptide receptor, which plays a role in the development of migraines. The calcitonin gene-related peptide is a protein that is involved in the transmission of pain and is released from nerve endings in the brain.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is there a link between rare variants in PPARG and type 1 diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Analyzing the relationship between rare variants in the PPARG gene and type 1 diabetes, considering the role of PPARG in glucose and lipid metabolism, and its potential impact on pancreatic beta-cell function and immune system regulation.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is there an association of alterations in ADCY7 and ulcerative colitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the relationship between genetic alterations and diseases, specifically the association between ADCY7 and ulcerative colitis, involves understanding the role of the ADCY7 gene in biological processes and its potential impact on the development or progression of ulcerative colitis. ADCY7 encodes for adenylate cyclase 7, an enzyme involved in signaling pathways within cells. Alterations in genes like ADCY7 could potentially disrupt normal cellular signaling, leading to various diseases, including inflammatory bowel diseases like ulcerative colitis. Research into specific genetic associations with ulcerative colitis has identified multiple susceptibility genes, but the direct involvement of ADCY7 needs to be clarified through scientific studies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there high nucleotide diversity in the Drosophila suzukii species?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Drosophila suzukii, also known as the spotted wing drosophila, is an invasive species that has been studied for its genetic diversity. Research has shown that this species exhibits high genetic diversity, including nucleotide diversity, which is the variation in nucleotide sequences among individuals. This diversity is likely due to the species' large population size, high mutation rate, and ability to adapt to different environments.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Î‘re plants from the genus Strychnos the original source of curare?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the original source of curare and its relation to plants from the genus Strychnos. To answer this, we need to understand what curare is and its historical use. Curare is a plant-based substance that has been used historically in hunting and warfare due to its neurotoxic properties, which can immobilize prey. The genus Strychnos is known for containing toxic compounds, notably strychnine, which is found in the seeds of the Strychnos nux-vomica tree. However, curare's composition and its original source need to be clarified in this context.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Does Curare function by stimulating the acetylcholine receptor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Curare is a plant-based substance that has been used in medicine for its neuromuscular blocking properties. It works by interfering with the transmission of nerve impulses to muscles, which leads to muscle relaxation. The mechanism of action of Curare involves its interaction with the acetylcholine receptor at the neuromuscular junction. However, instead of stimulating the receptor, Curare acts as a competitive antagonist, binding to the receptor and preventing acetylcholine from binding and stimulating the muscle. This prevents the muscle from contracting, leading to paralysis of the affected muscles.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is AZD9668 a VEGF mRNA drug?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"AZD9668 is being analyzed to determine if it is a VEGF mRNA drug. VEGF stands for Vascular Endothelial Growth Factor, which plays a crucial role in angiogenesis, the formation of new blood vessels from pre-existing ones. mRNA drugs are a new class of therapies that use messenger RNA to instruct cells to produce specific proteins. To answer this question, we need to know if AZD9668 works by targeting VEGF through mRNA technology.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Has AZD9668 been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to check if AZD9668 has been tested in clinical trials. This involves looking into clinical trial databases or scientific publications for any records of AZD9668 being used in human trials.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are TAMs good anticancer therapeutic targets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"TAMs, or tumor-associated macrophages, play a significant role in the tumor microenvironment, influencing cancer progression, metastasis, and the response to therapy. Their involvement in various aspects of cancer development and their impact on the immune response make them potential targets for anticancer therapy. Targeting TAMs could help in modulating the tumor microenvironment, enhancing the efficacy of existing cancer treatments, and potentially leading to new therapeutic strategies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tocilizumab, also known as Actemra, is an immunosuppressive drug used to treat various inflammatory conditions. It works by blocking the action of interleukin-6 (IL-6), a cytokine involved in the immune response. Specifically, Tocilizumab binds to the IL-6 receptor, preventing IL-6 from interacting with its receptor and thereby reducing inflammation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are PDXK mutations linked to polyneuropathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"PDXK mutations have been studied for their potential link to various neurological disorders, including polyneuropathy. Polyneuropathy refers to the simultaneous malfunction of many peripheral nerves, which can lead to a range of symptoms including weakness, numbness, and pain, typically in the hands and feet. The PDXK gene is involved in the synthesis of pyridoxal phosphate, an active form of vitamin B6 that plays a crucial role in numerous enzymatic reactions within the nervous system. Mutations in the PDXK gene could potentially disrupt pyridoxal phosphate production, leading to neurological deficits. Research into the genetic underpinnings of polyneuropathy has identified several genes whose mutations can cause or contribute to the disease, highlighting the genetic heterogeneity of the condition.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do bacteria release extracellular vesicles?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bacteria are known to release various types of extracellular structures, including vesicles, which can play roles in communication, toxin delivery, and other cellular processes. The release of extracellular vesicles by bacteria has been studied and documented in scientific research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Gram positive bacteria able to release extracellular vesicles?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Gram-positive bacteria have a unique cell wall structure that is distinct from Gram-negative bacteria, which are known to release extracellular vesicles. However, recent studies have shown that Gram-positive bacteria are also capable of releasing extracellular vesicles, which can play a role in various biological processes, including communication, virulence, and antimicrobial resistance.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the apilimod inhibitor effective against SARS-CoV-2?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Apilimod is an inhibitor that has been studied for its potential effectiveness against various diseases. To determine its effectiveness against SARS-CoV-2, we need to look at scientific research and studies. Some studies suggest that apilimod may have antiviral properties and could potentially inhibit the replication of SARS-CoV-2.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Hunter's disease is associated with the X Chromosome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Hunter's disease, also known as Mucopolysaccharidosis type II, is a genetic disorder that is inherited in an X-linked recessive pattern. This means that the gene responsible for the condition is located on the X chromosome. The disease is caused by a deficiency of the enzyme iduronate-2-sulfatase, which is essential for breaking down sugar molecules in the body. Because the gene is on the X chromosome, Hunter's disease is more common in males, who have only one X chromosome, than in females, who have two X chromosomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Toll-like receptors (TLRs) induced by microbes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate immune system. They are responsible for recognizing and responding to pathogens, such as microbes. When microbes are present, they can trigger the activation of TLRs, which then initiate an immune response. This suggests that TLRs are indeed induced by microbes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can Freund's complete adjuvant induce arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Freund's complete adjuvant is known to induce arthritis in animal models, particularly in rats and mice. It is often used in research to study rheumatoid arthritis and other autoimmune diseases. The adjuvant contains inactivated and dried Mycobacterium tuberculosis, which stimulates a strong immune response and can lead to joint inflammation and arthritis-like symptoms.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can saponins be used as adjuvant?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Saponins are a type of natural compound found in various plant species, known for their ability to create a rich lather when mixed with water. They have been studied for their potential use in vaccine formulations as adjuvants, which are substances that enhance the body's immune response to an antigen. Adjuvants can improve the efficacy of vaccines by stimulating a stronger immune response, thereby providing better protection against infections. The use of saponins as adjuvants is based on their ability to activate immune cells and increase the production of antibodies, which are crucial for fighting off pathogens.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is phosphoenolpyruvate carboxykinase 1 (PCK1) the rate-limiting enzyme in gluconeogenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Phosphoenolpyruvate carboxykinase 1 (PCK1) is an enzyme that plays a crucial role in gluconeogenesis, which is the process by which glucose is synthesized from non-carbohydrate sources. To determine if PCK1 is the rate-limiting enzyme in gluconeogenesis, we need to consider the steps involved in this metabolic pathway and the role of PCK1 within it. PCK1 catalyzes the conversion of oxaloacetate to phosphoenolpyruvate, a key step in gluconeogenesis. However, whether it is the rate-limiting step can depend on various factors including the tissue type, nutritional state, and hormonal regulation. Other enzymes like pyruvate carboxylase and glucose-6-phosphatase also play significant roles in gluconeogenesis and can be rate-limiting under different conditions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is histone variant H3.3K27M associated with gliomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Histone variant H3.3K27M is a mutation that has been identified in certain types of cancer, including brain tumors. This mutation leads to the replacement of lysine 27 with methionine on the H3.3 histone protein. The association of H3.3K27M with gliomas, which are a type of tumor that occurs in the brain and spinal cord, has been a subject of research. Studies have shown that this mutation is particularly prevalent in diffuse midline gliomas, a subtype of glioma that is often aggressive and has a poor prognosis. The presence of the H3.3K27M mutation can affect the diagnosis, treatment, and prognosis of gliomas.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do honey contain diastases/amylases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Honey is a natural sweetener produced by bees, and it contains various enzymes, including diastase, which is also known as amylase. Diastase is an enzyme that breaks down starches into simpler sugars, and it is present in honey to help convert the nectar's complex carbohydrates into simpler ones, making it easier for the bees to digest and store. Therefore, the presence of diastases or amylases in honey is a known fact.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is HbA1c an ideal biomarker of well-controlled diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"HbA1c is a widely used biomarker for assessing blood glucose control over time, but its idealness can be debated due to various factors such as individual variability, hemoglobinopathies, and red blood cell lifespan. It provides an average measurement of blood glucose levels over approximately 3 months, reflecting the percentage of glucose that has bound to hemoglobin in red blood cells. However, it may not accurately represent glucose control in certain populations or individuals with specific conditions.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is erabutoxin b usually found in plants?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Erabutoxin b is a toxin, and it is typically found in the venom of certain species of snakes, specifically the sea snake. It is not commonly associated with plants.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is autism thought to be related to the  Arginine Vasopressin Peptide (AVP)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Research has investigated the potential link between autism and various genetic and hormonal factors, including the Arginine Vasopressin Peptide (AVP). AVP is involved in social behavior and bonding, which are areas often affected in individuals with autism. Studies have suggested that AVP may play a role in the social deficits observed in autism.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ixodes a species of tick?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Ixodes is a genus of ticks, commonly known as hard ticks, which includes over 700 species. They are ectoparasites that feed on the blood of mammals, birds, and reptiles, and are known to transmit various diseases such as Lyme disease and tick-borne relapsing fever.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Are mucins glycosylated proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mucins are a family of high molecular weight, heavily glycosylated proteins produced by epithelial tissues. They are key components of mucus and play important roles in protecting and lubricating the surfaces of the body that are exposed to the external environment, such as the respiratory, gastrointestinal, and genitourinary tracts. The glycosylation of mucins is crucial for their function, as the carbohydrate chains attached to the protein backbone contribute to their viscoelastic properties and ability to form gels.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are mucin overexpression associated with disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mucin overexpression has been linked to various diseases, including cancer, where it can contribute to tumor progression and metastasis. Abnormal mucin expression is also associated with other conditions, such as cystic fibrosis and inflammatory bowel disease. The overexpression of mucin can lead to the disruption of normal cellular functions and contribute to disease pathology.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are interferons defensive proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. They are defensive in nature, triggering various cellular responses to combat viral infections.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is YKL-40 used as a biomarker for Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"YKL-40 is a glycoprotein that is involved in various inflammatory processes. Research has explored its potential as a biomarker for several diseases, including cancer and neurological disorders. For Alzheimer's disease, biomarkers are crucial for early diagnosis and monitoring disease progression. YKL-40 has been studied in the context of neuroinflammation and its levels have been found to be elevated in the cerebrospinal fluid of patients with Alzheimer's disease, suggesting its potential role as a biomarker.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is G3BP1 found in stress granules?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"G3BP1 is a protein known to be involved in the formation and regulation of stress granules, which are cytoplasmic structures that form in response to stress and play a role in the regulation of mRNA translation and degradation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has FTY720  been considered for the treatment of stroke?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"FTY720, also known as fingolimod, is a sphingosine 1-phosphate receptor modulator that has been explored for its potential therapeutic effects in various neurological conditions, including multiple sclerosis. Its mechanism of action involves the modulation of sphingosine 1-phosphate receptors, which play a role in the regulation of vascular integrity and immune cell migration. Given its effects on the vascular system and its neuroprotective properties, FTY720 has been considered for the treatment of stroke, with research focusing on its potential to reduce infarct size, improve neurological outcomes, and enhance recovery after stroke.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is FTY720 FDA approved?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"FTY720, also known as fingolimod, is a medication used to treat multiple sclerosis. To determine if it is FDA approved, we need to check the FDA's approved drug list. Fingolimod was approved by the FDA in 2010 for the treatment of relapsing forms of multiple sclerosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does the royal jelly contain proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Royal jelly is a substance produced by bees and is known for its nutritional and medicinal properties. It contains a variety of compounds, including proteins, vitamins, and minerals. The proteins in royal jelly are believed to contribute to its potential health benefits.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are the major royal jelly proteins similar to the yellow proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the similarity between major royal jelly proteins and yellow proteins. To answer this, we need to consider the characteristics and functions of both types of proteins. Royal jelly is a substance produced by bees and fed to larvae, and its proteins have been studied for their nutritional and medicinal properties. Yellow proteins, on the other hand, are a family of proteins found in various organisms, including insects and mammals, and are involved in different biological processes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Apis mellifera genome available?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The Apis mellifera, commonly known as the western honey bee, has been a subject of genomic studies. The genome of Apis mellifera was fully sequenced and assembled, providing insights into its genetic makeup and evolutionary history. This information is crucial for understanding the biology of the honey bee, including its social behavior, immune system, and adaptation to environments.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has the olive tree pollen proteome been studied?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The olive tree pollen proteome study would involve analyzing the proteins present in olive tree pollen to understand its composition and potential allergens. Research in this area could provide insights into the immune responses triggered by olive tree pollen and help in developing diagnostic and therapeutic strategies for allergies. To determine if such studies have been conducted, a review of scientific literature and databases would be necessary.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is hemoglobin antimicrobial?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Hemoglobin has been studied for its potential antimicrobial properties. Some research suggests that hemoglobin and its derivatives may have antimicrobial effects against certain microorganisms.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there antimicrobial proteins in royal jelly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Royal jelly is known for its various nutritional and medicinal properties. It contains a range of compounds, including proteins, that contribute to its health benefits. Among these, some proteins have been identified for their antimicrobial properties, which help in protecting the jelly and potentially offering health benefits to consumers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does Amblyopia affect the eye?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Amblyopia, also known as lazy eye, is a vision development disorder where an eye fails to achieve normal visual acuity, even with prescription eyeglasses or contact lenses. This condition affects the brain's ability to process visual information from one eye, but it originates from issues related to the eye itself, such as misalignment of the eyes, cataract, or significant differences in refractive errors between the two eyes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is atenolol metabolized by CYP2D6?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Atenolol is a beta-blocker used to treat high blood pressure and other heart-related conditions. CYP2D6 is an enzyme that plays a significant role in the metabolism of various drugs. To determine if atenolol is metabolized by CYP2D6, we need to consider the metabolic pathways of atenolol. Atenolol is primarily excreted unchanged in the urine, and its metabolism is not significantly dependent on the CYP2D6 enzyme.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is cadherin a plasma membrane marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cadherin is a type of cell adhesion molecule that plays a crucial role in the formation of adherens junctions, which are important for tissue structure and cell-cell interactions. It is typically found at the plasma membrane, where it mediates cell-cell adhesion. Therefore, cadherin can be considered a plasma membrane marker.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an upper limit on the functional fraction of the human genome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The question asks about the upper limit on the functional fraction of the human genome, which refers to the proportion of the genome that has a biological function. To address this, we need to consider what is meant by 'functional' and how it is measured. The functional fraction includes coding regions, regulatory elements, and other sequences that contribute to the development, growth, and maintenance of an organism. However, determining the exact functional fraction is challenging due to the complexity and the fact that some regions may have functions that are not yet understood or easily measurable. Recent studies and the ENCODE project have suggested that a significant portion of the genome has some level of functional activity, but this does not necessarily imply that all of it is essential or critical for the organism's survival and function. The concept of an 'upper limit' suggests a maximum threshold beyond which additional genomic material would not contribute to the organism's function or viability.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are synonymous sites in primates and rodents functionally constrained?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Synonymous sites in primates and rodents are under functional constraint due to their role in maintaining protein function and structure, despite not altering the amino acid sequence. These sites can be involved in various processes such as splicing, transcriptional regulation, and mRNA stability, which are crucial for the proper functioning of genes. The conservation of these sites across different species, including primates and rodents, suggests that they are under selective pressure to maintain their function.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does IL18 signaling have a role in thymus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"IL18 signaling has been studied in various immune contexts, including its potential role in the thymus, where T cells mature. The thymus is crucial for the development and selection of T lymphocytes. Interleukin 18 (IL18) is known for its involvement in inflammatory responses and the regulation of both innate and adaptive immunity. Considering the function of IL18 in other parts of the immune system, it is plausible that IL18 signaling could influence processes within the thymus, such as T cell development or selection. However, specific details about its role would depend on research findings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is metoprolol metabolized by CYP2D6?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Metoprolol is a beta-blocker used to treat various cardiovascular conditions. Its metabolism involves the cytochrome P450 enzyme system. Specifically, CYP2D6 is an enzyme that metabolizes a significant portion of metoprolol, contributing to its pharmacokinetics.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the glucocorticoid receptor a transcription factor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The glucocorticoid receptor is a type of nuclear receptor that is activated by glucocorticoids, which are a class of steroid hormones. Upon activation, it can bind to specific DNA sequences and regulate the transcription of target genes. This suggests that the glucocorticoid receptor plays a role in controlling gene expression, similar to transcription factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has dupilumab been FDA approved for atopic dermatitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Dupilumab is a medication used to treat atopic dermatitis. The FDA approval status of dupilumab for atopic dermatitis should be checked.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Has the companion diagnostic HercepTest received FDA approval?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The HercepTest is a companion diagnostic used to detect the HER2 protein in breast cancer patients. It is used in conjunction with trastuzumab, a targeted therapy. To determine if it has received FDA approval, we need to consider the regulatory process for companion diagnostics.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is FKBP52 encoding a chaperone ?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"FKBP52, which stands for FK506 Binding Protein 52, is known to be involved in various cellular processes including immunoregulation and protein folding. As a member of the FK506 binding protein family, it possesses peptidyl-prolyl cis-trans isomerase activity, which can assist in the folding of proteins. Given its role in assisting protein folding, it can be considered a type of molecular chaperone.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is colistin an antibiotic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Colistin is a type of antibiotic that belongs to the polymyxin class. It is used to treat various bacterial infections, particularly those caused by multidrug-resistant gram-negative bacteria.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Keutel syndrome a common genetic disorder?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Keutel syndrome is a rare genetic disorder characterized by abnormal deposits of calcium in the joints, eyes, and blood vessels. It is caused by mutations in the MGP gene and is typically inherited in an autosomal recessive pattern. Due to its rarity, there is limited information available about the prevalence of Keutel syndrome, but it is considered to be a rare condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Daprodustat effective for anemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Daprodustat is a medication that has been studied for its potential to treat anemia, particularly in patients with chronic kidney disease. It works by stimulating the production of erythropoietin, a hormone that helps produce red blood cells. Clinical trials have shown that daprodustat can increase hemoglobin levels and reduce the need for blood transfusions in patients with anemia related to chronic kidney disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an association between pyostomatitis vegetans and Crohn's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Pyostomatitis vegetans is a rare condition characterized by chronic inflammation and ulceration of the oral mucosa. It has been associated with various systemic diseases, including inflammatory bowel disease. Crohn's disease is a type of inflammatory bowel disease that can affect any part of the gastrointestinal tract. There have been reports in medical literature of an association between pyostomatitis vegetans and Crohn's disease, suggesting that the oral condition may be a manifestation of the underlying inflammatory bowel disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Sotrovimab effective for COVID-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Sotrovimab is a monoclonal antibody treatment that has been studied for its effectiveness against COVID-19. It has shown promise in reducing the risk of hospitalization and death in patients with mild to moderate COVID-19. The treatment works by binding to the spike protein of the SARS-CoV-2 virus, preventing it from entering host cells. Several clinical trials have demonstrated the efficacy of Sotrovimab in treating COVID-19, particularly in patients who are at high risk of severe illness.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ozanimod effective for Ulcerative Colitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ozanimod is a medication that has been studied for its effectiveness in treating ulcerative colitis, a type of inflammatory bowel disease. It works by targeting specific cells in the immune system that contribute to inflammation in the gut. Clinical trials have shown that ozanimod can be effective in inducing and maintaining remission in patients with ulcerative colitis, with a relatively favorable safety profile compared to other treatments.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Cabotegravir effective for HIV prevention?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cabotegravir is an antiretroviral medication used for the treatment and prevention of HIV/AIDS. It is an integrase strand transfer inhibitor, which works by blocking the integrase enzyme that the HIV virus needs to replicate. Research and clinical trials have shown that cabotegravir, particularly when used as part of a pre-exposure prophylaxis (PrEP) regimen, is highly effective in preventing HIV infection among individuals at high risk. The medication can be administered via injection once every two months, offering a convenient alternative to daily oral PrEP pills for some people.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is sacituzumab govitecan effective for breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Sacituzumab govitecan is an antibody-drug conjugate that has shown efficacy in treating certain types of breast cancer, particularly triple-negative breast cancer. It works by targeting the Trop-2 protein, which is often overexpressed in cancer cells, and delivering a cytotoxic drug directly to the cancer cells. Clinical trials have demonstrated significant improvements in progression-free survival and overall survival in patients with metastatic triple-negative breast cancer who received sacituzumab govitecan.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is rilonacept effective for pericarditis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Rilonacept is an interleukin-1 beta (IL-1Î²) trap that has been investigated for its potential in treating various inflammatory conditions, including pericarditis. Pericarditis is characterized by inflammation of the pericardium, the sac surrounding the heart. The effectiveness of rilonacept for pericarditis can depend on several factors, including the severity of the condition, the presence of recurrent episodes, and the patient's response to other treatments. Clinical trials and studies have explored the use of rilonacept in patients with recurrent pericarditis, showing promising results in reducing the frequency of recurrences and improving quality of life.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Sotatercept effective for Pulmonary Arterial Hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Sotatercept is an investigational therapy that has been studied for its potential to treat Pulmonary Arterial Hypertension (PAH). The drug works by targeting the TGF-Î² superfamily, which plays a role in the disease's progression. Clinical trials have shown promising results, with sotatercept demonstrating the ability to improve pulmonary vascular resistance and exercise capacity in patients with PAH. However, its effectiveness and safety are still under investigation, and it has not yet received full approval for this indication from regulatory authorities such as the FDA.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Belimumab used for lupus nephritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Belimumab is a medication used to treat systemic lupus erythematosus (SLE), and it has been studied for its potential use in lupus nephritis, a common complication of SLE. The medication works by targeting the BLyS protein, which is involved in the production of autoantibodies that contribute to lupus symptoms. While belimumab has shown efficacy in reducing SLE activity, its specific use for lupus nephritis has been explored in clinical trials.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an association between Guillainâ€“BarrÃ© syndrome and covid vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Guillainâ€“BarrÃ© syndrome is a rare autoimmune disorder, and there have been reports of a potential association with COVID-19 vaccines. Several studies and case reports have investigated this possible link, with some suggesting a small increased risk of developing Guillainâ€“BarrÃ© syndrome after receiving a COVID-19 vaccine.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do mutations in KCNT2 only cause phenotypes with epilepsy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider what is known about the KCNT2 gene and its association with human diseases. The KCNT2 gene encodes a sodium-activated potassium channel subunit. Mutations in this gene have been primarily associated with two neurological disorders: malignant migrating focal seizures of infancy (MMFSI) and autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Both of these conditions are characterized by epilepsy, suggesting a strong link between KCNT2 mutations and epileptic phenotypes. However, the question of whether mutations in KCNT2 exclusively cause phenotypes with epilepsy requires an examination of all known conditions associated with KCNT2 mutations.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do only changes in coding regions of MEF2C cause developmental disorders?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider what MEF2C is and its role in human development. MEF2C is a gene that provides instructions for making a protein called myocyte enhancer factor 2C. This protein is a transcription factor, which means it helps control the activity of other genes. The MEF2C gene is particularly important for the development of the brain and the formation of nerve cells. Changes or mutations in the MEF2C gene have been associated with various developmental disorders, including intellectual disability, autism spectrum disorders, and other neurodevelopmental disorders. However, the question asks if only changes in the coding regions of MEF2C cause these disorders. Coding regions are the parts of a gene that encode the amino acid sequence of a protein. Changes in non-coding regions, such as regulatory elements, can also affect gene function and contribute to disease. Therefore, considering the complexity of gene function and regulation, it's unlikely that only changes in coding regions of MEF2C are responsible for developmental disorders.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Algenpantucel-L effective for pancreatic cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Algenpantucel-L is an allogenic pancreatic cancer vaccine, and its effectiveness for pancreatic cancer is still being researched and studied in clinical trials. The vaccine works by stimulating the immune system to recognize and attack cancer cells. While it has shown promise in some studies, more research is needed to determine its overall efficacy and potential as a treatment option for pancreatic cancer.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is tivantinib effective for MET-high hepatocellular carcinoma?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tivantinib is an oral selective inhibitor of MET, a receptor tyrosine kinase. It has been investigated as a potential treatment for various cancers, including hepatocellular carcinoma (HCC). The effectiveness of tivantinib for MET-high hepatocellular carcinoma is based on clinical trials and research studies. MET-high HCC refers to a subtype of HCC characterized by high expression of the MET protein.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can Isradipine slow progression of Early Parkinson Disease?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Isradipine is a calcium channel blocker that has been studied for its potential to slow the progression of early Parkinson's disease. Research has investigated its effects on dopamine neurons and its potential neuroprotective properties.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is nerinetide effective for ischaemic stroke?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Nerinetide is an experimental drug that has been studied for its potential to improve outcomes in patients with ischaemic stroke. The results of clinical trials have shown that nerinetide may have a positive effect on functional outcomes in patients with ischaemic stroke, particularly when administered soon after stroke onset. However, more research is needed to fully determine its efficacy and safety.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Should perampanel be used for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Perampanel is an antiepileptic drug used primarily for the treatment of partial-onset seizures and generalized seizures. Its mechanism of action involves the inhibition of AMPA receptors, which are involved in excitatory neurotransmission. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord, leading to loss of muscle control. While there is some interest in the potential neuroprotective effects of various drugs, including those that might modulate glutamate signaling (such as AMPA receptor antagonists), perampanel's primary indication is not for the treatment of ALS. The use of perampanel for ALS would be considered off-label and not supported by standard clinical guidelines without specific research evidence indicating its efficacy and safety for this condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are variants in FHF2 (also known as FGF13) associated with encephalopathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the relationship between the FHF2 gene, also known as FGF13, and its potential association with encephalopathy. FHF2 or FGF13 is part of the fibroblast growth factor family and plays roles in various cellular processes, including development and potentially neurological functions. Variants in genes like FHF2 could theoretically impact neurological development or function, potentially leading to conditions such as encephalopathy, which is characterized by brain disease, damage, or malfunction. The specific connection between FHF2 variants and encephalopathy would depend on scientific research and clinical studies that investigate the genetic underpinnings of encephalopathy and the functional impact of FHF2 variants.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Adamts18 deficiency associated with cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of the ADAMTS18 gene and its potential association with cancer. The ADAMTS18 gene provides instructions for making a protein that is involved in various cellular processes. Research into the specific relationship between ADAMTS18 deficiency and cancer is necessary to determine if there is a direct link.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Erythropoietin effective for neuroprotection of Preterm Infants.",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Erythropoietin has been studied for its potential neuroprotective effects in preterm infants, with some research suggesting it may have beneficial effects on brain development and injury prevention. However, more studies are needed to confirm its efficacy and optimal dosage.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Should Intepirdine be used for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Intepirdine is an investigational medication that has been studied for its potential to treat Alzheimer's disease. However, its efficacy and safety for this use have not been fully established, and it has not received regulatory approval for this indication. The decision to use Intepirdine for Alzheimer's disease should be based on a thorough evaluation of the available evidence and consultation with a qualified healthcare professional.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should istiratumab be used for Pancreatic Cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Istiratumab is an experimental medication being researched for its potential in treating various types of cancer, including pancreatic cancer. The decision to use istiratumab for pancreatic cancer would depend on the results of clinical trials and the specific context of the patient's condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is vocimagene amiretrorepvec effective for recurrent high-grade glioma?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Vocimagene amiretrorepvec is an experimental gene therapy treatment for recurrent high-grade glioma, a type of brain cancer. The treatment involves injecting a virus into the tumor to stimulate an immune response. Clinical trials have been conducted to evaluate its efficacy.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Was ALVAC-HIV effective for HIV prevention in the HVTN 702 trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The HVTN 702 trial was a clinical trial that tested the efficacy of the ALVAC-HIV vaccine in preventing HIV infection. To answer this question, we need to look at the results of the trial.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does Î±CGRP have amyloidogenic properties?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the question about Î±CGRP and its potential amyloidogenic properties, which involves understanding the nature of Î±CGRP and its tendency to form amyloid fibrils, a characteristic of amyloidogenic proteins.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do SETD1A mutations predispose to schizophrenia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the relationship between SETD1A mutations and schizophrenia predisposition, considering genetic studies and research findings.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is covid-19 induced anosmia caused by disruption of nuclear architecture?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Covid-19 induced anosmia refers to the loss of smell caused by the SARS-CoV-2 virus. Research into the mechanisms behind this symptom has suggested several possible causes, including damage to the olfactory epithelium, inflammation, and disruption of the normal functioning of olfactory receptors. Disruption of nuclear architecture could potentially play a role in the pathogenesis of Covid-19 induced anosmia, as it could affect the expression of genes involved in the sense of smell. However, the exact relationship between Covid-19, nuclear architecture disruption, and anosmia is complex and requires further investigation.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is there any role of the 'Greek islands' in olfactory receptor choice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The question asks about the role of the 'Greek islands' in olfactory receptor choice, which seems unrelated as olfactory receptors are related to biology and genetics, while the Greek islands are a geographical location.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Is HDAC1 required for GATA-1 transcriptional activity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of HDAC1 in relation to GATA-1 transcriptional activity. GATA-1 is a transcription factor crucial for the development and maturation of erythroid cells. HDAC1 (Histone Deacetylase 1) is involved in the regulation of gene expression through the deacetylation of histones, which generally leads to chromatin compaction and suppression of gene transcription. However, the interaction between HDAC1 and transcription factors like GATA-1 can be complex, with HDAC1 sometimes acting as a cofactor to facilitate the transcriptional activity of certain factors by modifying chromatin structure or by directly interacting with the transcription factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a dependence between chromatin organization and dorsoventral gene expression in Drosophila?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To address this question, we need to consider the relationship between chromatin organization and gene expression patterns, specifically in the context of Drosophila development. Chromatin organization plays a crucial role in regulating gene expression by controlling access to transcriptional machinery. The dorsoventral axis in Drosophila is established through a complex interplay of signaling pathways and transcription factors. If chromatin organization influences the accessibility of regulatory elements to these transcription factors, it could indeed impact dorsoventral gene expression.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does atemoya juice inhibit the CYP1A2 enzyme?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer whether atemoya juice inhibits the CYP1A2 enzyme, we need to consider what CYP1A2 is and how various substances, including juices, can affect its activity. CYP1A2 is an enzyme that belongs to the cytochrome P450 family, playing a crucial role in the metabolism of many drugs and the bioactivation of certain carcinogens. Inhibition of this enzyme can lead to decreased metabolism of its substrates, potentially increasing their concentrations in the body and affecting their efficacy or toxicity. Atemoya is a fruit that results from the cross between annona cherimola (cherimoya) and annona squamosa (sugar apple), and like many other fruits, its juice could potentially interact with various enzymes, including CYP1A2. However, without specific studies or data indicating the effect of atemoya juice on CYP1A2, it's challenging to provide a definitive answer.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Does atemoya juice inhibit tye CYP3A4 enzyme?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Atemoya is a fruit that is a hybrid of annona and papaya, and its juice may have various effects on the body, including potential interactions with certain enzymes. The CYP3A4 enzyme is a significant enzyme in the cytochrome P450 family, playing a crucial role in the metabolism of many drugs. To determine if atemoya juice inhibits the CYP3A4 enzyme, we need to look at scientific studies or research that has investigated this specific interaction. If studies have found that compounds in atemoya juice can bind to and reduce the activity of the CYP3A4 enzyme, then it would be considered an inhibitor.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does daily atemoya juice intake change the pharmacokinetics of CYP1A2 substrates?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the potential interaction between atemoya juice and the enzyme CYP1A2, which is involved in the metabolism of various drugs. If atemoya juice affects the activity of CYP1A2, it could alter the pharmacokinetics of drugs that are substrates of this enzyme.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can bergapten cross the blood-brain barrier?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bergapten is a furanocoumarin compound found in certain plants, and its ability to cross the blood-brain barrier is a topic of interest due to its potential biological activities. The blood-brain barrier is a highly selective permeable barrier that separates the circulating blood from the brain's extracellular fluid in the central nervous system. To determine if bergapten can cross this barrier, we need to consider its chemical properties, such as molecular weight, lipophilicity, and the presence of specific transport mechanisms. Generally, lipophilic compounds with lower molecular weights are more likely to cross the blood-brain barrier. However, without specific studies or data on bergapten's pharmacokinetics and its interaction with the blood-brain barrier, it's challenging to make a definitive statement. Nonetheless, given the nature of furanocoumarins and their known biological activities, it is plausible that bergapten could cross the blood-brain barrier, especially considering the relatively small size and lipophilic nature of such compounds.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can bergapten cause phototoxicity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bergapten is a furanocoumarin compound found in certain plants, and it is known to have phototoxic properties. Phototoxicity occurs when a substance reacts with ultraviolet (UV) light, leading to cell damage and potentially causing skin reactions or other harmful effects. Bergapten can absorb UV light, which may lead to the formation of reactive oxygen species or direct DNA damage, resulting in phototoxicity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can whole genome sequencing be used for diagnosis of mitochondrial disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Whole genome sequencing can be used to identify genetic mutations associated with mitochondrial disease, which are often caused by mutations in mitochondrial DNA or nuclear DNA that affect mitochondrial function. This approach allows for the simultaneous analysis of all genes, including those related to mitochondrial function, and can help diagnose mitochondrial diseases by detecting pathogenic variants.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is AGO2 related to cytokinesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"AGO2, or Argonaute 2, is a protein involved in the RNA-induced silencing complex (RISC) and plays a crucial role in gene regulation through RNA interference (RNAi). Cytokinesis is the final stage of cell division, where the cytoplasm of a single eukaryotic cell divides to form two daughter cells. While AGO2's primary function is related to RNA interference, there is evidence suggesting that AGO2 and the RNAi pathway can influence various cellular processes, including cell cycle regulation and possibly cytokinesis, by regulating the expression of genes involved in these processes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does TIMELESS-TIPIN participate in replisome disassembly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"TIMELESS-TIPIN is a complex that plays a role in the regulation of the replisome, which is the molecular machinery responsible for DNA replication. The replisome is a dynamic structure that assembles and disassembles during the replication process. TIMELESS-TIPIN has been shown to interact with components of the replisome and influence its activity. Replisome disassembly is an important step in the replication process, as it allows for the proper termination of replication and the prevention of excessive replication. Given the role of TIMELESS-TIPIN in regulating the replisome, it is likely that it participates in replisome disassembly.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is METTL1 overexpression associated with better patient survival?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of METTL1 in patient survival. METTL1 is involved in the N6-methyladenosine (m6A) methylation of RNA, which can influence various cellular processes including cell growth, differentiation, and survival. Overexpression of METTL1 could potentially impact patient survival by altering the expression of genes involved in these processes.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Has CPX-351 been approved by the FDA and the EMA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CPX-351 is a liposomal formulation of cytarabine and daunorubicin, used for the treatment of acute myeloid leukemia. The FDA approved CPX-351 in 2017 for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplastic syndrome (MDS). The EMA also approved CPX-351 in 2018 for the treatment of adults with newly diagnosed t-AML or AML with MDS.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is REGN5458 a single-targeted antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"REGN5458 is described in some sources as a bispecific antibody, meaning it targets two different antigens or epitopes. This contrasts with single-targeted antibodies which bind to only one specific antigen or epitope. Therefore, based on its bispecific nature, REGN5458 does not fit the definition of a single-targeted antibody.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is MEDI2228 a bispecific antibody?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"MEDI2228 is being analyzed to determine if it is a bispecific antibody, which means it would bind to two different antigens or epitopes. This class of antibodies has gained significant attention for their potential in treating various diseases, including cancer, by targeting multiple pathways simultaneously. To confirm whether MEDI2228 falls into this category, specific details about its structure and function would be necessary.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is there a role for CADM1 in Myelodysplastic syndrome (MDS)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CADM1, also known as Cell Adhesion Molecule 1, is a protein that plays a role in cell adhesion and has been implicated in various cancers. Myelodysplastic syndrome (MDS) is a group of disorders caused by poorly formed or dysfunctional blood cells. Research has shown that CADM1 is involved in the regulation of hematopoiesis, which is the process by which blood cells are formed. Some studies have suggested that CADM1 may play a role in the development or progression of MDS, possibly by influencing the adhesion and homing of hematopoietic stem cells in the bone marrow. However, more research is needed to fully understand the role of CADM1 in MDS.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does UBE4B promote renal cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the role of UBE4B in renal cancer, UBE4B is a gene that encodes a protein involved in the ubiquitination pathway, which is crucial for protein degradation and regulation of various cellular processes. Some studies suggest that alterations in the ubiquitination pathway can contribute to cancer development, including renal cancer. Therefore, understanding the specific function of UBE4B in renal cancer is essential.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can IFNg induce the expression of IDO?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"IFNg, or Interferon-gamma, is a cytokine that plays a crucial role in the immune system, particularly in the activation of macrophages and the induction of various genes involved in immune responses. IDO, or Indoleamine 2,3-dioxygenase, is an enzyme that is involved in the metabolism of tryptophan and has been implicated in immune tolerance and suppression of T cell responses. The relationship between IFNg and IDO has been studied in the context of immune regulation and tolerance. IFNg is known to induce the expression of IDO in certain cell types, such as dendritic cells and macrophages, as part of its broader effects on immune response and tolerance.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Mycobacterium abscessus a human pathogen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mycobacterium abscessus is a type of bacteria that belongs to the genus Mycobacterium. It is known to cause a variety of infections, particularly in people with compromised immune systems or pre-existing lung conditions. The bacteria can lead to lung disease, skin and soft tissue infections, and other serious health issues. Given its ability to infect and cause disease in humans, it is classified as a human pathogen.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do we find bacteriophages in the gut?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Bacteriophages are viruses that infect bacteria and are found in various environments, including the human body. The gut, being a complex ecosystem with a large number of bacteria, is a potential habitat for bacteriophages. Research has shown that bacteriophages are indeed present in the gut and play a role in shaping the gut microbiome.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is NfL (neurofilament light chain) a biomarker of neurodegeneration?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"NfL, or neurofilament light chain, is a protein that is a component of the axoskeleton of neurons. Elevated levels of NfL in the cerebrospinal fluid or blood have been associated with various neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and frontotemporal dementia. The presence of NfL in bodily fluids is thought to reflect axonal damage or degeneration, making it a potential biomarker for neurodegenerative diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do the proteins Talin and Amot interact?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer whether the proteins Talin and Amot interact, we need to consider the biological functions and interactions of these proteins. Talin is known for its role in cell adhesion and the regulation of the cytoskeleton, particularly through its interaction with integrins. Amot (Angiomotin) is involved in the regulation of cellular processes such as cell migration, proliferation, and angiogenesis. The interaction between Talin and Amot could potentially influence cell adhesion, migration, and the organization of the actin cytoskeleton. Research into protein-protein interactions has shown that various proteins can interact in complex networks to regulate cellular functions. Therefore, understanding whether Talin and Amot interact requires examining specific studies or databases that catalog protein-protein interactions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is serotonin transported by platelets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Serotonin is a neurotransmitter that plays a crucial role in various bodily functions, including mood regulation, appetite, and sleep. Platelets are blood cells responsible for clotting. The relationship between serotonin and platelets involves the storage and transport of serotonin by platelets. Upon release, serotonin from platelets can contribute to various physiological and pathological processes. Therefore, considering the role of platelets in storing and releasing serotonin, it indicates that serotonin is indeed transported by these blood cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Otolin-1 a matrix protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Otolin-1 is a protein associated with the inner ear and has been studied for its role in the formation and maintenance of the otoliths, which are calcium carbonate structures in the inner ear. Matrix proteins are typically involved in the formation and structure of the extracellular matrix. Considering the function and location of Otolin-1, it is reasonable to analyze its characteristics to determine if it fits the definition of a matrix protein.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein HOXA11 associated with endometrial disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The protein HOXA11 is a homeobox gene that plays a crucial role in embryonic development and has been implicated in various diseases, including endometrial disease. Research has shown that HOXA11 is involved in the regulation of endometrial growth and differentiation, and its dysregulation has been linked to endometrial disorders such as endometriosis and endometrial cancer.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Lysozyme abundant in human tears?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Lysozyme is an enzyme found in various human secretions, including tears, saliva, and mucus. It plays a key role in the innate immune system by breaking down bacterial cell walls, thereby acting as an antimicrobial agent. The presence of lysozyme in human tears is significant because it helps protect the eyes from bacterial infections.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SMOC2 expressed during wound healing?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"SMOC2 is a gene that encodes a protein involved in various cellular processes, including cell signaling and adhesion. Wound healing is a complex process that involves the coordinated action of multiple cell types and signaling pathways. To determine if SMOC2 is expressed during wound healing, we need to consider the role of SMOC2 in tissue repair and regeneration. SMOC2 has been implicated in the regulation of cell migration, proliferation, and differentiation, which are all critical processes during wound healing.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is esophageal adenocarcinoma associated with aberrant glycosylation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Esophageal adenocarcinoma is a type of cancer that affects the esophagus, and aberrant glycosylation refers to changes in the way that carbohydrates are attached to proteins or lipids. Research has shown that many types of cancer, including esophageal adenocarcinoma, exhibit changes in glycosylation patterns. These changes can affect cell signaling, adhesion, and other processes, potentially contributing to cancer development and progression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is cytokeratin a tumor marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cytokeratins are proteins of keratin-containing intermediate filaments found in the intracytoplasmic cytoskeleton of epithelial tissue. Certain cytokeratins are used as markers for different types of epithelial tumors, such as cytokeratin 20 for gastrointestinal tumors and cytokeratin 7 for lung and breast tumors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there any R packages that help with visualizing data on spirals?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To address this question, we need to consider the availability of R packages that specialize in creating spiral visualizations. R is renowned for its extensive collection of packages that cater to various data visualization needs. A key package for creating spiral plots is the 'spirals' package, although its availability and functionality should be verified. Additionally, other general data visualization packages like 'ggplot2' could potentially be adapted for spiral plots through creative use of their plotting functions.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are there roles for cohesin mutations in AML?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Cohesin mutations have been identified in various types of cancer, including acute myeloid leukemia (AML). These mutations can disrupt the normal function of cohesin, a protein complex that plays a crucial role in chromosome segregation and DNA repair. Recent studies have investigated the role of cohesin mutations in AML, suggesting that they may contribute to the development and progression of the disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Epoxyeicosatrienoic acids (EETs) synthesized by cytochrome P450 epoxygenases from arachidonic acid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Epoxyeicosatrienoic acids (EETs) are metabolites of arachidonic acid, and their synthesis involves the cytochrome P450 enzyme family. Specifically, cytochrome P450 epoxygenases are known to catalyze the conversion of arachidonic acid into EETs.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Epistaxis associated with dental implant placement?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Epistaxis, also known as nosebleed, can be associated with various medical and surgical procedures, including those in the head and neck region. Dental implant placement involves surgical procedures in the oral cavity, which is close to the nasal cavity. There is a potential risk of bleeding during or after dental implant placement due to the proximity of the surgical site to major blood vessels and the nasal cavity. Therefore, it is plausible that epistaxis could be associated with dental implant placement, especially if the procedure involves the upper jaw, where the bone is thinner and closer to the nasal cavity.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Tregs CD4(+)CD25(+) regulatory T cells a positive regulator of the immune response?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Tregs, or regulatory T cells, are a subpopulation of T cells that play a crucial role in maintaining immune homeostasis and preventing autoimmunity. They are characterized by the expression of CD4 and CD25 markers. The primary function of Tregs is to suppress excessive or inappropriate activation of the immune system, thereby preventing damage to the body's own tissues. This suggests that Tregs are not typically considered a positive regulator of the immune response, but rather a negative regulator that helps to modulate and dampen the immune response.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Unlike DNA, RNA is not methylated, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"RNA methylation is a process by which methyl groups are added to RNA molecules, affecting their structure and function. While DNA methylation is a well-studied epigenetic modification, RNA methylation also occurs and plays important roles in various biological processes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do RNA binding Proteins  that bind to adenine uridine (AU)-rich elements (AREs) in the 5' untranslated region (UTR) of mRNAs (AU-RBPs) regulate the DNA Damage Response?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"RNA binding proteins that bind to adenine-uridine rich elements in the 3' untranslated region of mRNAs, not the 5' UTR, are known to play a role in regulating mRNA stability and translation. However, some RNA binding proteins can also influence the DNA damage response by regulating the expression of genes involved in this process. The specific role of AU-RBPs in the DNA damage response would depend on the particular proteins and mRNAs involved.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Are G-quadruplexes(G4) possible drug targets for glioblastoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"G-quadruplexes (G4) are structures of DNA or RNA that have been implicated in various biological processes, including cancer. Glioblastoma is a type of brain cancer that is aggressive and has a poor prognosis. Research has shown that G4 structures can play a role in the regulation of genes involved in cancer, including glioblastoma. Therefore, targeting G4 structures with small molecules could potentially be a therapeutic strategy for glioblastoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is CircRNA produced by back splicing of exon, intron or both, forming exon or intron circRNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CircRNA is produced through a process called back splicing, which involves the joining of a downstream donor splice site to an upstream acceptor splice site. This process can occur with exons, resulting in exon-derived circRNAs, also known as ecircRNAs, or with introns, leading to intron-derived circRNAs. The back splicing can form circRNAs that are composed of exons (exon circRNAs) or retain introns (intron circRNAs), depending on whether the introns are fully or partially removed during the splicing process.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are circRNAs susceptible to degradation by RNase R?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Circular RNAs (circRNAs) are a type of RNA that forms a covalently closed loop, which makes them distinct from linear RNAs. RNase R is an exonuclease that degrades single-stranded RNA in a 3' to 5' direction. Given the loop structure of circRNAs, they are generally resistant to degradation by RNase R because this enzyme typically requires a free 3' end to initiate degradation. Since circRNAs lack free ends, they are less susceptible to RNase R degradation compared to linear RNAs.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is RUNX1T1 associate with obesity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To answer whether RUNX1T1 is associated with obesity, we need to consider what RUNX1T1 is and its known functions. RUNX1T1, also known as RUNX1 translocation partner 1 or ETO, is a gene that encodes a protein involved in transcriptional regulation. It is well known for its role in the t(8;21) translocation associated with acute myeloid leukemia (AML). However, the question of its association with obesity requires examining if there are any studies or evidence linking RUNX1T1 to metabolic regulation, fat cell development, or energy balance, which are key aspects of obesity. Without direct evidence or studies specifically investigating RUNX1T1 in the context of obesity, it's challenging to definitively state an association.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Can FTO promote pancreatic cancer development?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The FTO gene has been associated with various diseases, including cancer. Research has shown that FTO may play a role in the development and progression of certain types of cancer, including pancreatic cancer. FTO's potential role in promoting pancreatic cancer development could be linked to its involvement in cellular processes such as cell growth, differentiation, and metabolism.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is Ameloblastoma (AB) a common benign tumor occurring in the brain?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Ameloblastoma (AB) is a type of tumor, but it is not typically associated with the brain. It is most commonly found in the jaw, specifically in the mandible or maxilla. The question asks if it is a common benign tumor occurring in the brain, which requires verification of its location and frequency.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is disruption of immune regulation mechanisms associated with adverse pregnancy outcomes, including preeclampsia (PE)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Disruption of immune regulation mechanisms can lead to various adverse pregnancy outcomes. Preeclampsia (PE) is a condition characterized by high blood pressure and often protein in the urine, occurring after the 20th week of pregnancy. It is known that immune maladaptation plays a significant role in the pathogenesis of PE. The immune system's failure to properly regulate the maternal-fetal interface can lead to inflammation and endothelial dysfunction, which are key components in the development of preeclampsia. Therefore, understanding the immune regulation mechanisms and their disruption is crucial in identifying the risk factors and potential therapeutic targets for PE and other adverse pregnancy outcomes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can METTL3 methylate long noncoding RNAs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"METTL3 is an enzyme involved in the methylation of RNA, specifically N6-methyladenosine (m6A) modification. This modification has been found in various types of RNA, including messenger RNA (mRNA), microRNA, and long noncoding RNA (lncRNA). The role of METTL3 in methylating lncRNAs suggests its involvement in regulating their functions, which can include influencing gene expression, nuclear organization, and other cellular processes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is PCAT6 a microRNA?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"PCAT6 is a long non-coding RNA, not a microRNA. MicroRNAs are small non-coding RNAs that regulate gene expression by binding to messenger RNA, whereas long non-coding RNAs like PCAT6 have various functions, including regulation of gene expression, but through different mechanisms.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can autophagy related lncRNAs be used for colorectal cancer prognosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Autophagy related lncRNAs have been studied for their potential role in cancer prognosis, including colorectal cancer. These lncRNAs can influence autophagy pathways, which are involved in cancer cell survival and death. Research has shown that certain lncRNAs can serve as biomarkers for cancer diagnosis and prognosis. Therefore, it is reasonable to consider that autophagy related lncRNAs could be used for colorectal cancer prognosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are circular RNAs implicated in diseases of the eye?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Circular RNAs have been studied for their potential roles in various diseases, including those affecting the eye. Research has indicated that circular RNAs may play a part in the pathogenesis of certain ocular diseases, suggesting their implication in diseases of the eye.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ameloblastoma (AB) a benign tumor that never metastasizes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Ameloblastoma (AB) is generally considered a benign tumor, but it can be locally aggressive. Although rare, there have been reports of ameloblastoma metastasizing, which complicates its classification as strictly benign in the traditional sense since it can, in very rare instances, spread to other parts of the body.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Acute Necrotizing Encephalopathy (ANE) which typically affects young, healthy children usually triggered by exposure to air pollution?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Acute Necrotizing Encephalopathy (ANE) is a rare but serious condition that primarily affects young, healthy children. It is characterized by brain damage and inflammation, often following a viral infection. While the exact triggers of ANE can vary, common precipitating factors include viral infections. There is limited direct evidence linking air pollution as a primary trigger for ANE, although environmental factors can influence susceptibility to infections and potentially exacerbate conditions.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is retinol binding protein 4 an adipokine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Retinol binding protein 4 (RBP4) is a protein secreted by adipocytes, which are cells in adipose tissue. Adipokines are proteins that are secreted by adipocytes and play roles in various physiological and pathological processes. Given that RBP4 is secreted by adipocytes, it can be classified as an adipokine.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do Afamin bind Vitamin E?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Afamin is a vitamin E-binding protein in human plasma. It has been identified as a specific binder of vitamin E, suggesting a role in the transport and regulation of this vitamin in the body.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is HYDIN (Hydrocephalus-inducing protein homolog) an axonemal protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"HYDIN is a protein associated with hydrocephalus, and it has been identified in the axoneme of cilia and flagella. Axonemal proteins are components of the axoneme, which is the structural core of cilia and flagella. Given that HYDIN is found in the axoneme, it suggests a role in the structure or function of cilia and flagella.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is ASF1 phopshorylated by  the Tousled-like kinases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the question about ASF1 phosphorylation by Tousled-like kinases, which are known to play roles in chromatin remodeling and DNA repair processes. ASF1 is a histone chaperone involved in nucleosome assembly and disassembly. The Tousled-like kinases have been implicated in the phosphorylation of various proteins involved in chromatin dynamics.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is paxillin affected by RANKL?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Paxillin is a protein involved in cell adhesion and signaling, while RANKL is a protein that plays a crucial role in the formation, function, and survival of osteoclasts. Research has shown that RANKL can activate various signaling pathways, including those that involve paxillin. Therefore, it is possible that paxillin is affected by RANKL.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is taxilin a cancer marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Taxilin is a protein that has been studied for its potential role in various cellular processes, including cell signaling and protein degradation. Some research has suggested that taxilin may be overexpressed in certain types of cancer, which could make it a potential marker for cancer diagnosis or prognosis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can parasite infections by Schistosoma japonicum prevent or improve asthma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Research has suggested that certain parasite infections, including those caused by Schistosoma species, may have immunomodulatory effects that could potentially influence the development or severity of allergic diseases like asthma. Schistosoma japonicum is a parasite known to cause schistosomiasis in humans. Some studies have indicated that infections with certain parasites can lead to a reduction in the incidence or severity of allergic reactions, possibly due to the parasite's ability to modulate the host's immune response, shifting it away from a Th2-dominated response, which is often associated with allergic diseases including asthma. However, it's crucial to note that this area of research is complex, and the relationship between parasite infections and allergic diseases is not fully understood. Moreover, while there might be some theoretical or observational evidence suggesting a potential beneficial effect of certain parasite infections on asthma, it is not a recommended or safe approach to intentionally infect oneself with parasites as a treatment for asthma, given the significant health risks associated with these infections.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Does sphingosine-1 phosphoate suppress epiregulin?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to understand the relationship between sphingosine-1 phosphate (S1P) and epiregulin. S1P is a signaling lipid that has various roles in cellular processes, including cell growth, survival, and migration. Epiregulin is a member of the epidermal growth factor family and is involved in cell proliferation. The interaction between S1P and epiregulin could be complex, involving multiple signaling pathways. If S1P suppresses epiregulin, it would likely do so by modulating these pathways to inhibit epiregulin's expression or activity.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is telomestatin, a novel statin drug used to treat high cholesterol?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Telomestatin is not typically classified as a statin drug, which are commonly used to treat high cholesterol. Statin drugs work by inhibiting the enzyme HMG-CoA reductase, a key component in the production of cholesterol in the liver. Telomestatin, on the other hand, is known for its ability to inhibit telomerase, an enzyme involved in the lengthening of telomeres, which are protective caps at the ends of chromosomes. This distinction in mechanism of action suggests that telomestatin is not used for treating high cholesterol but rather for its potential in cancer therapy due to its effects on telomerase activity.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Satb1 a transcription factor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Satb1, which stands for Special AT-rich sequence-binding protein 1, is known to be involved in the regulation of gene expression by binding to specific DNA sequences. It plays a role in chromatin remodeling and the modulation of transcriptional activity, which are characteristic functions of transcription factors.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is the 22-item sino-nasal outcome test (SNOT-22) a widely used measure for Health-Related Quality-of-Life (HRQOL) associated with chronic rhinosinusitis (CRS)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The SNOT-22 is a widely used patient-reported outcome measure for assessing health-related quality of life in patients with chronic rhinosinusitis. It evaluates various symptoms and their impact on daily life, making it a valuable tool for clinicians and researchers.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SOX10 expressed in melanoma cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"SOX10 is a transcription factor that plays a crucial role in the development and maintenance of melanocytes. It is often used as a marker for melanocytic lesions, including melanoma. Studies have shown that SOX10 is expressed in the majority of melanoma cells, making it a useful diagnostic tool.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is EuroQol 5-Dimension Health Assessment (EQ-5D) [a widely used, simple instrument that monitors the general health-related quality of life (HRQoL) in chronic disease] a 5 question assessment?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The EuroQol 5-Dimension Health Assessment (EQ-5D) is a widely used instrument that monitors the general health-related quality of life (HRQoL) in chronic disease. It is called the 5-Dimension because it assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three levels of severity: no problems, some problems, and extreme problems. The EQ-5D also includes a visual analog scale (VAS) to record the patient's self-rated health. Therefore, the EQ-5D is not exactly a 5 question assessment, but rather a 5 dimension assessment with an additional VAS question.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is neurofilament light marker for disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Neurofilament light chain (NfL) is a protein that is a component of the neurofilament, which is a part of the cytoskeleton in neurons. Elevated levels of NfL in the cerebrospinal fluid (CSF) or blood have been associated with various neurological diseases, including Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). The level of NfL can indicate the extent of neuronal damage or degeneration, making it a potential biomarker for these diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Phospholemman a membrane protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Phospholemman is known to be associated with the plasma membrane in various cell types, particularly in cardiac myocytes, where it plays a role in regulating the sodium-potassium pump and other ion transport processes. Its integration into the membrane is crucial for its function, indicating it is indeed a membrane protein.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Mical an oxidoreductase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Mical is known to be an oxidoreductase, specifically a flavoprotein monooxygenase, which catalyzes the post-translational modification of actin and other proteins, adding a hydroxyl group to certain residues. This enzymatic activity is characteristic of oxidoreductases, which facilitate the transfer of electrons from one molecule to another, often resulting in the reduction of one substrate and the oxidation of another.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is resistance training usually associated with increasing muscle hypertrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Resistance training is a type of exercise that involves working a muscle or group of muscles against an external load to build strength and endurance. Muscle hypertrophy refers to the increase in size of muscle fibers, which can occur as a result of resistance training. When an individual engages in resistance training, they are causing micro-tears in their muscle fibers, which then heal and adapt by growing stronger and larger. This process is a key component of muscle hypertrophy. Therefore, resistance training is indeed associated with increasing muscle hypertrophy.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is periampullary carcinoma (PAC) a relatively rare genitourinary malignancy",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Periampullary carcinoma (PAC) is a type of cancer that occurs near the ampulla of Vater, which is the area where the bile and pancreatic ducts empty into the small intestine. It is not typically classified as a genitourinary malignancy, as it arises from the digestive system rather than the genitourinary system. Genitourinary malignancies refer to cancers of the urinary tract and male and female reproductive organs. Therefore, considering the context of the question, the classification of PAC as a genitourinary malignancy is incorrect.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is pRETRO-SUPER an adenoviral vector?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"pRETRO-SUPER is a vector used in molecular biology, specifically it is based on the Moloney murine leukemia virus (MMLV) and is used for RNA interference (RNAi) experiments. It is not an adenoviral vector, which is a different type of viral vector derived from adenoviruses.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can epigenetic modifications be heritable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Epigenetic modifications refer to chemical changes to DNA or histone proteins that can affect gene expression without altering the underlying DNA sequence. These modifications can be influenced by various factors, including environmental conditions, lifestyle, and disease state. The question of whether epigenetic modifications can be heritable is complex, as it depends on the type of modification and the context in which it occurs. Some epigenetic marks can be passed on to daughter cells during cell division, and in some cases, to offspring through the germline. However, the stability and transmission of these marks across generations are still not fully understood and are the subject of ongoing research.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) increase the likelihood of severe COVID-19?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Analyzing the relationship between ACE inhibitors, ARBs, and COVID-19 severity. Several studies have investigated whether the use of ACE inhibitors and ARBs, which are commonly prescribed for hypertension and heart failure, could influence the risk or severity of COVID-19. Theoretically, there were concerns that these medications might increase the expression of ACE2, the receptor that SARS-CoV-2 uses to enter host cells, potentially enhancing the virus's ability to infect cells. However, clinical evidence and research findings have not supported the hypothesis that ACE inhibitors or ARBs increase the severity of COVID-19 or the risk of contracting the virus. Instead, many studies suggest that these medications may have neutral or even protective effects against severe COVID-19, possibly due to their beneficial effects on the cardiovascular system and their anti-inflammatory properties.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does p85Î± homodimerize?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer whether p85Î± homodimerizes, we need to consider the nature of the p85Î± protein, which is a regulatory subunit of the phosphatidylinositol 3-kinase (PI3K) enzyme. The p85Î± subunit is known to form heterodimers with the p110 catalytic subunit to create the active PI3K enzyme. However, the question of homodimerization refers to the ability of p85Î± to form dimers with itself. Research into the structural and functional properties of p85Î± would be necessary to determine if it can indeed homodimerize. Considering the specific roles and interactions of p85Î± within the cell, especially its known association with p110, any potential for homodimerization would need to be evaluated in the context of its biological function and the implications for PI3K signaling.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is thalidomide used as an immunomodulatory drug nowadays?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Thalidomide has a history of being used for its sedative properties but was withdrawn from the market due to severe side effects. However, it has been reintroduced for specific medical uses, including as an immunomodulatory drug for conditions like multiple myeloma and erythema nodosum leprosum, due to its ability to modulate the immune system.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are functional tests a good biomarker for Duchenne Muscular Dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider what biomarkers are and how they relate to Duchenne Muscular Dystrophy (DMD). Biomarkers are measurable indicators of the severity or presence of some disease state. Duchenne Muscular Dystrophy is a genetic disorder characterized by progressive muscle degeneration and weakness. Functional tests, which assess the ability of an individual to perform certain physical tasks, could potentially serve as biomarkers by measuring disease progression or the effectiveness of treatments. However, the question of whether they are 'good' biomarkers depends on their sensitivity, specificity, reliability, and how well they correlate with the underlying disease process.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, particularly influenza?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To distinguish COVID-19 clinically from other respiratory illnesses, particularly influenza, healthcare professionals consider various factors such as symptoms, patient history, and epidemiological context. Symptoms of COVID-19 can overlap significantly with those of influenza, including fever, cough, and shortness of breath. However, COVID-19 is also characterized by additional symptoms like loss of taste or smell, which can help in differentiation. Furthermore, the severity and progression of the disease can vary, with COVID-19 sometimes leading to more severe respiratory distress. Diagnostic tests, such as PCR for SARS-CoV-2 and influenza viruses, are crucial for a definitive diagnosis. Clinical judgment, combined with laboratory testing, is essential for distinguishing between these illnesses.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is lumbar puncture the first test that should be performed on a patient with increased intracranial pressure?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Lumbar puncture is a procedure that involves collecting a sample of cerebrospinal fluid to diagnose various conditions, including increased intracranial pressure. However, performing a lumbar puncture on a patient with increased intracranial pressure can be risky, as it may cause brain herniation. Typically, imaging tests such as CT or MRI scans are performed first to assess the cause of increased intracranial pressure and to rule out any space-occupying lesions. Therefore, lumbar puncture is not usually the first test performed on a patient with increased intracranial pressure.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does mutation of ARTEMIS gene causes severe combined immunodeficiency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The ARTEMIS gene is involved in the non-homologous end joining (NHEJ) pathway, which is crucial for repairing DNA double-strand breaks. Mutations in the ARTEMIS gene have been associated with severe combined immunodeficiency (SCID), a condition characterized by a severe impairment of the immune system. SCID patients with ARTEMIS mutations often have impaired V(D)J recombination, leading to defective development of T and B lymphocytes.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Cinpanemab effective for Parkinsonâ€™s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Cinpanemab is an antibody being researched for its potential in treating Parkinson's disease, specifically targeting alpha-synuclein, a protein associated with the disease. The effectiveness of Cinpanemab for Parkinson's disease is still under investigation in clinical trials.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is Prasinezumab effective for Parkinsonâ€™s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Prasinezumab is an experimental treatment for Parkinson's disease, it is a monoclonal antibody that targets alpha-synuclein, a protein implicated in the disease. While it has shown promise in early clinical trials, its effectiveness is still being researched and it has not yet been approved by regulatory authorities for the treatment of Parkinson's disease.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Does CIDEB mutation protect from liver disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CIDEB mutation has been studied for its potential impact on liver disease. The mutation affects the function of the CIDEB protein, which plays a role in lipid metabolism in the liver. Research suggests that the CIDEB mutation may influence the risk of developing certain liver conditions, such as non-alcoholic fatty liver disease (NAFLD). However, the relationship between CIDEB mutation and liver disease protection is complex and may depend on various factors, including the specific mutation, individual genetic background, and environmental influences.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between Tripe palms and cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tripe palms, also known as acanthosis palmaris or palmar keratosis, is a rare skin condition characterized by thickening of the skin on the palms. It has been associated with various conditions, including cancer. The condition is often linked to internal malignancies, particularly lung, gastric, and breast cancers. The exact mechanism of this association is not fully understood, but it is thought to be related to the body's immune response to the cancer. Therefore, the appearance of tripe palms can be a sign of an underlying cancer, and patients with this condition should undergo a thorough medical evaluation to rule out any potential malignancies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Was AAVS3 developed for hemophilia A?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"AAVS3 is a gene therapy treatment, and it was indeed developed for treating hemophilia A, which is a genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Was DNX-2401 tested for treatment of Diffuse Intrinsic Pontine Glioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"DNX-2401 is an oncolytic virus being tested for various cancer treatments, including brain tumors. Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor. The question is asking whether DNX-2401 was tested for the treatment of DIPG.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Baricitinib effective for Alopecia Areata?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Baricitinib is a medication that has been studied for its potential effectiveness in treating various autoimmune conditions, including Alopecia Areata. Research has shown that it can promote hair regrowth and improve symptoms in some patients with Alopecia Areata.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is erenumab effective for trigeminal neuralgia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Erenumab is a medication primarily used for the preventive treatment of migraine. Its effectiveness for trigeminal neuralgia, a chronic pain condition that affects the trigeminal nerve, is not well-established as its primary use. However, given its mechanism of action as a calcitonin gene-related peptide receptor antagonist, there might be some consideration for its potential in treating other types of neuropathic pain. Direct evidence or clinical trials specifically targeting trigeminal neuralgia with erenumab are necessary to determine its efficacy for this condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is alternative splicing associated with heart disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Alternative splicing is a process by which a single gene can produce multiple proteins, and it plays a crucial role in various biological processes. Research has shown that alternative splicing is associated with numerous diseases, including heart disease. Abnormal alternative splicing has been linked to cardiovascular diseases such as cardiac arrhythmias, cardiomyopathies, and atherosclerosis. For instance, alternative splicing of genes involved in cardiac ion channels and calcium handling can lead to arrhythmias, while alternative splicing of genes involved in cardiac hypertrophy and fibrosis can contribute to cardiomyopathies. Therefore, understanding the role of alternative splicing in heart disease can provide valuable insights into the development of novel therapeutic strategies.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is PRP-40 involved in microexon splicing?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"PRP-40 is a protein involved in the splicing process, specifically in the removal of introns from pre-mRNA. Microexons are small exons that are typically 3-15 nucleotides in length and are often involved in alternative splicing. Research has shown that PRP-40, along with other proteins, plays a role in the recognition and splicing of microexons.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does microexon alternative splicing of small GTPase regulators have implication in central nervous system diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Microexon alternative splicing affects the function of small GTPase regulators, which play crucial roles in various cellular processes, including those in the central nervous system. Alterations in these regulators due to microexon splicing could potentially lead to disruptions in normal cellular functions, contributing to the development or progression of central nervous system diseases.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does silencing of SRRM4 promote microexon inclusion?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of SRRM4 in the regulation of microexon inclusion. SRRM4 is a protein that has been implicated in the regulation of alternative splicing, including the inclusion of microexons. Microexons are small exons that are often skipped during alternative splicing. If SRRM4 promotes the skipping of microexons, then silencing of SRRM4 would be expected to promote microexon inclusion.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does silencing of SRRM4 inhibit tumor growth across cancers?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the role of SRRM4 in cancer. SRRM4, or serine/arginine repetitive matrix 4, is involved in RNA splicing and has been implicated in various cancers. The silencing of SRRM4 could potentially impact tumor growth by affecting splicing patterns that are crucial for cancer cell proliferation and survival. Research into specific cancers where SRRM4 has been studied would provide insights into whether its silencing consistently inhibits tumor growth across different cancer types.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Does SRRM4 regulate neuronal-specific microexon splicing of TAF1 mRNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to understand the role of SRRM4 in regulating neuronal-specific microexon splicing and its potential impact on TAF1 mRNA. SRRM4 is known to be involved in the regulation of microexon splicing in neurons, which affects the expression of various genes. TAF1 is a gene that encodes a transcription factor, and its mRNA splicing could be influenced by SRRM4.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is PRP-40 regulation of microexons a conserved phenomenon?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider what is known about PRP-40 and its role in regulating microexons. Microexons are small exons that can be included or excluded from messenger RNA transcripts during the process of alternative splicing. PRP-40, a component of the spliceosome, has been implicated in the regulation of microexon splicing. The conservation of this regulatory mechanism across different species would indicate a fundamental role in gene expression and cellular function. Given the importance of microexons in developmental and cellular processes, it is plausible that mechanisms regulating their inclusion, such as those involving PRP-40, are conserved.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does nintedanib improve response rate in patients with bladder cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Nintedanib is a small molecule tyrosine kinase inhibitor that has been investigated for its potential in treating various types of cancer, including bladder cancer. The efficacy of nintedanib in improving response rates in patients with bladder cancer would depend on clinical trial data and research findings.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Was prehospital transdermal glyceryl trinitrate effective for stroke in the RIGHT-2 trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The RIGHT-2 trial investigated the effectiveness of prehospital transdermal glyceryl trinitrate for stroke. To answer this question, we need to consider the results of the trial.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Was erythropoietin effective for optic neuritis in the TONE trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"The TONE trial investigated the efficacy of erythropoietin for treating optic neuritis. To answer this question, we need to consider the results of the trial.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can losartan reduce brain atrophy in Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Losartan is an angiotensin II receptor antagonist used primarily to treat high blood pressure. Some research has explored its potential effects on Alzheimer's disease, considering its ability to cross the blood-brain barrier and its impact on vascular health, which is relevant to the disease's progression. The question of whether losartan can reduce brain atrophy in Alzheimer's disease involves understanding the complex interplay between vascular health, neurodegeneration, and the specific mechanisms of losartan. Brain atrophy in Alzheimer's is associated with the loss of neurons and their connections, leading to a decline in cognitive function. If losartan has neuroprotective effects or can improve vascular function in the brain, it might potentially influence the rate of brain atrophy. However, the direct evidence linking losartan use with reduced brain atrophy in Alzheimer's patients would need to come from clinical trials specifically designed to assess this outcome.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is levosimendan effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Levosimendan is a calcium sensitizer that has been studied for its potential therapeutic effects in various conditions, including heart failure and amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The effectiveness of levosimendan for ALS would depend on its ability to slow disease progression, improve muscle strength, or enhance survival rates. Research into the use of levosimendan for ALS has been conducted, but the outcomes and its efficacy for this specific condition need to be evaluated based on clinical trial data and scientific evidence.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Should be used bexarotene for relapsing-remitting multiple sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Bexarotene is a medication primarily used for the treatment of cutaneous T-cell lymphoma. Its use in relapsing-remitting multiple sclerosis (RRMS) is not a standard or widely recommended practice. The primary treatments for RRMS include disease-modifying therapies such as interferons, glatiramer acetate, and several oral and infused medications. The decision to use any medication for MS should be based on evidence of its efficacy and safety for this specific condition, and bexarotene's efficacy and safety for MS are not well-established.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can Efgartigimod be used for myasthenia gravis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Efgartigimod is an antibody that targets the neonatal Fc receptor, which is involved in the regulation of IgG antibodies. Myasthenia gravis is an autoimmune disease characterized by the production of autoantibodies against the acetylcholine receptor at the neuromuscular junction. The use of efgartigimod for myasthenia gravis is based on its ability to reduce the levels of these autoantibodies by blocking the neonatal Fc receptor, potentially leading to an improvement in symptoms. Clinical trials have been conducted to evaluate the efficacy and safety of efgartigimod in patients with myasthenia gravis.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Based on clinical trial data, can pioglitazone delay cognitive impairment for people at risk for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analyzing the effects of pioglitazone on cognitive impairment in individuals at risk for Alzheimer's disease based on clinical trial data.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is Tilavonemab effective for progressive supranuclear palsy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Tilavonemab is an antibody being researched for its potential in treating progressive supranuclear palsy (PSP), a rare brain disorder. The effectiveness of Tilavonemab for PSP is still under investigation, with clinical trials aiming to assess its efficacy and safety. As of my last update, there isn't conclusive evidence to definitively state its effectiveness for this condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is ocrelizumab effective for primary progressive multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Ocrelizumab is a medication used to treat multiple sclerosis. Primary progressive multiple sclerosis is a type of MS characterized by worsening symptoms from the start, without distinct relapses. Clinical trials have shown that ocrelizumab can slow disease progression in primary progressive MS.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is deucravacitinib effective for psoriasis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor that has been studied for its efficacy in treating psoriasis. Clinical trials have shown that deucravacitinib is effective in improving symptoms of psoriasis, including reducing the severity of plaques and improving quality of life. The drug has been compared to placebo and other treatments, such as apremilast, and has demonstrated significant improvements in psoriasis area and severity index (PASI) scores.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is daridorexant effective for insomnia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Daridorexant is a dual orexin receptor antagonist that has been studied for its efficacy in treating insomnia. Clinical trials have shown that it can improve sleep onset and maintenance, as well as reduce symptoms of insomnia.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is tebentafusp effective for uveal melanoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Tebentafusp is an immunotherapy drug that targets gp100, a protein expressed by melanoma cells. It has been investigated as a potential treatment for uveal melanoma, a type of cancer that arises from the pigment cells of the eye. Clinical trials have evaluated the efficacy of tebentafusp in patients with metastatic uveal melanoma.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can lenacapavir be used for HIV?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Lenacapavir is an antiretroviral medication used in combination with other medications to treat HIV-1 infection. It works by inhibiting the capsid protein of the virus, which is essential for the virus to replicate. The medication has shown efficacy in clinical trials and has been approved for use in certain countries.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Wilson's disease described as an iron storage disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Wilson's disease is actually described as a copper storage disease, not an iron storage disease. It is a genetic disorder characterized by excessive accumulation of copper in the body, particularly in the liver, brain, and other vital organs.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is medical hydrology the same as Spa therapy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Medical hydrology and spa therapy share similarities in using water for therapeutic purposes, but they may have different focuses and approaches. Medical hydrology is a broader field that encompasses the use of water for medical treatment, prevention, and rehabilitation, often under medical supervision. Spa therapy, on the other hand, typically involves the use of water and other spa treatments for relaxation, wellness, and aesthetic purposes. While there can be overlap, they are not exactly the same.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is North Star Ambulatory Assessment score a reliable clinical outcome for disease progression assessment in Duchenne Muscular Dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The North Star Ambulatory Assessment (NSAA) score is a clinical outcome measure used to assess the progression of Duchenne Muscular Dystrophy (DMD) in patients. It evaluates the patient's ability to perform various physical activities, such as walking, running, and rising from the floor. The reliability of the NSAA score as a clinical outcome measure for disease progression assessment in DMD has been studied in several research studies. These studies have shown that the NSAA score is a reliable and sensitive measure of disease progression in DMD patients, as it can detect changes in muscle function and mobility over time.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can modulation of KCNQ1 splicing prevent arrhythmias?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Modulation of KCNQ1 splicing has been studied for its potential to prevent arrhythmias, as KCNQ1 is a gene that codes for a potassium channel subunit important in heart function. Abnormalities in KCNQ1, including splicing variants, have been associated with arrhythmias. Therefore, modifying or correcting the splicing of KCNQ1 could theoretically prevent or reduce the incidence of arrhythmias by ensuring proper potassium channel function.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can the concept of digital twins be applied in Precision Nutrition?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The concept of digital twins can be applied in various fields, including healthcare and nutrition. In Precision Nutrition, digital twins could potentially be used to create personalized models of an individual's nutritional needs and responses, allowing for tailored dietary recommendations and interventions. This could involve using data from various sources, such as genetic information, health records, and wearable devices, to create a virtual replica of an individual's nutritional profile.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is prosopagnosia also known as lack of auditory recognition?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Prosopagnosia is a condition where a person has difficulty recognizing faces, but the question asks about lack of auditory recognition. This suggests a mix-up with another condition, possibly auditory agnosia, which involves difficulty recognizing sounds or auditory information.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do cells undergoing necroptosis show disruption of their cell membranes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Necroptosis is a form of programmed cell death that is characterized by the disruption of the cell membrane, leading to the release of cellular contents and inflammation. In contrast to apoptosis, which is another form of programmed cell death, necroptosis involves the loss of membrane integrity and the uncontrolled release of cellular components.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Iron deficiency anemia a common complication of chronic kidney disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Iron deficiency anemia is often associated with chronic kidney disease due to various factors such as decreased erythropoietin production, blood loss during dialysis, and inflammation. These factors contribute to the development of anemia in patients with chronic kidney disease.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Anemia is not associated with chronic kidney failure",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Anemia is often associated with chronic kidney failure due to the decreased production of erythropoietin by the kidneys, which is essential for red blood cell production. Chronic kidney disease can lead to a reduction in erythropoietin production, resulting in anemia.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is anaphylaxis a results of mast cell activation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Anaphylaxis is a severe, potentially life-threatening allergic reaction that can occur within minutes of exposure to an allergen. It involves the release of mediators from mast cells, which are a type of immune system cell. When mast cells are activated, they release histamine and other chemical mediators, leading to increased vascular permeability, smooth muscle contraction, and other systemic effects. Therefore, anaphylaxis is indeed a result of mast cell activation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is trichotillomania encountered with equali frequency in males and females?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Trichotillomania is a psychological disorder characterized by a recurring and irresistible urge to pull out one's own hair, resulting in noticeable hair loss. Research suggests that the frequency of trichotillomania may vary between males and females, with some studies indicating that it is more common in females. However, the exact frequency and prevalence of trichotillomania in males and females can depend on various factors, including the population being studied and the diagnostic criteria used.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can skin picking phenotype present following methylphenidate treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Methylphenidate is a central nervous system stimulant commonly used to treat attention deficit hyperactivity disorder (ADHD). Skin picking, also known as dermatillomania or excoriation disorder, is a psychological condition characterized by repetitive and compulsive picking at one's own skin. The relationship between methylphenidate treatment and the onset or exacerbation of skin picking behaviors can be complex and may involve various factors, including individual susceptibility, dosage, and the presence of underlying psychological conditions. There have been reports and studies suggesting that certain medications, including stimulants like methylphenidate, may trigger or worsen symptoms of skin picking in some individuals.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Optogenetics refers to the study of gene expression optimization",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Optogenetics is a field of study that involves the use of light to control cells within living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. It does not directly refer to the study of gene expression optimization, although gene expression is a crucial step in the process of making cells responsive to light.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Have chimeric antigen receptor (CAR)-T cell therapies been approved for the treatment of B cell malignancies?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Chimeric antigen receptor (CAR)-T cell therapies have shown significant promise in treating various types of cancer, including B cell malignancies. The question asks whether these therapies have been approved for the treatment of B cell malignancies. To answer this, we need to consider the current state of CAR-T cell therapy approvals.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is deflazacort more efficient than prednisone/prednisolone for the treatment of Duchenne muscular dystrophy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Deflazacort and prednisone/prednisolone are corticosteroids used in the treatment of Duchenne muscular dystrophy (DMD). The efficiency of these drugs can depend on various factors including patient response, side effect profiles, and dosing regimens. Studies have compared the efficacy and safety of deflazacort to prednisone/prednisolone in DMD patients, considering outcomes such as muscle strength, functional abilities, and side effects. The choice between deflazacort and prednisone/prednisolone may also be influenced by regulatory approvals, availability, and individual patient characteristics.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is casimersen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Casimersen is an antisense oligonucleotide drug designed to treat Duchenne muscular dystrophy (DMD) by skipping exon 45 of the dystrophin gene, aiming to restore the production of a functional dystrophin protein. Its effectiveness is based on clinical trials and research studies that have shown it can improve or stabilize dystrophin production in patients with DMD amenable to exon 45 skipping. However, the effectiveness can vary among patients depending on several factors including the specific mutation in the dystrophin gene, the stage of the disease, and individual patient response to the treatment.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is viltolarsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Viltolarsen is an exon-skipping therapy that has been studied for the treatment of Duchenne muscular dystrophy (DMD). It targets exon 53 of the dystrophin gene, which is mutated in some patients with DMD. Clinical trials have shown that viltolarsen can increase dystrophin production and improve muscle function in patients with DMD amenable to exon 53 skipping. The US FDA has approved viltolarsen for the treatment of DMD in patients with a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is golodirsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Golodirsen is an antisense oligonucleotide drug designed to treat Duchenne muscular dystrophy (DMD) by skipping exon 53 in the dystrophin gene, allowing for the production of a truncated but functional dystrophin protein. Its effectiveness is based on clinical trials and research studies that have shown it can improve dystrophin production and slow disease progression in some patients with DMD amenable to exon 53 skipping.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is eteplirsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Eteplirsen is a drug used to treat Duchenne muscular dystrophy, specifically for patients with a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping. Its effectiveness has been evaluated in clinical trials, which have shown that it can help slow the progression of the disease by increasing dystrophin production in muscle cells.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is SARS-CoV-2 transmitted through breast milk?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Current research suggests that the transmission of SARS-CoV-2 through breast milk is highly unlikely. Studies have found that breast milk from mothers with COVID-19 has not contained the live virus, although some have detected viral RNA. However, the presence of viral RNA does not necessarily indicate the presence of live, infectious virus. The World Health Organization and other health authorities have stated that the benefits of breastfeeding outweigh the potential risks of COVID-19 transmission through breast milk, and recommend that mothers with COVID-19 continue to breastfeed, taking appropriate precautions to prevent transmission through respiratory droplets.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do machine learning-based methods outperform statistical methods for survival analysis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the characteristics and performance of both machine learning-based methods and statistical methods in the context of survival analysis. Survival analysis is a branch of statistics that deals with the analysis of time-to-event data, which can be used to predict the probability of survival or the time of occurrence of a specific event. Machine learning-based methods have gained popularity in recent years due to their ability to handle complex and high-dimensional data. On the other hand, statistical methods have been widely used for survival analysis and provide a well-established framework for modeling and interpreting time-to-event data.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Does iron regulate oligodendrocyte maturation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Iron is an essential mineral that plays a crucial role in various biological processes, including the development and maintenance of the central nervous system. Oligodendrocytes are a type of glial cell responsible for myelinating neurons, facilitating the transmission of electrical signals. Research has shown that iron is involved in the regulation of oligodendrocyte maturation, as it is required for the synthesis of myelin and the maintenance of oligodendrocyte health. Iron deficiency has been linked to impaired oligodendrocyte maturation and myelination, highlighting the importance of iron in this process.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are LOQ and LOD the same?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"LOQ (Limit of Quantitation) and LOD (Limit of Detection) are related but distinct concepts in analytical chemistry. LOQ refers to the lowest concentration of a substance that can be quantitatively determined with a specified degree of accuracy and precision, whereas LOD refers to the lowest concentration of a substance that can be detected, but not necessarily quantified.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can Amyotrophic Lateral Sclerosis (ALS) be associated with a mutation of the Super Oxide Dismutase 1 (SOD) gene?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, and research has identified several genetic mutations associated with the disease. One of the genes implicated in ALS is the SOD1 gene, which encodes for the enzyme superoxide dismutase 1. Mutations in the SOD1 gene have been shown to cause familial ALS, a rare inherited form of the disease. The mutation leads to the production of a toxic form of the SOD1 protein, which accumulates in motor neurons and causes their degeneration.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Have Quercetin-biapigenin nanoparticles been shown to be effective in penetrating the blood-brain barrier",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Quercetin-biapigenin nanoparticles have been studied for their potential to penetrate the blood-brain barrier, which is a significant challenge in treating neurological disorders. The effectiveness of these nanoparticles in crossing the blood-brain barrier would depend on various factors, including their size, surface charge, and composition. Research in this area is ongoing, and some studies suggest that certain nanoparticles can indeed penetrate the blood-brain barrier, but more research is needed to confirm the efficacy and safety of Quercetin-biapigenin nanoparticles specifically.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is OXLUMO (lumasiran) used for the treatment of primary hyperoxaluria?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"OXLUMO, also known as lumasiran, is an RNA interference therapeutic used for the treatment of primary hyperoxaluria type 1.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can untranslated regions (UTRs) regulate gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Untranslated regions (UTRs) are segments of a gene that are not translated into protein. They are located at the 5' and 3' ends of a mature mRNA molecule. UTRs can regulate gene expression by influencing mRNA stability, localization, and translation efficiency. They can also contain regulatory elements, such as binding sites for microRNAs or RNA-binding proteins, which can modulate gene expression. Therefore, UTRs play a crucial role in the regulation of gene expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can the epigenetic status of introns affect gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Epigenetic modifications can influence gene expression by altering chromatin structure and recruiting regulatory proteins. Introns, the non-coding regions of genes, can also be subject to epigenetic modifications. These modifications may affect the inclusion or exclusion of introns during RNA splicing, thereby influencing the final mRNA product and ultimately gene expression.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, such as influenza?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"COVID-19 and other respiratory illnesses like influenza share similar symptoms, making clinical distinction challenging without laboratory confirmation. Symptoms such as fever, cough, and shortness of breath are common to many respiratory infections. However, specific combinations of symptoms, the severity of the illness, and the presence of other signs such as loss of taste or smell might help in suspecting COVID-19. Nonetheless, definitive diagnosis relies on laboratory tests like PCR or antigen tests.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is COVID-19 caused by the Omicron variant less severe than infection caused by other variants?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Research suggests that the Omicron variant of COVID-19 may cause less severe illness compared to other variants, such as Delta. Studies have shown that Omicron tends to result in milder symptoms and lower hospitalization rates. However, it's essential to note that the severity of COVID-19 can depend on various factors, including the individual's overall health, vaccination status, and age.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Should patients using inhaled glucocorticoids for asthma or COPD be advised to stop these medications to prevent COVID-19?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Patients using inhaled glucocorticoids for asthma or COPD should continue their prescribed medication as stopping it could lead to worsening of their respiratory condition. The decision to stop or modify any medication should be made in consultation with a healthcare provider, considering the individual's health status and the current COVID-19 guidelines. Inhaled glucocorticoids are crucial for managing inflammation and preventing exacerbations in asthma and COPD. There is no conclusive evidence to suggest that inhaled glucocorticoids increase the risk of COVID-19 or its severity. Therefore, advising patients to stop these medications solely to prevent COVID-19 is not recommended without a thorough medical evaluation.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is adenosine methylation an epigenetic modification?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Adenosine methylation refers to the process of adding a methyl group to adenosine, a nucleoside found in RNA. Epigenetic modifications are heritable changes in gene function that occur without a change in the underlying DNA sequence. Considering this, adenosine methylation can indeed influence gene expression and is a type of epigenetic modification.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can analgesics or antipyretics be taken for side effects following COVID-19 vaccination?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Analgesics or antipyretics can be considered for managing side effects such as pain or fever following COVID-19 vaccination, but it's essential to follow specific guidelines and consult healthcare professionals for personalized advice.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Are Luminopsins a fusion proteins of luminol and Rhodopsin ?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Luminopsins are a type of optogenetic tool that combines the light-sensitive properties of rhodopsin with the ability to produce light through a chemical reaction, but they are not a direct fusion of luminol and rhodopsin. Instead, they are engineered proteins that allow for the optical control of cellular processes.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "In twin-twin transfusion syndrome, are the twins identical?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Twin-twin transfusion syndrome is a condition that occurs in identical twin fetuses who share a common placenta, leading to an unequal exchange of blood between the two fetuses.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Zanubrutinib a first-generation BTK inhibitor approved by US Food and Drug Administration (FDA)?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Zanubrutinib is a BTK inhibitor, and it has been approved by the FDA. To answer this question, we need to determine if it is a first-generation BTK inhibitor. First-generation BTK inhibitors include Ibrutinib. Zanubrutinib is actually a second-generation BTK inhibitor.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Can CRISPR/Cas12a be used for the detection of EGFR mutations in circulating DNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"CRISPR/Cas12a is a powerful tool for detecting specific DNA sequences, and EGFR mutations are a common target for non-invasive diagnostics using circulating DNA. The CRISPR/Cas12a system can be programmed to recognize and cleave specific sequences, including those associated with EGFR mutations. This makes it a promising approach for detecting these mutations in circulating DNA.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is Functional Neurological Disorder (FND) classified as a psychosomatic disorder?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Functional Neurological Disorder (FND) is a condition where there are neurological symptoms that cannot be explained by any other medical condition. It is characterized by a range of symptoms including weakness, movement disorders, and gait problems. The classification of FND has evolved over time, and it is now recognized as a neurological disorder rather than a psychosomatic disorder. However, the exact cause of FND is still not fully understood, and it is believed that psychological factors may play a role in its development. Historically, FND was often misclassified as a psychosomatic disorder, also known as a conversion disorder, which implies that the symptoms are caused by psychological distress. However, this classification is no longer widely accepted, and FND is now recognized as a distinct neurological condition.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are any medications available to prevent COVID-19 following exposure?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"To answer this question, we need to consider the current medical understanding and treatments available for COVID-19, specifically focusing on post-exposure prophylaxis (PEP) which refers to preventive measures taken after exposure to a disease to prevent the development of the disease. Several medications and treatments have been studied or are in use for COVID-19 prevention and treatment, including antiviral drugs and monoclonal antibodies. The key is identifying which of these, if any, are approved or recommended for use after exposure to prevent the onset of COVID-19.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Can reinfection occur after SARS-CoV-2 infection?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Reinfection refers to the phenomenon where an individual becomes infected with the same virus or pathogen after having previously recovered from an initial infection. For SARS-CoV-2, the virus responsible for COVID-19, there have been reports and studies indicating that reinfection can occur, although the frequency and circumstances under which this happens are subjects of ongoing research. Factors such as the immune response generated by the initial infection, the presence of variants of the virus, and the level of immunity conferred by vaccination or natural infection play significant roles in determining the likelihood of reinfection.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can other vaccines be given with COVID-19 vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"The COVID-19 vaccine can be co-administered with other vaccines, but the decision to do so should be made on a case-by-case basis, taking into account the individual's health status, age, and other factors. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have provided guidance on the co-administration of COVID-19 vaccines with other vaccines.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is omaveloxolone a suppressor of Nrf2?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Omaveloxolone is an investigational drug that has been studied for its potential therapeutic effects. One of its mechanisms of action is related to the activation of Nrf2, a transcription factor that plays a crucial role in cellular defense mechanisms. Nrf2 activation leads to the upregulation of various antioxidant and detoxification genes, which can help protect cells against oxidative stress and damage. Given this context, it seems that omaveloxolone acts as an activator rather than a suppressor of Nrf2.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Is omaveloxolone an activator of NFkB?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Omaveloxolone is a small molecule that has been investigated for its potential therapeutic effects. To determine if it is an activator of NFkB, we need to consider what NFkB is and how omaveloxolone interacts with it. NFkB is a protein complex that controls DNA transcription and cell survival, playing a key role in immune responses and inflammation. Omaveloxolone, also known as RTA 408, has been studied for its anti-inflammatory and antioxidant properties. It is designed to activate Nrf2, a transcription factor that regulates the expression of antioxidant proteins, but its effect on NFkB needs to be specifically considered. If omaveloxolone inhibits or modulates NFkB activity, it could have implications for its use in treating inflammatory diseases. However, the direct question of whether omaveloxolone is an activator of NFkB requires specific knowledge of its mechanism of action on this particular pathway.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Has RTA 408 received FDA approval?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"RTA 408 is an experimental drug, and its approval status needs to be checked with the FDA for the most current information.\", \"answer\": \"no\"}",
    "correct": false
  },
  {
    "question": "Can salivary cortisol be used to evaluate pain in neonates?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Salivary cortisol has been studied as a potential biomarker for pain assessment in neonates, as it is a non-invasive and relatively easy to collect sample. Research has shown that cortisol levels can increase in response to painful stimuli in neonates. However, the relationship between salivary cortisol and pain is complex and can be influenced by various factors, such as the type and duration of pain, as well as individual differences in cortisol response.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Can breastfeeding be used to alleviate the procedural pain in neonates?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Breastfeeding has been studied as a method to reduce procedural pain in neonates, with research indicating that it can have a positive effect on pain relief due to the release of endogenous opioids and the comforting, calming presence of the mother.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Is music therapy effective for pain management in neonates?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Music therapy has been studied as a potential method for pain management in various populations, including neonates. Research indicates that music therapy can have a positive impact on pain reduction and stress alleviation in newborns. Studies have shown that music therapy can decrease pain responses and improve physiological stability in neonates undergoing painful procedures. The effectiveness of music therapy for pain management in neonates is supported by evidence suggesting its ability to reduce pain and promote comfort.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Is there any treatment for the Facioscapulohumeral Muscular Dystrophy?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic disorder that affects the muscles of the face, shoulder blades, and upper arms. While there is no cure for FSHD, various treatments can help manage its symptoms and slow down disease progression. These treatments may include physical therapy, occupational therapy, speech therapy, and the use of orthotics and other assistive devices. In some cases, surgery may be necessary to correct skeletal deformities or improve mobility. Researchers are also exploring potential therapeutic approaches, such as gene therapy and pharmacological interventions, to target the underlying causes of FSHD.\", \"answer\": \"yes\"}",
    "correct": false
  },
  {
    "question": "Are there any other types of Spinal Muscular Atrophy except for types 1-4?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Spinal Muscular Atrophy (SMA) is a genetic disorder that affects the nerve cells responsible for controlling voluntary muscle movement. The most common classification of SMA includes types 1-4, which are distinguished by the age of onset and the severity of symptoms. However, there are other forms of SMA, such as SMA type 0, which is a very severe form that affects infants in utero or at birth, and other rare forms like SMA with respiratory distress type 1 (SMARD1), which is caused by a different genetic mutation.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do all proteins start with methionine?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"In eukaryotic cells, protein synthesis typically begins with the amino acid methionine, which serves as the start codon. However, in prokaryotic cells, the start codon is usually formylmethionine. Considering these facts, it can be determined whether all proteins start with methionine.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Do epigenetic changes change the DNA sequence?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Epigenetic changes involve chemical modifications to DNA or histone proteins, which affect gene expression without altering the underlying DNA sequence. These changes can remain through cell divisions for the remainder of the cell's life and may last for multiple generations. However, they do not change the sequence of nucleotides in the DNA itself.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are epigenetic changes heritable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\": \"Epigenetic changes refer to chemical modifications to DNA or histone proteins that can affect gene expression without altering the underlying DNA sequence. These changes can be influenced by various factors, including environmental conditions, lifestyle, and disease state. The question of whether epigenetic changes are heritable is complex, as it depends on the type of epigenetic mark and the context in which it occurs. Some epigenetic changes can be reversed or removed during cell division, while others may be more stable and potentially heritable. Research has shown that certain epigenetic marks can be inherited through cell division, and in some cases, even transmitted to offspring. However, the extent to which epigenetic changes are heritable and can influence the development and traits of subsequent generations is still a topic of ongoing research and debate.\", \"answer\": \"yes\"}",
    "correct": true
  },
  {
    "question": "Do enhancers have to be close to their gene targets?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"Enhancers are short segments of DNA that, when bound with appropriate proteins, can significantly increase or enhance the transcription of a gene. They can be located upstream, downstream, or even within introns of the genes they regulate. The question of whether enhancers need to be close to their gene targets is complex because, although proximity can facilitate interaction, enhancers can also act over long distances due to the looping of chromatin, bringing the enhancer close to the promoter region of the target gene. This looping allows for the interaction between enhancers and promoters regardless of their linear distance on the chromosome.\", \"answer\": \"no\"}",
    "correct": true
  },
  {
    "question": "Are accessible enhancers necessarily active?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\": \"To determine if accessible enhancers are necessarily active, we must consider the definitions and roles of both accessibility and activity in the context of enhancers. Enhancers are short segments of DNA that, when bound with appropriate proteins, can significantly increase or enhance the transcription of a gene. Accessibility refers to the openness of the chromatin structure, allowing regulatory proteins to bind. Activity, on the other hand, refers to the actual enhancement of gene transcription. While accessibility is a prerequisite for enhancer activity, not all accessible enhancers are actively enhancing gene transcription at any given time. Various factors, including the presence of specific transcription factors, the chromatin environment, and cellular signals, determine whether an accessible enhancer is active.\", \"answer\": \"no\"}",
    "correct": true
  }
]